_unit_id,_created_at,_canary,_id,_started_at,_channel,_trust,_worker_id,_country,_region,_city,_ip,b1,b2,confirmids1,confirmids2,e1,e2,factor1,factor2,firstfactor,saveselectionids1,saveselectionids2,secondfactor,sentence,wordid1,wordid2,orig_b1,orig_b2,orig_e1,orig_e2,expertdecision,relation,sent_id,orig_sentence,term1,term2
502540464,7/12/2014 00:00:53,,1321078555,7/12/2014 00:00:36,clixsense,1,27871219,NLD,07,Amsterdam,87.210.207.223,91,37,,,118,49,POSTMENOPAUSAL OSTEOPOROSIS,TERIPARATIDE,"POSTMENOPAUSAL OSTEOPOROSIS,",91-106,24-37,subcutaneous TERIPARATIDE,"Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis.",91 106,37,91,37,118,49,1,RO-may_treat,908089,"Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis",postmenopausal osteoporosis,teriparatide
502540464,7/12/2014 00:06:15,,1321081751,7/12/2014 00:05:51,clixsense,1,19803139,NLD,11,Leiden,82.139.76.131,91,37,,,118,49,POSTMENOPAUSAL OSTEOPOROSIS,TERIPARATIDE,"POSTMENOPAUSAL OSTEOPOROSIS,",91-106,37,TERIPARATIDE,"Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis.",91 106,37,91,37,118,49,1,RO-may_treat,908089,"Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis",postmenopausal osteoporosis,teriparatide
502540464,7/12/2014 00:17:27,,1321088498,7/12/2014 00:17:15,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,91,37,,,118,49,POSTMENOPAUSAL OSTEOPOROSIS,TERIPARATIDE,"POSTMENOPAUSAL OSTEOPOROSIS,",91-106,37,TERIPARATIDE,"Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis.",91 106,37,91,37,118,49,1,RO-may_treat,908089,"Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis",postmenopausal osteoporosis,teriparatide
502540464,7/12/2014 00:19:28,,1321089549,7/12/2014 00:19:15,neodev,1,15848372,AUS,02,Jannali,27.96.208.89,91,37,,,118,49,POSTMENOPAUSAL OSTEOPOROSIS,TERIPARATIDE,"POSTMENOPAUSAL OSTEOPOROSIS,",91-106,24-37,subcutaneous TERIPARATIDE,"Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis.",91 106,37,91,37,118,49,1,RO-may_treat,908089,"Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis",postmenopausal osteoporosis,teriparatide
502540464,7/12/2014 00:26:54,,1321093594,7/12/2014 00:26:38,instagc,1,13763729,USA,"","",75.182.89.225,91,37,,,118,49,POSTMENOPAUSAL OSTEOPOROSIS,TERIPARATIDE,"POSTMENOPAUSAL OSTEOPOROSIS,",91-106,37,TERIPARATIDE,"Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis.",91 106,37,91,37,118,49,1,RO-may_treat,908089,"Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis",postmenopausal osteoporosis,teriparatide
502540464,7/12/2014 00:28:08,,1321094174,7/12/2014 00:27:43,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,91,37,,,118,49,POSTMENOPAUSAL OSTEOPOROSIS,TERIPARATIDE,"POSTMENOPAUSAL OSTEOPOROSIS,",91-106,37,TERIPARATIDE,"Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis.",91 106,37,91,37,118,49,1,RO-may_treat,908089,"Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis",postmenopausal osteoporosis,teriparatide
502540464,7/12/2014 00:29:13,,1321094694,7/12/2014 00:29:01,instagc,1,15445601,USA,FL,Jacksonville,24.129.68.254,91,37,,,118,49,POSTMENOPAUSAL OSTEOPOROSIS,TERIPARATIDE,"POSTMENOPAUSAL OSTEOPOROSIS,",91-106,24-37,subcutaneous TERIPARATIDE,"Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis.",91 106,37,91,37,118,49,1,RO-may_treat,908089,"Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis",postmenopausal osteoporosis,teriparatide
502540464,7/12/2014 00:29:52,,1321095038,7/12/2014 00:29:27,instagc,1,18531561,CAN,ON,Mississauga,99.229.185.45,91,37,,,118,49,POSTMENOPAUSAL OSTEOPOROSIS,TERIPARATIDE,"POSTMENOPAUSAL OSTEOPOROSIS,",91-106,24-37,subcutaneous TERIPARATIDE,"Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis.",91 106,37,91,37,118,49,1,RO-may_treat,908089,"Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis",postmenopausal osteoporosis,teriparatide
502540464,7/12/2014 00:33:01,,1321096742,7/12/2014 00:32:20,instagc,1,19686223,CAN,BC,Surrey,184.65.16.6,91,37,,,118,49,POSTMENOPAUSAL OSTEOPOROSIS,TERIPARATIDE,"subcutaneous teriparatide 20 microg day in women with POSTMENOPAUSAL OSTEOPOROSIS, men with idiopathic hypogonadal osteoporosis patients with glucocorticoid induced osteoporosis.",24-37-50-53-60-77-80-86-91-106-120-124-129-143-155-172-186-201-209-181,13-19-24-37-50-53-60-80-86-91-106-124-129-172-181-186-201-209-120,"shown that subcutaneous TERIPARATIDE 20 microg day women with postmenopausal osteoporosis, men with idiopathic patients with glucocorticoid induced osteoporosis.","Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis.",91 106,37,91,37,118,49,1,RO-may_treat,908089,"Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis",postmenopausal osteoporosis,teriparatide
502540464,7/12/2014 00:40:13,,1321100165,7/12/2014 00:39:54,eup_slw,1,19200983,USA,WA,Renton,63.224.47.154,91,37,,,118,49,POSTMENOPAUSAL OSTEOPOROSIS,TERIPARATIDE,"POSTMENOPAUSAL OSTEOPOROSIS,",91-106,24-37,subcutaneous TERIPARATIDE,"Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis.",91 106,37,91,37,118,49,1,RO-may_treat,908089,"Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis and patients with glucocorticoid-induced osteoporosis",postmenopausal osteoporosis,teriparatide
502540465,7/11/2014 23:56:57,,1321076653,7/11/2014 23:56:39,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,137,158,,,142,163,GROUP,LUPUS,GROUP,137,149-158-164,systemic LUPUS erythematosus,"We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake.",137,158,137,158,142,163,-1,RO-cause_of,900425,"We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake",group,lupus
502540465,7/12/2014 00:13:53,,1321086368,7/12/2014 00:12:02,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,137,158,,,142,163,GROUP,LUPUS,"the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a GROUP of 40 systemic lupus erythematosus (SLE) patients, correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake.",28-32-43-46-56-70-76-79-88-98-106-112-115-120-126-132-135-137-143-146-149-158-164-178-184-198-209-213-221-226-232-238-255-264-269-273-280-284-290-305-310,28-32-43-46-56-70-76-79-88-98-106-112-115-120-126-149-158-164-184-198-213-221-226-232-238-255-264-269-273-280-284-290-305-310,"the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs systemic LUPUS erythematosus patients, correlated results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake.","We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake.",137,158,137,158,142,163,-1,RO-cause_of,900425,"We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake",group,lupus
502540465,7/12/2014 00:23:13,,1321091679,7/12/2014 00:23:08,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,137,158,,,142,163,GROUP,LUPUS,limbs in a GROUP of 40 systemic,126-132-135-137-143-146-149,143-146-149-158-164-184,"of 40 systemic LUPUS erythematosus patients,","We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake.",137,158,137,158,142,163,-1,RO-cause_of,900425,"We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake",group,lupus
502540465,7/12/2014 00:23:34,,1321091906,7/12/2014 00:22:54,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,137,158,,,142,163,GROUP,LUPUS,GROUP,137,158,LUPUS,"We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake.",137,158,137,158,142,163,-1,RO-cause_of,900425,"We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake",group,lupus
502540465,7/12/2014 00:25:28,,1321092870,7/12/2014 00:24:11,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,137,158,,,142,163,GROUP,LUPUS,lower limbs in a GROUP,120-126-132-137-135,149-158-164,systemic LUPUS erythematosus,"We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake.",137,158,137,158,142,163,-1,RO-cause_of,900425,"We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake",group,lupus
502540465,7/12/2014 00:26:00,,1321093133,7/12/2014 00:25:18,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,137,158,,,142,163,GROUP,LUPUS,"GROUP of 40 systemic lupus erythematosus (SLE) patients,",137-143-146-149-158-164-178-184,137-146-149-158-164-178-184-143,"group of 40 systemic LUPUS erythematosus (SLE) patients,","We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake.",137,158,137,158,142,163,-1,RO-cause_of,900425,"We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake",group,lupus
502540465,7/12/2014 00:34:43,,1321097566,7/12/2014 00:34:21,bitcoinget,1,24792414,USA,"","",166.181.81.197,137,158,,,142,163,GROUP,LUPUS,GROUP,137,149-158-164,systemic LUPUS erythematosus,"We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake.",137,158,137,158,142,163,-1,RO-cause_of,900425,"We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake",group,lupus
502540465,7/12/2014 01:14:57,,1321114321,7/12/2014 01:14:34,prodege,1,7664351,USA,NY,Cicero,74.111.0.21,137,158,,,142,163,GROUP,LUPUS,"GROUP of 40 systemic lupus erythematosus (SLE) patients,",137-143-146-149-158-164-178-184,143-146-149-158-164-184,"of 40 systemic LUPUS erythematosus patients,","We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake.",137,158,137,158,142,163,-1,RO-cause_of,900425,"We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake",group,lupus
502540465,7/12/2014 01:29:15,,1321120051,7/12/2014 01:29:01,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,137,158,,,142,163,GROUP,LUPUS,limbs in a GROUP of 40 systemic lupus erythematosus,126-132-135-137-143-146-149-158-164,143-146-149-158-164-184,"of 40 systemic LUPUS erythematosus patients,","We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake.",137,158,137,158,142,163,-1,RO-cause_of,900425,"We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake",group,lupus
502540465,7/12/2014 01:35:24,,1321122788,7/12/2014 01:34:06,prodege,1,21318648,GBR,G7,Kingston Upon Thames,81.157.193.175,137,158,,,142,163,GROUP,LUPUS,avascular osteonecrosis (AON) magnetic resonance imaging (MRI) limbs GROUP lupus erythematosus (SLE) serum antiphospholipid antibody (APL Ab) glucocorticoid,46-56-70-88-98-106-126-137-158-164-178-232-238-255-264-269-290-79,46-56-70-79-88-98-106-126-137-158-164-178-184-238-255-264-269-290-305-232,"avascular osteonecrosis (AON) magnetic resonance imaging (MRI) limbs group LUPUS erythematosus (SLE) patients, serum antiphospholipid antibody (APL Ab) glucocorticoid (GC)","We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake.",137,158,137,158,142,163,-1,RO-cause_of,900425,"We determined prospectively the prevalence of avascular osteonecrosis (AON) by magnetic resonance imaging (MRI) of both lower limbs in a group of 40 systemic lupus erythematosus (SLE) patients, and correlated the results with their serum antiphospholipid antibody (APL Ab) status and their glucocorticoid (GC) intake",group,lupus
502540466,7/11/2014 23:54:31,,1321075304,7/11/2014 23:54:16,neodev,1,11382239,AUS,02,Strathfield,60.241.129.81,154,86,,,166,96,INFLAMMATION,PREDNISONE,INFLAMMATION,154,81-86,oral PREDNISONE,"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease.",154,86,154,86,166,96,1,RO-may_treat,907653,"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease",inflammation,prednisone
502540466,7/12/2014 00:04:43,,1321080932,7/12/2014 00:04:21,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,154,86,,,166,96,INFLAMMATION,PREDNISONE,INFLAMMATION,154,81-86,oral PREDNISONE,"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease.",154,86,154,86,166,96,1,RO-may_treat,907653,"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease",inflammation,prednisone
502540466,7/12/2014 00:15:20,,1321087254,7/12/2014 00:15:07,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,154,86,,,166,96,INFLAMMATION,PREDNISONE,INFLAMMATION,154,86,PREDNISONE,"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease.",154,86,154,86,166,96,1,RO-may_treat,907653,"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease",inflammation,prednisone
502540466,7/12/2014 00:23:54,,1321092112,7/12/2014 00:23:36,instagc,1.0,13763729,USA,"","",75.182.89.225,154,86,,,166,96,INFLAMMATION,PREDNISONE,INFLAMMATION,154,86,PREDNISONE,"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease.",154,86,154,86,166,96,1,RO-may_treat,907653,"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease",inflammation,prednisone
502540466,7/12/2014 00:24:16,,1321092284,7/12/2014 00:24:00,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,154,86,,,166,96,INFLAMMATION,PREDNISONE,INFLAMMATION,154,86-97-101,PREDNISONE and cyclophosphamide),"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease.",154,86,154,86,166,96,1,RO-may_treat,907653,"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease",inflammation,prednisone
502540466,7/12/2014 00:27:39,,1321093924,7/12/2014 00:27:21,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,154,86,,,166,96,INFLAMMATION,PREDNISONE,INFLAMMATION,154,81-86-97-101,oral PREDNISONE and cyclophosphamide),"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease.",154,86,154,86,166,96,1,RO-may_treat,907653,"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease",inflammation,prednisone
502540466,7/12/2014 00:30:54,,1321095646,7/12/2014 00:30:19,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,154,86,,,166,96,INFLAMMATION,PREDNISONE,INFLAMMATION,154,86,PREDNISONE,"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease.",154,86,154,86,166,96,1,RO-may_treat,907653,"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease",inflammation,prednisone
502540466,7/12/2014 00:31:00,,1321095706,7/12/2014 00:30:13,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,154,86,,,166,96,INFLAMMATION,PREDNISONE,immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) INFLAMMATION renal disease.,14-32-40-47-50-69-78-81-86-97-101-154-198-204,14-32-40-47-50-69-78-81-86-97-101-154-198-204,immunosuppressive therapy (pulse IV methylprednisolone followed by oral PREDNISONE and cyclophosphamide) inflammation renal disease.,"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease.",154,86,154,86,166,96,1,RO-may_treat,907653,"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease",inflammation,prednisone
502540466,7/12/2014 00:43:15,,1321101553,7/12/2014 00:42:50,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,154,86,,,166,96,INFLAMMATION,PREDNISONE,INFLAMMATION,154,81-86,oral PREDNISONE,"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease.",154,86,154,86,166,96,1,RO-may_treat,907653,"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease",inflammation,prednisone
502540466,7/12/2014 00:44:29,,1321102018,7/12/2014 00:44:05,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,154,86,,,166,96,INFLAMMATION,PREDNISONE,INFLAMMATION,154,86,PREDNISONE,"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease.",154,86,154,86,166,96,1,RO-may_treat,907653,"Nevertheless, immunosuppressive therapy (pulse IV methylprednisolone followed by oral prednisone and cyclophosphamide) can be given to attempt to control inflammation in patients who develop severe renal disease",inflammation,prednisone
502540467,7/11/2014 23:55:23,,1321075726,7/11/2014 23:55:09,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,71,101,,,76,112,LUNGS,LUNG CANCER,LUNGS,71,101-106,LUNG CANCER,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients.,71,101 106,71,101,76,112,1,RO-disease_has_primary_anatomic_site,902120,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients,lungs,lung cancer
502540467,7/11/2014 23:57:11,,1321076743,7/11/2014 23:56:58,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,71,101,,,76,112,LUNGS,LUNG CANCER,LUNGS,71,101-106,LUNG CANCER,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients.,71,101 106,71,101,76,112,1,RO-disease_has_primary_anatomic_site,902120,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients,lungs,lung cancer
502540467,7/12/2014 00:02:17,,1321079458,7/12/2014 00:01:53,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,71,101,,,76,112,LUNGS,LUNG CANCER,digests of LUNGS,60-68-71,101-106,LUNG CANCER,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients.,71,101 106,71,101,76,112,1,RO-disease_has_primary_anatomic_site,902120,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients,lungs,lung cancer
502540467,7/12/2014 00:03:13,,1321079973,7/12/2014 00:02:57,prodege,1,23541832,USA,AZ,Tempe,149.169.133.153,71,101,,,76,112,LUNGS,LUNG CANCER,digests of LUNGS,60-71-68,101-106-113,LUNG CANCER patients.,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients.,71,101 106,71,101,76,112,1,RO-disease_has_primary_anatomic_site,902120,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients,lungs,lung cancer
502540467,7/12/2014 00:13:25,,1321086027,7/12/2014 00:13:06,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,71,101,,,76,112,LUNGS,LUNG CANCER,LUNGS,71,101-106,LUNG CANCER,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients.,71,101 106,71,101,76,112,1,RO-disease_has_primary_anatomic_site,902120,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients,lungs,lung cancer
502540467,7/12/2014 00:15:23,,1321087300,7/12/2014 00:15:10,clixsense,1,26889820,GBR,C3,Shelford,92.18.120.203,71,101,,,76,112,LUNGS,LUNG CANCER,LUNGS,71,101-106,LUNG CANCER,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients.,71,101 106,71,101,76,112,1,RO-disease_has_primary_anatomic_site,902120,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients,lungs,lung cancer
502540467,7/12/2014 00:26:53,,1321093578,7/12/2014 00:26:26,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,71,101,,,76,112,LUNGS,LUNG CANCER,LUNGS,71,101-106,LUNG CANCER,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients.,71,101 106,71,101,76,112,1,RO-disease_has_primary_anatomic_site,902120,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients,lungs,lung cancer
502540467,7/12/2014 00:27:11,,1321093728,7/12/2014 00:26:55,instagc,1.0,13763729,USA,"","",75.182.89.225,71,101,,,76,112,LUNGS,LUNG CANCER,LUNGS,71,101-106,LUNG CANCER,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients.,71,101 106,71,101,76,112,1,RO-disease_has_primary_anatomic_site,902120,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients,lungs,lung cancer
502540467,7/12/2014 00:28:18,,1321094239,7/12/2014 00:27:46,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,71,101,,,76,112,LUNGS,LUNG CANCER,ferruginous bodies LUNGS,23-35-71,23-35-71-101-106-113,ferruginous bodies lungs LUNG CANCER patients.,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients.,71,101 106,71,101,76,112,1,RO-disease_has_primary_anatomic_site,902120,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients,lungs,lung cancer
502540467,7/12/2014 00:30:03,,1321095133,7/12/2014 00:29:28,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,71,101,,,76,112,LUNGS,LUNG CANCER,LUNGS,71,101-106,LUNG CANCER,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients.,71,101 106,71,101,76,112,1,RO-disease_has_primary_anatomic_site,902120,Quantitative counts of ferruginous bodies were performed on digests of lungs from 100 control and 30 lung cancer patients,lungs,lung cancer
502540468,7/12/2014 00:22:24,,1321091199,7/12/2014 00:22:04,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,75,69,,,87,73,SPLENOMEGALY,SMZL,"diagnosis of SMZL, SPLENOMEGALY is seen in",56-66-69-75-88-91-96,54-56-66-69-75-88-91,"a diagnosis of SMZL, splenomegaly is seen","Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL.",75,69,75,69,87,73,1,RO-disease_has_finding,901827,"Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL",splenomegaly,SMZL
502540468,7/12/2014 00:26:25,,1321093346,7/12/2014 00:25:01,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,75,69,,,87,73,SPLENOMEGALY,SMZL,SPLENOMEGALY,75,69,"SMZL,","Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL.",75,69,75,69,87,73,1,RO-disease_has_finding,901827,"Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL",splenomegaly,SMZL
502540468,7/12/2014 00:26:38,,1321093429,7/12/2014 00:26:19,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,75,69,,,87,73,SPLENOMEGALY,SMZL,"diagnosis of SMZL, SPLENOMEGALY",56-66-69-75,54-56-66-69-75,"a diagnosis of SMZL, splenomegaly","Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL.",75,69,75,69,87,73,1,RO-disease_has_finding,901827,"Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL",splenomegaly,SMZL
502540468,7/12/2014 00:28:47,,1321094502,7/12/2014 00:28:32,instagc,1.0,13763729,USA,"","",75.182.89.225,75,69,,,87,73,SPLENOMEGALY,SMZL,SPLENOMEGALY,75,69,"SMZL,","Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL.",75,69,75,69,87,73,1,RO-disease_has_finding,901827,"Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL",splenomegaly,SMZL
502540468,7/12/2014 00:29:27,,1321094827,7/12/2014 00:29:14,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,75,69,,,87,73,SPLENOMEGALY,SMZL,"SMZL, SPLENOMEGALY",69-75,69-75,"SMZL, splenomegaly","Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL.",75,69,75,69,87,73,1,RO-disease_has_finding,901827,"Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL",splenomegaly,SMZL
502540468,7/12/2014 00:29:28,,1321094830,7/12/2014 00:28:44,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,75,69,,,87,73,SPLENOMEGALY,SMZL,"Diagnosis With splenic involvement diagnosis of SMZL, SPLENOMEGALY is seen in lymphadenopathy.[1]",0-11-16-24-56-66-69-75-88-91-96-137,0-11-16-24-54-56-66-69-75-88-91-137,"Diagnosis With splenic involvement a diagnosis of SMZL, splenomegaly is seen lymphadenopathy.[1]","Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL.",75,69,75,69,87,73,1,RO-disease_has_finding,901827,"Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL",splenomegaly,SMZL
502540468,7/12/2014 00:37:39,,1321099060,7/12/2014 00:37:21,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,75,69,,,87,73,SPLENOMEGALY,SMZL,"SMZL, SPLENOMEGALY",69-75,69,"SMZL,","Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL.",75,69,75,69,87,73,1,RO-disease_has_finding,901827,"Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL",splenomegaly,SMZL
502540468,7/12/2014 00:44:13,,1321101936,7/12/2014 00:43:56,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,75,69,,,87,73,SPLENOMEGALY,SMZL,SPLENOMEGALY,75,69,"SMZL,","Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL.",75,69,75,69,87,73,1,RO-disease_has_finding,901827,"Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL",splenomegaly,SMZL
502540468,7/12/2014 00:49:23,,1321103843,7/12/2014 00:48:43,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,75,69,,,87,73,SPLENOMEGALY,SMZL,SPLENOMEGALY in,75-96,69,"SMZL,","Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL.",75,69,75,69,87,73,1,RO-disease_has_finding,901827,"Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL",splenomegaly,SMZL
502540468,7/12/2014 01:14:34,,1321114113,7/12/2014 01:14:10,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,75,69,,,87,73,SPLENOMEGALY,SMZL,"SMZL, SPLENOMEGALY",69-75,54-56-66-69-75-88-91,"a diagnosis of SMZL, splenomegaly is seen","Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL.",75,69,75,69,87,73,1,RO-disease_has_finding,901827,"Diagnosis  With splenic involvement a requirement for a diagnosis of SMZL, splenomegaly is seen in almost all patients, commonly without lymphadenopathy.[1] Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with SMZL",splenomegaly,SMZL
502540469,7/12/2014 00:05:05,,1321081123,7/12/2014 00:04:20,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,78,40,,,82,50,PAIN,GABAPENTIN,decrease pain and sleep disturbance diabetic peripheral neuropathy postherpetic neuralgia,83-92-97-101-107-136-145-156-184-197,54,gabapentin,"鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106.",,,78,40,82,50,1,RO-may_treat,907733,"鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106",pain,gabapentin
502540469,7/12/2014 00:12:24,,1321085481,7/12/2014 00:12:00,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,78,40,,,82,50,PAIN,GABAPENTIN,decrease pain,83-92,54,gabapentin,"鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106.",,,78,40,82,50,1,RO-may_treat,907733,"鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106",pain,gabapentin
502540469,7/12/2014 00:17:14,,1321088363,7/12/2014 00:16:59,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,78,40,,,82,50,PAIN,GABAPENTIN,TO,80,35-46,"contrOLLED TRIAls,","鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106.",,,78,40,82,50,1,RO-may_treat,907733,"鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106",pain,gabapentin
502540469,7/12/2014 00:24:54,,1321092619,7/12/2014 00:24:49,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,78,40,,,82,50,PAIN,GABAPENTIN,has been showN TO decrease pain,65-69-74-80-83-92,19-23-35-46-54-65,"two randomized, contrOLLED TRIAls, gabapentin has","鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106.",,,78,40,82,50,1,RO-may_treat,907733,"鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106",pain,gabapentin
502540469,7/12/2014 00:30:36,,1321095421,7/12/2014 00:30:11,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,78,40,,,82,50,PAIN,GABAPENTIN,pain,92,54,gabapentin,"鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106.",,,78,40,82,50,1,RO-may_treat,907733,"鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106",pain,gabapentin
502540469,7/12/2014 00:31:28,,1321095934,7/12/2014 00:30:05,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,78,40,,,82,50,PAIN,GABAPENTIN,pain,92,54,gabapentin,"鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106.",,,78,40,82,50,1,RO-may_treat,907733,"鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106",pain,gabapentin
502540469,7/12/2014 00:32:12,,1321096276,7/12/2014 00:31:24,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,78,40,,,82,50,PAIN,GABAPENTIN,gabapentin,54,54,gabapentin,"鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106.",,,78,40,82,50,1,RO-may_treat,907733,"鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106",pain,gabapentin
502540469,7/12/2014 00:35:59,,1321098259,7/12/2014 00:33:28,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,78,40,,,82,50,PAIN,GABAPENTIN,gabapentin has been showN TO decrease pain patients with diabetic peripheral neuropathy with postherpetic neuralgia,54-65-69-74-80-83-92-122-131-136-145-156-184-197-179,19-23-35-46-54-65-122-131-136-145-156-179-184-197,"two randomized, contrOLLED TRIAls, gabapentin has patients with diabetic peripheral neuropathy with postherpetic neuralgia","鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106.",,,78,40,82,50,1,RO-may_treat,907733,"鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106",pain,gabapentin
502540469,7/12/2014 01:15:46,,1321114655,7/12/2014 01:15:23,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,78,40,,,82,50,PAIN,GABAPENTIN,has been showN TO decrease pain,65-69-74-80-83-92,54-65-69-74-80-83-92-97-101-107,gabapentin has been shown to decrease pain and sleep disturbance,"鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106.",,,78,40,82,50,1,RO-may_treat,907733,"鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106",pain,gabapentin
502540469,7/12/2014 01:28:01,,1321119565,7/12/2014 01:27:37,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,78,40,,,82,50,PAIN,GABAPENTIN,decrease pain,83-92,19-23-35-46-54,"two randomized, contrOLLED TRIAls, gabapentin","鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106.",,,78,40,82,50,1,RO-may_treat,907733,"鐃緒申鐃緒申羝�申��申鐃緒申鐃順� two randomized, controlled trials, gabapentin has been shown to decrease pain and sleep disturbance in patients with diabetic peripheral neuropathy ( 105 ) and with postherpetic neuralgia ( 106",pain,gabapentin
502540470,7/11/2014 23:53:51,,1321075075,7/11/2014 23:53:37,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,98,48,,,103,57,SPINE,SCOLIOSIS,SPINE,98,39-48,advanced SCOLIOSIS,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views.,98,48,98,48,103,57,1,RO-has_finding_site,905265,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views,spine,scoliosis
502540470,7/12/2014 00:02:19,,1321079470,7/12/2014 00:02:03,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,98,48,,,103,57,SPINE,SCOLIOSIS,SPINE,98,48,SCOLIOSIS,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views.,98,48,98,48,103,57,1,RO-has_finding_site,905265,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views,spine,scoliosis
502540470,7/12/2014 00:12:49,,1321085721,7/12/2014 00:12:16,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,98,48,,,103,57,SPINE,SCOLIOSIS,SPINE,98,39-48,advanced SCOLIOSIS,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views.,98,48,98,48,103,57,1,RO-has_finding_site,905265,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views,spine,scoliosis
502540470,7/12/2014 00:23:15,,1321091688,7/12/2014 00:23:00,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,98,48,,,103,57,SPINE,SCOLIOSIS,SPINE in anterior posterior,98-104-107-116,39-48-58-67-70,advanced SCOLIOSIS consists of roentgenograms,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views.,98,48,98,48,103,57,1,RO-has_finding_site,905265,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views,spine,scoliosis
502540470,7/12/2014 00:23:19,,1321091782,7/12/2014 00:21:38,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,98,48,,,103,57,SPINE,SCOLIOSIS,the total SPINE in anterior posterior and lateral views.,88-92-98-104-107-116-126-130-138,26-36-39-48,diagnosis of advanced SCOLIOSIS,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views.,98,48,98,48,103,57,1,RO-has_finding_site,905265,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views,spine,scoliosis
502540470,7/12/2014 00:24:31,,1321092434,7/12/2014 00:24:03,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,98,48,,,103,57,SPINE,SCOLIOSIS,SPINE,98,48,SCOLIOSIS,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views.,98,48,98,48,103,57,1,RO-has_finding_site,905265,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views,spine,scoliosis
502540470,7/12/2014 00:24:57,,1321092635,7/12/2014 00:24:41,instagc,1.0,13763729,USA,"","",75.182.89.225,98,48,,,103,57,SPINE,SCOLIOSIS,SPINE,98,48,SCOLIOSIS,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views.,98,48,98,48,103,57,1,RO-has_finding_site,905265,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views,spine,scoliosis
502540470,7/12/2014 00:25:39,,1321092967,7/12/2014 00:25:35,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,98,48,,,103,57,SPINE,SCOLIOSIS,of the total SPINE in anterior posterior,85-88-92-98-104-107-116,26-36-39-48-58-67-70,diagnosis of advanced SCOLIOSIS consists of roentgenograms,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views.,98,48,98,48,103,57,1,RO-has_finding_site,905265,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views,spine,scoliosis
502540470,7/12/2014 00:33:27,,1321096973,7/12/2014 00:33:01,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,98,48,,,103,57,SPINE,SCOLIOSIS,radiological diagnosis of advanced scoliosis consists of roentgenograms of the total SPINE in anterior posterior,13-26-36-39-48-58-67-85-88-92-98-104-107-116-70,13-26-36-39-48-58-67-70-85-88-92-98-104-107-116,radiological diagnosis of advanced SCOLIOSIS consists of roentgenograms of the total spine in anterior posterior,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views.,98,48,98,48,103,57,1,RO-has_finding_site,905265,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views,spine,scoliosis
502540470,7/12/2014 01:25:03,,1321118099,7/12/2014 01:22:07,prodege,1.0,21318648,GBR,G7,Kingston Upon Thames,81.157.193.175,98,48,,,103,57,SPINE,SCOLIOSIS,radiological diagnosis scoliosis roentgenograms SPINE anterior posterior,26-48-70-98-107-116-13,13-26-48-70-107-116,radiological diagnosis SCOLIOSIS roentgenograms anterior posterior,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views.,98,48,98,48,103,57,1,RO-has_finding_site,905265,The standard radiological diagnosis of advanced scoliosis consists of roentgenograms of the total spine in anterior-posterior and lateral views,spine,scoliosis
502540471,7/12/2014 00:02:29,,1321079530,7/12/2014 00:02:14,prodege,1.0,23541832,USA,AZ,Tempe,149.169.133.153,85,141,,,93,149,HEADACHE,MIGRAINE,HEADACHE,85,141,MIGRAINE,"An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test.",85,141,85,141,93,149,-1,RO-has_definitional_manifestation,904763,"An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test",headache,migraine
502540471,7/12/2014 00:14:54,,1321087058,7/12/2014 00:14:38,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,85,141,,,93,149,HEADACHE,MIGRAINE,HEADACHE,85,141,MIGRAINE,"An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test.",85,141,85,141,93,149,-1,RO-has_definitional_manifestation,904763,"An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test",headache,migraine
502540471,7/12/2014 00:25:00,,1321092660,7/12/2014 00:24:55,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,85,141,,,93,149,HEADACHE,MIGRAINE,"and ENTC, for HEADACHE and or other",71-75-81-85-94-98-101,129-133-136-141-150-153-159,out to have MIGRAINE by means of,"An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test.",85,141,85,141,93,149,-1,RO-has_definitional_manifestation,904763,"An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test",headache,migraine
502540471,7/12/2014 00:25:16,,1321092775,7/12/2014 00:24:50,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,85,141,,,93,149,HEADACHE,MIGRAINE,"ENTC, for HEADACHE",75-81-85,141,MIGRAINE,"An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test.",85,141,85,141,93,149,-1,RO-has_definitional_manifestation,904763,"An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test",headache,migraine
502540471,7/12/2014 00:25:19,,1321092805,7/12/2014 00:23:20,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,85,141,,,93,149,HEADACHE,MIGRAINE,HEADACHE and or other complaints,85-94-98-101-107,133-136-141,to have MIGRAINE,"An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test.",85,141,85,141,93,149,-1,RO-has_definitional_manifestation,904763,"An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test",headache,migraine
502540471,7/12/2014 00:28:31,,1321094357,7/12/2014 00:28:17,instagc,1.0,13763729,USA,"","",75.182.89.225,85,141,,,93,149,HEADACHE,MIGRAINE,HEADACHE,85,141,MIGRAINE,"An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test.",85,141,85,141,93,149,-1,RO-has_definitional_manifestation,904763,"An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test",headache,migraine
502540471,7/12/2014 00:29:28,,1321094829,7/12/2014 00:29:06,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,85,141,,,93,149,HEADACHE,MIGRAINE,HEADACHE,85,141,MIGRAINE,"An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test.",85,141,85,141,93,149,-1,RO-has_definitional_manifestation,904763,"An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test",headache,migraine
502540471,7/12/2014 00:44:45,,1321102093,7/12/2014 00:44:27,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,85,141,,,93,149,HEADACHE,MIGRAINE,HEADACHE,85,141,MIGRAINE,"An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test.",85,141,85,141,93,149,-1,RO-has_definitional_manifestation,904763,"An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test",headache,migraine
502540471,7/12/2014 01:13:18,,1321113578,7/12/2014 01:12:53,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,85,141,,,93,149,HEADACHE,MIGRAINE,HEADACHE have migraine by means of a simple screening test.,85-136-141-150-153-159-162-164-171-181,129-133-136-141-150-153-159-162-164-171-181,out to have MIGRAINE by means of a simple screening test.,"An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test.",85,141,85,141,93,149,-1,RO-has_definitional_manifestation,904763,"An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test",headache,migraine
502540471,7/12/2014 01:22:06,,1321116885,7/12/2014 01:19:54,prodege,1.0,21318648,GBR,G7,Kingston Upon Thames,81.157.193.175,85,141,,,93,149,HEADACHE,MIGRAINE,"patients admitted NC, OC ENTC, HEADACHE migraine screening test.",29-38-50-68-75-85-141-171-181,29-38-50-75-85-141-171-181-68,"patients admitted NC, OC ENTC, headache MIGRAINE screening test.","An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test.",85,141,85,141,93,149,-1,RO-has_definitional_manifestation,904763,"An important fraction of the patients admitted to NC, as well as to OC and ENTC, for headache and/or other complaints were found out to have migraine by means of a simple screening test",headache,migraine
502540472,7/11/2014 23:55:08,,1321075629,7/11/2014 23:54:46,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,53,0,,,59,21,MASSES,GRANULOCYTIC SARCOMAS,extramedullary tumour MASSES of immature myeloid,31-46-53-60-63-72,0-13-22,GRANULOCYTIC SARCOMAS (GS),"Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour.",53,0 13,53,0,59,21,1,RO-disease_has_finding,901845,"Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour",masses,Granulocytic sarcomas
502540472,7/11/2014 23:57:30,,1321076827,7/11/2014 23:57:12,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,53,0,,,59,21,MASSES,GRANULOCYTIC SARCOMAS,extramedullary tumour MASSES,31-46-53,0-13,GRANULOCYTIC SARCOMAS,"Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour.",53,0 13,53,0,59,21,1,RO-disease_has_finding,901845,"Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour",masses,Granulocytic sarcomas
502540472,7/12/2014 00:04:23,,1321080759,7/12/2014 00:04:12,prodege,1.0,23541832,USA,AZ,Tempe,149.169.133.153,53,0,,,59,21,MASSES,GRANULOCYTIC SARCOMAS,"extramedullary tumour MASSES of immature myeloid cells,",31-46-53-60-63-72-80,0-13-22,GRANULOCYTIC SARCOMAS (GS),"Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour.",53,0 13,53,0,59,21,1,RO-disease_has_finding,901845,"Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour",masses,Granulocytic sarcomas
502540472,7/12/2014 00:15:06,,1321087190,7/12/2014 00:14:46,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,53,0,,,59,21,MASSES,GRANULOCYTIC SARCOMAS,MASSES,53,0-13,GRANULOCYTIC SARCOMAS,"Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour.",53,0 13,53,0,59,21,1,RO-disease_has_finding,901845,"Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour",masses,Granulocytic sarcomas
502540472,7/12/2014 00:15:09,,1321087215,7/12/2014 00:14:26,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,53,0,,,59,21,MASSES,GRANULOCYTIC SARCOMAS,"extramedullary tumour MASSES of immature myeloid cells,",31-46-53-60-63-72-80,0-13-22-27-31-46-53-60-63-72-80,"GRANULOCYTIC SARCOMAS (GS) are extramedullary tumour masses of immature myeloid cells,","Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour.",53,0 13,53,0,59,21,1,RO-disease_has_finding,901845,"Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour",masses,Granulocytic sarcomas
502540472,7/12/2014 00:20:43,,1321090202,7/12/2014 00:19:54,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,53,0,,,59,21,MASSES,GRANULOCYTIC SARCOMAS,MASSES,53,0-13-22,GRANULOCYTIC SARCOMAS (GS),"Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour.",53,0 13,53,0,59,21,1,RO-disease_has_finding,901845,"Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour",masses,Granulocytic sarcomas
502540472,7/12/2014 00:23:46,,1321092012,7/12/2014 00:23:31,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,53,0,,,59,21,MASSES,GRANULOCYTIC SARCOMAS,"extramedullary tumour MASSES of immature myeloid cells,",31-46-53-60-63-72-80,0-13,GRANULOCYTIC SARCOMAS,"Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour.",53,0 13,53,0,59,21,1,RO-disease_has_finding,901845,"Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour",masses,Granulocytic sarcomas
502540472,7/12/2014 00:38:27,,1321099366,7/12/2014 00:38:11,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,53,0,,,59,21,MASSES,GRANULOCYTIC SARCOMAS,"extramedullary tumour MASSES of immature myeloid cells,",31-46-53-60-63-72-80,0-13-22,GRANULOCYTIC SARCOMAS (GS),"Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour.",53,0 13,53,0,59,21,1,RO-disease_has_finding,901845,"Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour",masses,Granulocytic sarcomas
502540472,7/12/2014 00:40:16,,1321100177,7/12/2014 00:39:36,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,53,0,,,59,21,MASSES,GRANULOCYTIC SARCOMAS,"Granulocytic sarcomas (GS) are extramedullary tumour MASSES of immature myeloid cells, known as chloroma and extramedullary myeloid cell tumour.",0-13-22-27-31-46-53-60-63-72-80-92-101-110-114-129-137-142-98,0-13-22-27-31-46-53-60-63-72-92-98-101-110-114-129-137-142-80,"GRANULOCYTIC SARCOMAS (GS) are extramedullary tumour masses of immature myeloid cells, known as chloroma and extramedullary myeloid cell tumour.","Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour.",53,0 13,53,0,59,21,1,RO-disease_has_finding,901845,"Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour",masses,Granulocytic sarcomas
502540472,7/12/2014 00:43:39,,1321101725,7/12/2014 00:43:17,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,53,0,,,59,21,MASSES,GRANULOCYTIC SARCOMAS,"extramedullary tumour MASSES of immature myeloid cells,",31-46-53-60-63-72-80,0-13-22,GRANULOCYTIC SARCOMAS (GS),"Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour.",53,0 13,53,0,59,21,1,RO-disease_has_finding,901845,"Granulocytic sarcomas (GS) are extramedullary tumour masses of immature myeloid cells, also known as chloroma and extramedullary myeloid cell tumour",masses,Granulocytic sarcomas
502540473,7/12/2014 00:03:48,,1321080335,7/12/2014 00:03:30,prodege,1.0,23541832,USA,AZ,Tempe,149.169.133.153,377,338,,,393,363,IMMUNODEFICIENCY,GRAFT-VERSUS-HOST DISEASE,HIV human IMMUNODEFICIENCY virus;,371-377-394-365,338-344-351-356-331,GVHD GRAFT VERSUS HOST DISEASE;,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome.,377,338 344 351 356,377,338,393,363,-1,RO-disease_has_finding,901656,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome,immunodeficiency,graft-versus-host disease
502540473,7/12/2014 00:08:33,,1321083134,7/12/2014 00:07:57,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,377,338,,,393,363,IMMUNODEFICIENCY,GRAFT-VERSUS-HOST DISEASE,human IMMUNODEFICIENCY virus;,371-377-394,338-344-351-356,GRAFT VERSUS HOST DISEASE;,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome.,377,338 344 351 356,377,338,393,363,-1,RO-disease_has_finding,901656,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome,immunodeficiency,graft-versus-host disease
502540473,7/12/2014 00:14:26,,1321086705,7/12/2014 00:12:16,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,377,338,,,393,363,IMMUNODEFICIENCY,GRAFT-VERSUS-HOST DISEASE,HIV = human IMMUNODEFICIENCY virus;,365-369-371-377-394,331-336-338-344-351-356,GVHD = GRAFT VERSUS HOST DISEASE;,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome.,377,338 344 351 356,377,338,393,363,-1,RO-disease_has_finding,901656,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome,immunodeficiency,graft-versus-host disease
502540473,7/12/2014 00:18:32,,1321089047,7/12/2014 00:18:15,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,377,338,,,393,363,IMMUNODEFICIENCY,GRAFT-VERSUS-HOST DISEASE,IMMUNODEFICIENCY virus;,377-394,338-344-351-356,GRAFT VERSUS HOST DISEASE;,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome.,377,338 344 351 356,377,338,393,363,-1,RO-disease_has_finding,901656,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome,immunodeficiency,graft-versus-host disease
502540473,7/12/2014 00:22:41,,1321091311,7/12/2014 00:22:13,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,377,338,,,393,363,IMMUNODEFICIENCY,GRAFT-VERSUS-HOST DISEASE,HIV = human IMMUNODEFICIENCY virus; MDS = myelodysplastic syndrome.,365-369-371-377-394-401-407-423-405,331-336-338-344-351-356-365-371-377-369,GVHD = GRAFT VERSUS HOST DISEASE; HIV = human immunodeficiency,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome.,377,338 344 351 356,377,338,393,363,-1,RO-disease_has_finding,901656,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome,immunodeficiency,graft-versus-host disease
502540473,7/12/2014 00:25:20,,1321092806,7/12/2014 00:24:58,instagc,1.0,13763729,USA,"","",75.182.89.225,377,338,,,393,363,IMMUNODEFICIENCY,GRAFT-VERSUS-HOST DISEASE,IMMUNODEFICIENCY,377,338-344-351-356,GRAFT VERSUS HOST DISEASE;,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome.,377,338 344 351 356,377,338,393,363,-1,RO-disease_has_finding,901656,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome,immunodeficiency,graft-versus-host disease
502540473,7/12/2014 00:26:01,,1321093142,7/12/2014 00:25:55,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,377,338,,,393,363,IMMUNODEFICIENCY,GRAFT-VERSUS-HOST DISEASE,HIV = human IMMUNODEFICIENCY virus; MDS myelodysplastic,365-369-371-377-394-401-407,323-331-336-338-344-351-356-365-371-377,factor; GVHD = GRAFT VERSUS HOST DISEASE; HIV human immunodeficiency,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome.,377,338 344 351 356,377,338,393,363,-1,RO-disease_has_finding,901656,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome,immunodeficiency,graft-versus-host disease
502540473,7/12/2014 00:32:51,,1321096674,7/12/2014 00:32:41,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,377,338,,,393,363,IMMUNODEFICIENCY,GRAFT-VERSUS-HOST DISEASE,HIV = human IMMUNODEFICIENCY virus; MDS myelodysplastic,365-369-371-377-394-401-407,331-336-338-344-351-356-365-371-377,GVHD = GRAFT VERSUS HOST DISEASE; HIV human immunodeficiency,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome.,377,338 344 351 356,377,338,393,363,-1,RO-disease_has_finding,901656,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome,immunodeficiency,graft-versus-host disease
502540473,7/12/2014 00:38:03,,1321099223,7/12/2014 00:37:19,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,377,338,,,393,363,IMMUNODEFICIENCY,GRAFT-VERSUS-HOST DISEASE,human IMMUNODEFICIENCY virus;,371-377-394,338-344-351-356,GRAFT VERSUS HOST DISEASE;,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome.,377,338 344 351 356,377,338,393,363,-1,RO-disease_has_finding,901656,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome,immunodeficiency,graft-versus-host disease
502540473,7/12/2014 00:38:46,,1321099529,7/12/2014 00:38:30,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,377,338,,,393,363,IMMUNODEFICIENCY,GRAFT-VERSUS-HOST DISEASE,HIV = human IMMUNODEFICIENCY virus;,365-369-371-377-394,331-336-338-344-351-356,GVHD = GRAFT VERSUS HOST DISEASE;,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome.,377,338 344 351 356,377,338,393,363,-1,RO-disease_has_finding,901656,Remind patient to avoid high-risk activities that increase chance of infection AIDS = acquired immunodeficiency syndrome; ALT = alanine aminotransferase; AST = aspartate aminotransferase; BUN = blood urea nitrogen; CBC = complete blood count; DNA = deoxyribonucleic acid; GM-CSF = granulocyte-macrophage colony-stimulating factor; GVHD = graft-versus-host disease; HIV = human immunodeficiency virus; MDS = myelodysplastic syndrome,immunodeficiency,graft-versus-host disease
502540474,7/11/2014 23:59:01,,1321077574,7/11/2014 23:58:46,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,71,121,,,79,125,NECROSIS,SCLC,"NECROSIS,",71,121-126,SCLC origin.,"Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin.",71,121,71,121,79,125,-1,RO-disease_has_finding,901513,"Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin",necrosis,SCLC
502540474,7/12/2014 00:13:42,,1321086266,7/12/2014 00:13:18,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,71,121,,,79,125,NECROSIS,SCLC,"NECROSIS,",71,121,SCLC,"Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin.",71,121,71,121,79,125,-1,RO-disease_has_finding,901513,"Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin",necrosis,SCLC
502540474,7/12/2014 00:21:54,,1321090886,7/12/2014 00:20:43,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,71,121,,,79,125,NECROSIS,SCLC,"NECROSIS, fibrosis",71-81,103-112-118-121-126,residual cells of SCLC origin.,"Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin.",71,121,71,121,79,125,-1,RO-disease_has_finding,901513,"Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin",necrosis,SCLC
502540474,7/12/2014 00:25:46,,1321093062,7/12/2014 00:25:41,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,71,121,,,79,125,NECROSIS,SCLC,"large areas of NECROSIS, fibrosis and very",56-62-68-71-81-90-94,103-112-118-121-126,residual cells of SCLC origin.,"Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin.",71,121,71,121,79,125,-1,RO-disease_has_finding,901513,"Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin",necrosis,SCLC
502540474,7/12/2014 00:28:40,,1321094440,7/12/2014 00:28:09,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,71,121,,,79,125,NECROSIS,SCLC,"NECROSIS,",71,121,SCLC,"Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin.",71,121,71,121,79,125,-1,RO-disease_has_finding,901513,"Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin",necrosis,SCLC
502540474,7/12/2014 00:30:09,,1321095202,7/12/2014 00:29:56,instagc,1.0,13763729,USA,"","",75.182.89.225,71,121,,,79,125,NECROSIS,SCLC,"NECROSIS,",71,121,SCLC,"Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin.",71,121,71,121,79,125,-1,RO-disease_has_finding,901513,"Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin",necrosis,SCLC
502540474,7/12/2014 00:36:34,,1321098521,7/12/2014 00:36:00,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,71,121,,,79,125,NECROSIS,SCLC,"Xenograft histology radioimmunotherapy large areas of NECROSIS, fibrosis and very",0-10-56-62-68-71-81-90-94-30,0-10-30-62-68-71-81-103-112-118-121-126-56,"Xenograft histology radioimmunotherapy large areas of necrosis, fibrosis residual cells of SCLC origin.","Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin.",71,121,71,121,79,125,-1,RO-disease_has_finding,901513,"Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin",necrosis,SCLC
502540474,7/12/2014 00:41:23,,1321100746,7/12/2014 00:41:07,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,71,121,,,79,125,NECROSIS,SCLC,"NECROSIS,",71,121,SCLC,"Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin.",71,121,71,121,79,125,-1,RO-disease_has_finding,901513,"Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin",necrosis,SCLC
502540474,7/12/2014 01:08:24,,1321111339,7/12/2014 01:07:55,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,71,121,,,79,125,NECROSIS,SCLC,"NECROSIS,",71,121,SCLC,"Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin.",71,121,71,121,79,125,-1,RO-disease_has_finding,901513,"Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin",necrosis,SCLC
502540474,7/12/2014 01:14:09,,1321113940,7/12/2014 01:13:45,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,71,121,,,79,125,NECROSIS,SCLC,"Xenograft histology following radioimmunotherapy showed large areas NECROSIS,",0-10-20-30-49-62-71-56,103-112-118-121-126,residual cells of SCLC origin.,"Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin.",71,121,71,121,79,125,-1,RO-disease_has_finding,901513,"Xenograft histology following radioimmunotherapy showed large areas of necrosis, fibrosis and very few residual cells of SCLC origin",necrosis,SCLC
502540475,7/11/2014 23:56:18,,1321076309,7/11/2014 23:56:06,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,346,278,,,350,286,HAIR,ALOPECIA,HAIR loss.,346-351,278-287,ALOPECIA areata,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss.",346,278,346,278,350,286,1,RO-disease_has_primary_anatomic_site,902345,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss",hair,alopecia
502540475,7/12/2014 00:00:18,,1321078217,7/12/2014 00:00:01,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,346,278,,,350,286,HAIR,ALOPECIA,HAIR loss.,346-351,278-287,ALOPECIA areata,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss.",346,278,346,278,350,286,1,RO-disease_has_primary_anatomic_site,902345,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss",hair,alopecia
502540475,7/12/2014 00:09:59,,1321084063,7/12/2014 00:09:39,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,346,278,,,350,286,HAIR,ALOPECIA,HAIR loss.,346-351,278-287,ALOPECIA areata,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss.",346,278,346,278,350,286,1,RO-disease_has_primary_anatomic_site,902345,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss",hair,alopecia
502540475,7/12/2014 00:10:32,,1321084390,7/12/2014 00:10:11,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,346,278,,,350,286,HAIR,ALOPECIA,HAIR loss.,346-351,278-287,ALOPECIA areata,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss.",346,278,346,278,350,286,1,RO-disease_has_primary_anatomic_site,902345,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss",hair,alopecia
502540475,7/12/2014 00:22:59,,1321091560,7/12/2014 00:22:43,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,346,278,,,350,286,HAIR,ALOPECIA,HAIR loss.,346-351,278,ALOPECIA,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss.",346,278,346,278,350,286,1,RO-disease_has_primary_anatomic_site,902345,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss",hair,alopecia
502540475,7/12/2014 00:25:07,,1321092690,7/12/2014 00:25:01,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,346,278,,,350,286,HAIR,ALOPECIA,image due to HAIR loss.,333-339-343-346-351,250-267-275-278-287-294-298,universalis.[8] Effects of ALOPECIA areata are mainly,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss.",346,278,346,278,350,286,1,RO-disease_has_primary_anatomic_site,902345,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss",hair,alopecia
502540475,7/12/2014 00:32:36,,1321096513,7/12/2014 00:31:54,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,346,278,,,350,286,HAIR,ALOPECIA,HAIR,346,278,ALOPECIA,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss.",346,278,346,278,350,286,1,RO-disease_has_primary_anatomic_site,902345,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss",hair,alopecia
502540475,7/12/2014 00:32:53,,1321096696,7/12/2014 00:32:17,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,346,278,,,350,286,HAIR,ALOPECIA,HAIR loss.,346-351,278-287,ALOPECIA areata,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss.",346,278,346,278,350,286,1,RO-disease_has_primary_anatomic_site,902345,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss",hair,alopecia
502540475,7/12/2014 00:33:33,,1321097022,7/12/2014 00:33:19,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,346,278,,,350,286,HAIR,ALOPECIA,HAIR loss.,346-351,267-275-278-287,Effects of ALOPECIA areata,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss.",346,278,346,278,350,286,1,RO-disease_has_primary_anatomic_site,902345,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss",hair,alopecia
502540475,7/12/2014 00:41:49,,1321100925,7/12/2014 00:40:15,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,346,278,,,350,286,HAIR,ALOPECIA,HAIR loss.,346-351,278-287,ALOPECIA areata,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss.",346,278,346,278,350,286,1,RO-disease_has_primary_anatomic_site,902345,"Prognosis  In most cases that begin with a small number of patches of hair loss, hair grows back after a few months to a year.[8] In cases with a greater number of patches, hair can either grow back or progress to alopecia totalis or, in rare cases, universalis.[8]  Effects of alopecia areata are mainly psychological (loss of self image due to hair loss",hair,alopecia
502540476,7/11/2014 23:53:47,,1321075020,7/11/2014 23:53:32,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,97,0,,,108,12,BONE MARROW,MASTOCYTOSIS,"BONE MARROW,",97-102,0,MASTOCYTOSIS,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin.",97 102,0,97,0,108,12,1,RO-disease_has_primary_anatomic_site,902194,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin",bone marrow,Mastocytosis
502540476,7/12/2014 00:17:34,,1321088538,7/12/2014 00:17:11,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,97,0,,,108,12,BONE MARROW,MASTOCYTOSIS,"hyperplasia in the BONE MARROW, liver, spleen, lymph nodes, gastrointestinal tract,",78-90-93-97-102-110-117-125-131-138-155,0,MASTOCYTOSIS,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin.",97 102,0,97,0,108,12,1,RO-disease_has_primary_anatomic_site,902194,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin",bone marrow,Mastocytosis
502540476,7/12/2014 00:17:37,,1321088631,7/12/2014 00:17:04,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,97,0,,,108,12,BONE MARROW,MASTOCYTOSIS,"hyperplasia in the BONE MARROW, liver, spleen, lymph nodes, gastrointestinal tract, and skin.",78-90-93-97-102-110-117-125-131-138-155-162-166,0-13-16-18-32-38-41,MASTOCYTOSIS is a heterogeneous group of disorders,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin.",97 102,0,97,0,108,12,1,RO-disease_has_primary_anatomic_site,902194,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin",bone marrow,Mastocytosis
502540476,7/12/2014 00:27:17,,1321093765,7/12/2014 00:26:54,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,97,0,,,108,12,BONE MARROW,MASTOCYTOSIS,"BONE MARROW,",97-102,0,MASTOCYTOSIS,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin.",97 102,0,97,0,108,12,1,RO-disease_has_primary_anatomic_site,902194,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin",bone marrow,Mastocytosis
502540476,7/12/2014 00:37:13,,1321098857,7/12/2014 00:36:33,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,97,0,,,108,12,BONE MARROW,MASTOCYTOSIS,"BONE MARROW,",97-102,0,MASTOCYTOSIS,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin.",97 102,0,97,0,108,12,1,RO-disease_has_primary_anatomic_site,902194,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin",bone marrow,Mastocytosis
502540476,7/12/2014 00:39:35,,1321099880,7/12/2014 00:38:41,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,97,0,,,108,12,BONE MARROW,MASTOCYTOSIS,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the BONE MARROW, liver, spleen, lymph nodes, gastrointestinal tract, and skin.",0-13-16-18-32-38-41-51-65-68-73-78-90-93-97-102-110-117-125-131-138-155-162-166,0-13-16-18-32-38-41-51-65-68-73-78-90-93-97-102-110-125-131-138-155-162-166-117,"MASTOCYTOSIS is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin.","Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin.",97 102,0,97,0,108,12,1,RO-disease_has_primary_anatomic_site,902194,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin",bone marrow,Mastocytosis
502540476,7/12/2014 00:43:37,,1321101711,7/12/2014 00:43:23,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,97,0,,,108,12,BONE MARROW,MASTOCYTOSIS,"BONE MARROW,",97-102,0,MASTOCYTOSIS,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin.",97 102,0,97,0,108,12,1,RO-disease_has_primary_anatomic_site,902194,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin",bone marrow,Mastocytosis
502540476,7/12/2014 00:50:36,,1321104316,7/12/2014 00:50:03,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,97,0,,,108,12,BONE MARROW,MASTOCYTOSIS,"BONE MARROW,",97-102,0,MASTOCYTOSIS,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin.",97 102,0,97,0,108,12,1,RO-disease_has_primary_anatomic_site,902194,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin",bone marrow,Mastocytosis
502540476,7/12/2014 01:04:36,,1321109847,7/12/2014 01:04:23,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,97,0,,,108,12,BONE MARROW,MASTOCYTOSIS,"mast cell hyperplasia in the BONE MARROW,",68-73-78-90-93-97-102,0,MASTOCYTOSIS,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin.",97 102,0,97,0,108,12,1,RO-disease_has_primary_anatomic_site,902194,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin",bone marrow,Mastocytosis
502540476,7/12/2014 01:12:25,,1321113092,7/12/2014 01:12:12,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,97,0,,,108,12,BONE MARROW,MASTOCYTOSIS,"hyperplasia in the BONE MARROW, liver, spleen, lymph nodes, gastrointestinal tract, skin.",78-90-93-97-102-110-117-125-131-138-155-166,0-13-16-18-32-38-41,MASTOCYTOSIS is a heterogeneous group of disorders,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin.",97 102,0,97,0,108,12,1,RO-disease_has_primary_anatomic_site,902194,"Mastocytosis is a heterogeneous group of disorders characterized by mast cell hyperplasia in the bone marrow, liver, spleen, lymph nodes, gastrointestinal tract, and skin",bone marrow,Mastocytosis
502540477,7/11/2014 23:56:04,,1321076154,7/11/2014 23:55:47,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,69,37,,,74,61,LIVER,UNDIFFERENTIATED SARCOMA,"LIVER,",69,29-37-54,primary UNDIFFERENTIATED SARCOMA,"The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man.",69,37 54,69,37,74,61,1,RO-disease_has_primary_anatomic_site,902305,"The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man",liver,undifferentiated sarcoma
502540477,7/12/2014 00:03:57,,1321080430,7/12/2014 00:03:49,prodege,1.0,23541832,USA,AZ,Tempe,149.169.133.153,69,37,,,74,61,LIVER,UNDIFFERENTIATED SARCOMA,"sarcoma of the LIVER,",54-62-65-69,29-37-54-62-65-69,"primary UNDIFFERENTIATED SARCOMA of the liver,","The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man.",69,37 54,69,37,74,61,1,RO-disease_has_primary_anatomic_site,902305,"The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man",liver,undifferentiated sarcoma
502540477,7/12/2014 00:08:36,,1321083146,7/12/2014 00:08:16,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,69,37,,,74,61,LIVER,UNDIFFERENTIATED SARCOMA,"LIVER,",69,37-54,UNDIFFERENTIATED SARCOMA,"The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man.",69,37 54,69,37,74,61,1,RO-disease_has_primary_anatomic_site,902305,"The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man",liver,undifferentiated sarcoma
502540477,7/12/2014 00:09:38,,1321083851,7/12/2014 00:08:51,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,69,37,,,74,61,LIVER,UNDIFFERENTIATED SARCOMA,"LIVER,",69,37-54,UNDIFFERENTIATED SARCOMA,"The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man.",69,37 54,69,37,74,61,1,RO-disease_has_primary_anatomic_site,902305,"The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man",liver,undifferentiated sarcoma
502540477,7/12/2014 00:12:15,,1321085355,7/12/2014 00:11:47,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,69,37,,,74,61,LIVER,UNDIFFERENTIATED SARCOMA,"primary undifferentiated sarcoma of the LIVER,",29-54-62-65-69-37,29-37-54-62-65-69,"primary UNDIFFERENTIATED SARCOMA of the liver,","The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man.",69,37 54,69,37,74,61,1,RO-disease_has_primary_anatomic_site,902305,"The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man",liver,undifferentiated sarcoma
502540477,7/12/2014 00:19:13,,1321089415,7/12/2014 00:19:02,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,69,37,,,74,61,LIVER,UNDIFFERENTIATED SARCOMA,"sarcoma of the LIVER,",54-62-65-69,29-37-54-62-65-69,"primary UNDIFFERENTIATED SARCOMA of the liver,","The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man.",69,37 54,69,37,74,61,1,RO-disease_has_primary_anatomic_site,902305,"The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man",liver,undifferentiated sarcoma
502540477,7/12/2014 00:29:55,,1321095053,7/12/2014 00:29:40,instagc,1.0,13763729,USA,"","",75.182.89.225,69,37,,,74,61,LIVER,UNDIFFERENTIATED SARCOMA,"LIVER,",69,37-54,UNDIFFERENTIATED SARCOMA,"The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man.",69,37 54,69,37,74,61,1,RO-disease_has_primary_anatomic_site,902305,"The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man",liver,undifferentiated sarcoma
502540477,7/12/2014 00:32:15,,1321096309,7/12/2014 00:31:29,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,69,37,,,74,61,LIVER,UNDIFFERENTIATED SARCOMA,"sarcoma of the LIVER,",54-62-69-65,29-37-54-62-65-69,"primary UNDIFFERENTIATED SARCOMA of the liver,","The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man.",69,37 54,69,37,74,61,1,RO-disease_has_primary_anatomic_site,902305,"The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man",liver,undifferentiated sarcoma
502540477,7/12/2014 00:33:06,,1321096810,7/12/2014 00:32:52,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,69,37,,,74,61,LIVER,UNDIFFERENTIATED SARCOMA,"primary undifferentiated sarcoma of the LIVER,",37-54-62-65-69-29,29-37-54-62-65-69,"primary UNDIFFERENTIATED SARCOMA of the liver,","The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man.",69,37 54,69,37,74,61,1,RO-disease_has_primary_anatomic_site,902305,"The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man",liver,undifferentiated sarcoma
502540477,7/12/2014 00:33:38,,1321097047,7/12/2014 00:32:31,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,69,37,,,74,61,LIVER,UNDIFFERENTIATED SARCOMA,"LIVER,",69,29-37-54,primary UNDIFFERENTIATED SARCOMA,"The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man.",69,37 54,69,37,74,61,1,RO-disease_has_primary_anatomic_site,902305,"The authors report a case of primary undifferentiated sarcoma of the liver, observed in a 36-year-old man",liver,undifferentiated sarcoma
502540478,7/11/2014 23:55:09,,1321075638,7/11/2014 23:54:57,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,165,75,,,182,88,VASOVAGAL SYNCOPE,ISOPROTERENOL,VASOVAGAL SYNCOPE.,165-175,75,"ISOPROTERENOL,","Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope.",165 175,75,165,75,182,88,1,RO-may_diagnose,906688,"Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope",vasovagal syncope,isoproterenol
502540478,7/12/2014 00:01:26,,1321078969,7/12/2014 00:01:14,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,165,75,,,182,88,VASOVAGAL SYNCOPE,ISOPROTERENOL,VASOVAGAL SYNCOPE.,165-175,75,"ISOPROTERENOL,","Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope.",165 175,75,165,75,182,88,1,RO-may_diagnose,906688,"Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope",vasovagal syncope,isoproterenol
502540478,7/12/2014 00:28:43,,1321094467,7/12/2014 00:28:19,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,165,75,,,182,88,VASOVAGAL SYNCOPE,ISOPROTERENOL,"graded dose infusion of isoproterenol, are susceptible to VASOVAGAL SYNCOPE.",51-58-63-72-146-150-162-165-175-75,51-58-63-72-75-90-93-95-175-165,"graded dose infusion of ISOPROTERENOL, is a useful vasovagal syncope.","Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope.",165 175,75,165,75,182,88,1,RO-may_diagnose,906688,"Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope",vasovagal syncope,isoproterenol
502540478,7/12/2014 00:34:14,,1321097359,7/12/2014 00:33:35,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,165,75,,,182,88,VASOVAGAL SYNCOPE,ISOPROTERENOL,VASOVAGAL SYNCOPE.,165-175,75,"ISOPROTERENOL,","Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope.",165 175,75,165,75,182,88,1,RO-may_diagnose,906688,"Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope",vasovagal syncope,isoproterenol
502540478,7/12/2014 00:37:35,,1321098968,7/12/2014 00:37:15,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,165,75,,,182,88,VASOVAGAL SYNCOPE,ISOPROTERENOL,VASOVAGAL SYNCOPE.,165-175,75,"ISOPROTERENOL,","Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope.",165 175,75,165,75,182,88,1,RO-may_diagnose,906688,"Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope",vasovagal syncope,isoproterenol
502540478,7/12/2014 00:38:58,,1321099599,7/12/2014 00:38:46,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,165,75,,,182,88,VASOVAGAL SYNCOPE,ISOPROTERENOL,VASOVAGAL SYNCOPE.,165-175,51-58-63-72-75,"graded dose infusion of ISOPROTERENOL,","Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope.",165 175,75,165,75,182,88,1,RO-may_diagnose,906688,"Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope",vasovagal syncope,isoproterenol
502540478,7/12/2014 01:22:02,,1321116842,7/12/2014 01:21:40,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,165,75,,,182,88,VASOVAGAL SYNCOPE,ISOPROTERENOL,"graded dose infusion of isoproterenol, VASOVAGAL SYNCOPE.",51-58-63-75-165-175-72,75-90-93-95-102-113,"ISOPROTERENOL, is a useful diagnostic test","Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope.",165 175,75,165,75,182,88,1,RO-may_diagnose,906688,"Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope",vasovagal syncope,isoproterenol
502540478,7/12/2014 01:24:59,,1321118078,7/12/2014 01:24:47,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,165,75,,,182,88,VASOVAGAL SYNCOPE,ISOPROTERENOL,VASOVAGAL SYNCOPE.,165-175,75,"ISOPROTERENOL,","Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope.",165 175,75,165,75,182,88,1,RO-may_diagnose,906688,"Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope",vasovagal syncope,isoproterenol
502540478,7/12/2014 01:30:28,,1321120633,7/12/2014 01:28:05,prodege,1.0,21318648,GBR,G7,Kingston Upon Thames,81.157.193.175,165,75,,,182,88,VASOVAGAL SYNCOPE,ISOPROTERENOL,"infusion isoproterenol, diagnostic test susceptible VASOVAGAL SYNCOPE.",63-75-102-113-150-165-175,63-75-102-150-165-175-113,"infusion ISOPROTERENOL, diagnostic test susceptible vasovagal syncope.","Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope.",165 175,75,165,75,182,88,1,RO-may_diagnose,906688,"Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope",vasovagal syncope,isoproterenol
502540478,7/12/2014 01:36:26,,1321123186,7/12/2014 01:35:52,instagc,1,25387994,CAN,BC,Cache Creek,208.114.155.4,165,75,,,182,88,VASOVAGAL SYNCOPE,ISOPROTERENOL,VASOVAGAL SYNCOPE.,165-175,51-58-63-72-75,"graded dose infusion of ISOPROTERENOL,","Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope.",165 175,75,165,75,182,88,1,RO-may_diagnose,906688,"Head-up tilt table testing, either alone or with a graded-dose infusion of isoproterenol, is a useful diagnostic test for identifying persons who are susceptible to vasovagal syncope",vasovagal syncope,isoproterenol
502540479,7/11/2014 23:56:41,,1321076519,7/11/2014 23:56:04,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,59,88,,,76,105,PHAEOCHROMOCYTOMA,SIPPLE'S SYNDROME,PHAEOCHROMOCYTOMA,59,88-97,SIPPLE'S SYNDROME),We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members.,59,88 97,59,88,76,105,1,RO-has_manifestation,906145,We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members,phaeochromocytoma,Sipple's syndrome
502540479,7/12/2014 00:04:11,,1321080612,7/12/2014 00:03:58,prodege,1.0,23541832,USA,AZ,Tempe,149.169.133.153,59,88,,,76,105,PHAEOCHROMOCYTOMA,SIPPLE'S SYNDROME,PHAEOCHROMOCYTOMA (MEN 2A or Sipple's syndrome),59-77-82-85-88-97,77-82-85-88-97,(MEN 2A or SIPPLE'S SYNDROME),We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members.,59,88 97,59,88,76,105,1,RO-has_manifestation,906145,We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members,phaeochromocytoma,Sipple's syndrome
502540479,7/12/2014 00:18:11,,1321088893,7/12/2014 00:17:53,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,59,88,,,76,105,PHAEOCHROMOCYTOMA,SIPPLE'S SYNDROME,medullary thyroid carcinoma and PHAEOCHROMOCYTOMA 2A or,37-45-55-59-82-85-27,88-97,SIPPLE'S SYNDROME),We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members.,59,88 97,59,88,76,105,1,RO-has_manifestation,906145,We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members,phaeochromocytoma,Sipple's syndrome
502540479,7/12/2014 00:18:26,,1321089021,7/12/2014 00:18:04,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,59,88,,,76,105,PHAEOCHROMOCYTOMA,SIPPLE'S SYNDROME,medullary thyroid carcinoma and PHAEOCHROMOCYTOMA,27-37-45-55-59,77-82-85-88-97,(MEN 2A or SIPPLE'S SYNDROME),We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members.,59,88 97,59,88,76,105,1,RO-has_manifestation,906145,We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members,phaeochromocytoma,Sipple's syndrome
502540479,7/12/2014 00:20:24,,1321089998,7/12/2014 00:20:13,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,59,88,,,76,105,PHAEOCHROMOCYTOMA,SIPPLE'S SYNDROME,PHAEOCHROMOCYTOMA,59,88-97,SIPPLE'S SYNDROME),We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members.,59,88 97,59,88,76,105,1,RO-has_manifestation,906145,We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members,phaeochromocytoma,Sipple's syndrome
502540479,7/12/2014 00:23:10,,1321091662,7/12/2014 00:22:46,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,59,88,,,76,105,PHAEOCHROMOCYTOMA,SIPPLE'S SYNDROME,medullary thyroid carcinoma and PHAEOCHROMOCYTOMA (MEN 2A or Sipple's syndrome),27-37-45-55-59-77-82-85-88-97,27-37-45-59-77-82-85-88-97-107-110-116,medullary thyroid carcinoma phaeochromocytoma (MEN 2A or SIPPLE'S SYNDROME) in which a,We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members.,59,88 97,59,88,76,105,1,RO-has_manifestation,906145,We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members,phaeochromocytoma,Sipple's syndrome
502540479,7/12/2014 00:26:36,,1321093423,7/12/2014 00:26:23,instagc,1.0,13763729,USA,"","",75.182.89.225,59,88,,,76,105,PHAEOCHROMOCYTOMA,SIPPLE'S SYNDROME,PHAEOCHROMOCYTOMA,59,88-97,SIPPLE'S SYNDROME),We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members.,59,88 97,59,88,76,105,1,RO-has_manifestation,906145,We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members,phaeochromocytoma,Sipple's syndrome
502540479,7/12/2014 01:04:22,,1321109758,7/12/2014 01:04:05,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,59,88,,,76,105,PHAEOCHROMOCYTOMA,SIPPLE'S SYNDROME,medullary thyroid carcinoma and PHAEOCHROMOCYTOMA,27-37-45-55-59,77-82-85-88-97,(MEN 2A or SIPPLE'S SYNDROME),We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members.,59,88 97,59,88,76,105,1,RO-has_manifestation,906145,We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members,phaeochromocytoma,Sipple's syndrome
502540479,7/12/2014 01:16:08,,1321114784,7/12/2014 01:15:47,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,59,88,,,76,105,PHAEOCHROMOCYTOMA,SIPPLE'S SYNDROME,thyroid PHAEOCHROMOCYTOMA (MEN 2A or Sipple's syndrome),37-59-77-82-85-88-97,59-77-82-85-88-97,phaeochromocytoma (MEN 2A or SIPPLE'S SYNDROME),We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members.,59,88 97,59,88,76,105,1,RO-has_manifestation,906145,We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members,phaeochromocytoma,Sipple's syndrome
502540479,7/12/2014 01:19:18,,1321115816,7/12/2014 01:18:40,prodege,1.0,21318648,GBR,G7,Kingston Upon Thames,81.157.193.175,59,88,,,76,105,PHAEOCHROMOCYTOMA,SIPPLE'S SYNDROME,medullary thyroid carcinoma PHAEOCHROMOCYTOMA Sipple's syndrome) cutaneous manifestation affected,27-37-45-59-88-97-118-128-161,37-45-59-88-97-118-128-27,medullary thyroid carcinoma phaeochromocytoma SIPPLE'S SYNDROME) cutaneous manifestation,We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members.,59,88 97,59,88,76,105,1,RO-has_manifestation,906145,We describe a kindred with medullary thyroid carcinoma and phaeochromocytoma (MEN 2A or Sipple's syndrome) in which a cutaneous manifestation is only present in affected members,phaeochromocytoma,Sipple's syndrome
502540480,7/11/2014 23:58:34,,1321077330,7/11/2014 23:58:17,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,168,141,,,182,149,HYPOTHYROIDISM,THYROXIN,HYPOTHYROIDISM.,168,141,THYROXIN,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism.,168,141,168,141,182,149,1,RO-may_prevent,907372,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism,hypothyroidism,thyroxin
502540480,7/12/2014 00:03:28,,1321080153,7/12/2014 00:02:55,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,168,141,,,182,149,HYPOTHYROIDISM,THYROXIN,HYPOTHYROIDISM.,168,129-137-141,results for THYROXIN,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism.,168,141,168,141,182,149,1,RO-may_prevent,907372,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism,hypothyroidism,thyroxin
502540480,7/12/2014 00:07:11,,1321082333,7/12/2014 00:06:52,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,168,141,,,182,149,HYPOTHYROIDISM,THYROXIN,HYPOTHYROIDISM.,168,141,THYROXIN,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism.,168,141,168,141,182,149,1,RO-may_prevent,907372,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism,hypothyroidism,thyroxin
502540480,7/12/2014 00:19:59,,1321089840,7/12/2014 00:19:41,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,168,141,,,182,149,HYPOTHYROIDISM,THYROXIN,HYPOTHYROIDISM.,168,141,THYROXIN,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism.,168,141,168,141,182,149,1,RO-may_prevent,907372,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism,hypothyroidism,thyroxin
502540480,7/12/2014 00:21:50,,1321090830,7/12/2014 00:21:44,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,168,141,,,182,149,HYPOTHYROIDISM,THYROXIN,are suggestive of HYPOTHYROIDISM.,150-154-165-168,125-129-137-141-150-154-165,the results for THYROXIN are suggestive of,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism.,168,141,168,141,182,149,1,RO-may_prevent,907372,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism,hypothyroidism,thyroxin
502540480,7/12/2014 00:25:00,,1321092658,7/12/2014 00:24:32,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,168,141,,,182,149,HYPOTHYROIDISM,THYROXIN,HYPOTHYROIDISM.,168,141,THYROXIN,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism.,168,141,168,141,182,149,1,RO-may_prevent,907372,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism,hypothyroidism,thyroxin
502540480,7/12/2014 00:28:19,,1321094282,7/12/2014 00:27:54,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,168,141,,,182,149,HYPOTHYROIDISM,THYROXIN,HYPOTHYROIDISM.,168,141,THYROXIN,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism.,168,141,168,141,182,149,1,RO-may_prevent,907372,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism,hypothyroidism,thyroxin
502540480,7/12/2014 00:35:07,,1321097755,7/12/2014 00:34:56,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,168,141,,,182,149,HYPOTHYROIDISM,THYROXIN,HYPOTHYROIDISM.,168,141,THYROXIN,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism.,168,141,168,141,182,149,1,RO-may_prevent,907372,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism,hypothyroidism,thyroxin
502540480,7/12/2014 00:38:17,,1321099296,7/12/2014 00:38:01,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,168,141,,,182,149,HYPOTHYROIDISM,THYROXIN,HYPOTHYROIDISM.,168,141,THYROXIN,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism.,168,141,168,141,182,149,1,RO-may_prevent,907372,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism,hypothyroidism,thyroxin
502540480,7/12/2014 00:43:22,,1321101587,7/12/2014 00:42:56,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,168,141,,,182,149,HYPOTHYROIDISM,THYROXIN,HYPOTHYROIDISM.,168,141,THYROXIN,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism.,168,141,168,141,182,149,1,RO-may_prevent,907372,The screening usually consists of measuring thyroxin in dried blood spot specimens followed by measurement of thyrotropin if the results for thyroxin are suggestive of hypothyroidism,hypothyroidism,thyroxin
502540481,7/11/2014 23:56:37,,1321076488,7/11/2014 23:56:19,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,101,32,,,105,50,DRUG,TARDIVE DYSKINESIA,DRUG histories,101-106,23-32-40,moderate TARDIVE DYSKINESIA,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia.",101,32 40,101,32,105,50,-1,RO-has_causative_agent,903956,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia",drug,tardive dyskinesia
502540481,7/12/2014 00:15:49,,1321087499,7/12/2014 00:15:10,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,101,32,,,105,50,DRUG,TARDIVE DYSKINESIA,DRUG histories,101-106,23-32-40,moderate TARDIVE DYSKINESIA,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia.",101,32 40,101,32,105,50,-1,RO-has_causative_agent,903956,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia",drug,tardive dyskinesia
502540481,7/12/2014 00:21:43,,1321090767,7/12/2014 00:21:39,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,101,32,,,105,50,DRUG,TARDIVE DYSKINESIA,periods in their DRUG histories than did,84-92-95-101-106-116-121,9-18-23-32-40-51-55-69,patients with moderate TARDIVE DYSKINESIA had significantly more,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia.",101,32 40,101,32,105,50,-1,RO-has_causative_agent,903956,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia",drug,tardive dyskinesia
502540481,7/12/2014 00:22:27,,1321091212,7/12/2014 00:22:15,instagc,1.0,13763729,USA,"","",75.182.89.225,101,32,,,105,50,DRUG,TARDIVE DYSKINESIA,DRUG,101,32-40,TARDIVE DYSKINESIA,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia.",101,32 40,101,32,105,50,-1,RO-has_causative_agent,903956,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia",drug,tardive dyskinesia
502540481,7/12/2014 00:26:18,,1321093290,7/12/2014 00:26:03,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,101,32,,,105,50,DRUG,TARDIVE DYSKINESIA,DRUG histories,101-106,9-18-23-32-40,patients with moderate TARDIVE DYSKINESIA,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia.",101,32 40,101,32,105,50,-1,RO-has_causative_agent,903956,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia",drug,tardive dyskinesia
502540481,7/12/2014 00:29:26,,1321094819,7/12/2014 00:27:27,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,101,32,,,105,50,DRUG,TARDIVE DYSKINESIA,DRUG histories,101-106,32-40,TARDIVE DYSKINESIA,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia.",101,32 40,101,32,105,50,-1,RO-has_causative_agent,903956,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia",drug,tardive dyskinesia
502540481,7/12/2014 00:30:27,,1321095330,7/12/2014 00:30:08,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,101,32,,,105,50,DRUG,TARDIVE DYSKINESIA,DRUG,101,23-32-40,moderate TARDIVE DYSKINESIA,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia.",101,32 40,101,32,105,50,-1,RO-has_causative_agent,903956,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia",drug,tardive dyskinesia
502540481,7/12/2014 00:32:25,,1321096416,7/12/2014 00:32:13,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,101,32,,,105,50,DRUG,TARDIVE DYSKINESIA,DRUG histories did,101-106-121,23-32-40,moderate TARDIVE DYSKINESIA,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia.",101,32 40,101,32,105,50,-1,RO-has_causative_agent,903956,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia",drug,tardive dyskinesia
502540481,7/12/2014 00:39:25,,1321099843,7/12/2014 00:39:00,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,101,32,,,105,50,DRUG,TARDIVE DYSKINESIA,DRUG histories,101-106,23-32-40,moderate TARDIVE DYSKINESIA,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia.",101,32 40,101,32,105,50,-1,RO-has_causative_agent,903956,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia",drug,tardive dyskinesia
502540481,7/12/2014 00:41:07,,1321100535,7/12/2014 00:40:18,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,101,32,,,105,50,DRUG,TARDIVE DYSKINESIA,patients with moderate tardive dyskinesia DRUG histories than did patients with mild tardive dyskinesia.,9-18-23-32-40-101-106-116-121-125-134-139-144-152,9-18-23-32-40-125-134-139-144-152,patients with moderate TARDIVE DYSKINESIA patients with mild tardive dyskinesia.,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia.",101,32 40,101,32,105,50,-1,RO-has_causative_agent,903956,"However, patients with moderate tardive dyskinesia had significantly more drug-free periods in their drug histories than did patients with mild tardive dyskinesia",drug,tardive dyskinesia
502540482,7/11/2014 23:59:39,,1321077886,7/11/2014 23:59:26,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,82,31,,,93,49,NEUTROPENIA,CYCLIC NEUTROPENIA,chemotherapy induced NEUTROPENIA,61-74-82,31-38,CYCLIC NEUTROPENIA,Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors.,82,31 38,82,31,93,49,-1,RO-has_definitional_manifestation,904686,Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors,neutropenia,cyclic neutropenia
502540482,7/12/2014 00:02:01,,1321079290,7/12/2014 00:01:46,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,82,31,,,93,49,NEUTROPENIA,CYCLIC NEUTROPENIA,chemotherapy induced NEUTROPENIA (chNP),61-74-82-94,31-38-50,CYCLIC NEUTROPENIA (cyNP),Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors.,82,31 38,82,31,93,49,-1,RO-has_definitional_manifestation,904686,Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors,neutropenia,cyclic neutropenia
502540482,7/12/2014 00:06:34,,1321081960,7/12/2014 00:06:17,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,82,31,,,93,49,NEUTROPENIA,CYCLIC NEUTROPENIA,NEUTROPENIA,82,31-38,CYCLIC NEUTROPENIA,Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors.,82,31 38,82,31,93,49,-1,RO-has_definitional_manifestation,904686,Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors,neutropenia,cyclic neutropenia
502540482,7/12/2014 00:11:46,,1321085060,7/12/2014 00:10:51,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,82,31,,,93,49,NEUTROPENIA,CYCLIC NEUTROPENIA,cyclic neutropenia (cyNP) and chemotherapy induced NEUTROPENIA (chNP) mobilized [Ca2+]i,31-38-50-57-61-74-82-94-101-111,0-12-17-26-31-38-50-57-61-74-82-94-101-111,Neutrophils from patients with CYCLIC NEUTROPENIA (cyNP) and chemotherapy induced neutropenia (chNP) mobilized [Ca2+]i,Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors.,82,31 38,82,31,93,49,-1,RO-has_definitional_manifestation,904686,Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors,neutropenia,cyclic neutropenia
502540482,7/12/2014 00:16:29,,1321087884,7/12/2014 00:16:18,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,82,31,,,93,49,NEUTROPENIA,CYCLIC NEUTROPENIA,NEUTROPENIA,82,31-38,CYCLIC NEUTROPENIA,Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors.,82,31 38,82,31,93,49,-1,RO-has_definitional_manifestation,904686,Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors,neutropenia,cyclic neutropenia
502540482,7/12/2014 00:24:02,,1321092182,7/12/2014 00:23:35,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,82,31,,,93,49,NEUTROPENIA,CYCLIC NEUTROPENIA,NEUTROPENIA,82,31-38,CYCLIC NEUTROPENIA,Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors.,82,31 38,82,31,93,49,-1,RO-has_definitional_manifestation,904686,Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors,neutropenia,cyclic neutropenia
502540482,7/12/2014 00:29:21,,1321094789,7/12/2014 00:29:07,instagc,1.0,13763729,USA,"","",75.182.89.225,82,31,,,93,49,NEUTROPENIA,CYCLIC NEUTROPENIA,NEUTROPENIA,82,31-38,CYCLIC NEUTROPENIA,Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors.,82,31 38,82,31,93,49,-1,RO-has_definitional_manifestation,904686,Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors,neutropenia,cyclic neutropenia
502540482,7/12/2014 00:30:54,,1321095653,7/12/2014 00:30:36,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,82,31,,,93,49,NEUTROPENIA,CYCLIC NEUTROPENIA,chemotherapy induced NEUTROPENIA,61-74-82,31-38-57-61-74-82,CYCLIC NEUTROPENIA and chemotherapy induced neutropenia,Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors.,82,31 38,82,31,93,49,-1,RO-has_definitional_manifestation,904686,Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors,neutropenia,cyclic neutropenia
502540482,7/12/2014 00:34:02,,1321097280,7/12/2014 00:33:32,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,82,31,,,93,49,NEUTROPENIA,CYCLIC NEUTROPENIA,chemotherapy induced NEUTROPENIA (chNP),61-74-82-94,31-38,CYCLIC NEUTROPENIA,Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors.,82,31 38,82,31,93,49,-1,RO-has_definitional_manifestation,904686,Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors,neutropenia,cyclic neutropenia
502540482,7/12/2014 00:36:11,,1321098367,7/12/2014 00:35:56,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,82,31,,,93,49,NEUTROPENIA,CYCLIC NEUTROPENIA,chemotherapy induced NEUTROPENIA,61-74-82,31-38,CYCLIC NEUTROPENIA,Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors.,82,31 38,82,31,93,49,-1,RO-has_definitional_manifestation,904686,Neutrophils from patients with cyclic neutropenia (cyNP) and chemotherapy-induced neutropenia (chNP) mobilized [Ca2+]i similar to those from healthy donors,neutropenia,cyclic neutropenia
502540483,7/11/2014 23:56:55,,1321076632,7/11/2014 23:56:42,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,51,83,,,59,96,SEIZURES,GANGLIOGLIOMA,SEIZURES,51,83,GANGLIOGLIOMA,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle.,51,83,51,83,59,96,1,RO-disease_may_have_finding,902994,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle,seizures,ganglioglioma
502540483,7/12/2014 00:11:59,,1321085164,7/12/2014 00:11:39,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,51,83,,,59,96,SEIZURES,GANGLIOGLIOMA,SEIZURES,51,83,GANGLIOGLIOMA,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle.,51,83,51,83,59,96,1,RO-disease_may_have_finding,902994,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle,seizures,ganglioglioma
502540483,7/12/2014 00:18:57,,1321089256,7/12/2014 00:18:46,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,51,83,,,59,96,SEIZURES,GANGLIOGLIOMA,SEIZURES,51,83,GANGLIOGLIOMA,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle.,51,83,51,83,59,96,1,RO-disease_may_have_finding,902994,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle,seizures,ganglioglioma
502540483,7/12/2014 00:22:45,,1321091349,7/12/2014 00:22:27,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,51,83,,,59,96,SEIZURES,GANGLIOGLIOMA,adult patient without SEIZURES who is found ganglioglioma cerebellopontine angle.,29-35-43-51-60-64-67-83-114-131,73-76-81-83-97-107-110-114-131,to have a GANGLIOGLIOMA occurring in the cerebellopontine angle.,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle.,51,83,51,83,59,96,1,RO-disease_may_have_finding,902994,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle,seizures,ganglioglioma
502540483,7/12/2014 00:25:34,,1321092917,7/12/2014 00:25:28,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,51,83,,,59,96,SEIZURES,GANGLIOGLIOMA,adult patient without SEIZURES who is found,29-35-43-51-60-64-67,73-76-81-83-97-107-110,to have a GANGLIOGLIOMA occurring in the,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle.,51,83,51,83,59,96,1,RO-disease_may_have_finding,902994,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle,seizures,ganglioglioma
502540483,7/12/2014 00:28:10,,1321094193,7/12/2014 00:27:57,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,51,83,,,59,96,SEIZURES,GANGLIOGLIOMA,SEIZURES,51,83,GANGLIOGLIOMA,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle.,51,83,51,83,59,96,1,RO-disease_may_have_finding,902994,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle,seizures,ganglioglioma
502540483,7/12/2014 00:29:06,,1321094608,7/12/2014 00:28:49,instagc,1.0,13763729,USA,"","",75.182.89.225,51,83,,,59,96,SEIZURES,GANGLIOGLIOMA,SEIZURES,51,83,GANGLIOGLIOMA,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle.,51,83,51,83,59,96,1,RO-disease_may_have_finding,902994,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle,seizures,ganglioglioma
502540483,7/12/2014 00:36:29,,1321098500,7/12/2014 00:36:14,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,51,83,,,59,96,SEIZURES,GANGLIOGLIOMA,SEIZURES,51,83,GANGLIOGLIOMA,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle.,51,83,51,83,59,96,1,RO-disease_may_have_finding,902994,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle,seizures,ganglioglioma
502540483,7/12/2014 01:05:45,,1321110358,7/12/2014 01:05:23,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,51,83,,,59,96,SEIZURES,GANGLIOGLIOMA,adult patient without SEIZURES,29-35-43-51,83,GANGLIOGLIOMA,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle.,51,83,51,83,59,96,1,RO-disease_may_have_finding,902994,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle,seizures,ganglioglioma
502540483,7/12/2014 01:17:02,,1321115017,7/12/2014 01:16:30,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,51,83,,,59,96,SEIZURES,GANGLIOGLIOMA,SEIZURES ganglioglioma occurring in the cerebellopontine angle.,51-83-97-107-110-114-131,83-97-107-110-114-131,GANGLIOGLIOMA occurring in the cerebellopontine angle.,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle.,51,83,51,83,59,96,1,RO-disease_may_have_finding,902994,We present a rare case of an adult patient without seizures who is found to have a ganglioglioma occurring in the cerebellopontine angle,seizures,ganglioglioma
502540484,7/12/2014 00:01:44,,1321079125,7/12/2014 00:01:28,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,86,21,,,104,40,METASTATIC LESIONS,METASTATIC MELANOMA,METASTATIC LESIONS,86-97,21-32-41-46,METASTATIC MELANOMA cell lines,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma.,86 97,21 32,86,21,104,40,-1,RO-disease_has_finding,901775,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma,metastatic lesions,metastatic melanoma
502540484,7/12/2014 00:05:10,,1321081160,7/12/2014 00:04:44,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,86,21,,,104,40,METASTATIC LESIONS,METASTATIC MELANOMA,METASTATIC LESIONS,86-97,21-32,METASTATIC MELANOMA,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma.,86 97,21 32,86,21,104,40,-1,RO-disease_has_finding,901775,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma,metastatic lesions,metastatic melanoma
502540484,7/12/2014 00:16:17,,1321087732,7/12/2014 00:16:01,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,86,21,,,104,40,METASTATIC LESIONS,METASTATIC MELANOMA,METASTATIC LESIONS,86-97,21-32,METASTATIC MELANOMA,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma.,86 97,21 32,86,21,104,40,-1,RO-disease_has_finding,901775,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma,metastatic lesions,metastatic melanoma
502540484,7/12/2014 00:24:31,,1321092435,7/12/2014 00:24:18,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,86,21,,,104,40,METASTATIC LESIONS,METASTATIC MELANOMA,primary and METASTATIC LESIONS 4,74-82-86-97-108,21-32-41-46,METASTATIC MELANOMA cell lines,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma.,86 97,21 32,86,21,104,40,-1,RO-disease_has_finding,901775,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma,metastatic lesions,metastatic melanoma
502540484,7/12/2014 00:31:53,,1321096162,7/12/2014 00:31:25,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,86,21,,,104,40,METASTATIC LESIONS,METASTATIC MELANOMA,METASTATIC LESIONS,86-97,21-32,METASTATIC MELANOMA,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma.,86 97,21 32,86,21,104,40,-1,RO-disease_has_finding,901775,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma,metastatic lesions,metastatic melanoma
502540484,7/12/2014 00:33:31,,1321096987,7/12/2014 00:32:56,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,86,21,,,104,40,METASTATIC LESIONS,METASTATIC MELANOMA,primary and METASTATIC LESIONS,74-82-86-97,6-14-21-32-41-46,primary and METASTATIC MELANOMA cell lines,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma.,86 97,21 32,86,21,104,40,-1,RO-disease_has_finding,901775,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma,metastatic lesions,metastatic melanoma
502540484,7/12/2014 00:34:51,,1321097628,7/12/2014 00:34:16,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,86,21,,,104,40,METASTATIC LESIONS,METASTATIC MELANOMA,METASTATIC LESIONS,86-97,21-32-41-46,METASTATIC MELANOMA cell lines,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma.,86 97,21 32,86,21,104,40,-1,RO-disease_has_finding,901775,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma,metastatic lesions,metastatic melanoma
502540484,7/12/2014 00:41:05,,1321100520,7/12/2014 00:40:43,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,86,21,,,104,40,METASTATIC LESIONS,METASTATIC MELANOMA,METASTATIC LESIONS,86-97,21-32,METASTATIC MELANOMA,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma.,86 97,21 32,86,21,104,40,-1,RO-disease_has_finding,901775,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma,metastatic lesions,metastatic melanoma
502540484,7/12/2014 01:05:11,,1321110094,7/12/2014 01:05:00,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,86,21,,,104,40,METASTATIC LESIONS,METASTATIC MELANOMA,primary and METASTATIC LESIONS,74-82-86-97,21-32-41-46,METASTATIC MELANOMA cell lines,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma.,86 97,21 32,86,21,104,40,-1,RO-disease_has_finding,901775,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma,metastatic lesions,metastatic melanoma
502540484,7/12/2014 01:20:51,,1321116456,7/12/2014 01:20:34,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,86,21,,,104,40,METASTATIC LESIONS,METASTATIC MELANOMA,melanoma cell lines METASTATIC LESIONS,32-41-86-97-46,21-32-41-46,METASTATIC MELANOMA cell lines,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma.,86 97,21 32,86,21,104,40,-1,RO-disease_has_finding,901775,Three primary and 16 metastatic melanoma cell lines were established from primary and metastatic lesions of 4 patients with malignant melanoma,metastatic lesions,metastatic melanoma
502540485,7/11/2014 23:54:18,,1321075223,7/11/2014 23:53:52,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,182,234,,,191,250,ALLERGIES,HYPERSENSITIVITY,"drug ALLERGIES,",177-182,224-234-251,immediate HYPERSENSITIVITY reactions.,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions.",182,234,182,234,191,250,-1,RO-cause_of,900341,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions",allergies,hypersensitivity
502540485,7/12/2014 00:19:12,,1321089388,7/12/2014 00:18:58,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,182,234,,,191,250,ALLERGIES,HYPERSENSITIVITY,"ALLERGIES,",182,234,HYPERSENSITIVITY,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions.",182,234,182,234,191,250,-1,RO-cause_of,900341,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions",allergies,hypersensitivity
502540485,7/12/2014 00:20:23,,1321089996,7/12/2014 00:20:00,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,182,234,,,191,250,ALLERGIES,HYPERSENSITIVITY,"food or drug ALLERGIES,",169-174-177-182,211-215-224-234-251,IgE mediated immediate HYPERSENSITIVITY reactions.,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions.",182,234,182,234,191,250,-1,RO-cause_of,900341,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions",allergies,hypersensitivity
502540485,7/12/2014 00:26:43,,1321093481,7/12/2014 00:26:06,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,182,234,,,191,250,ALLERGIES,HYPERSENSITIVITY,"vitro vivo diagnostic tests food or drug ALLERGIES, as well as",109-121-126-137-169-174-177-182-193-196-201,109-121-211-215-224-234-251-126,vitro vivo diagnostic IgE mediated immediate HYPERSENSITIVITY reactions.,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions.",182,234,182,234,191,250,-1,RO-cause_of,900341,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions",allergies,hypersensitivity
502540485,7/12/2014 00:27:42,,1321093950,7/12/2014 00:27:18,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,182,234,,,191,250,ALLERGIES,HYPERSENSITIVITY,"ALLERGIES,",182,234,HYPERSENSITIVITY,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions.",182,234,182,234,191,250,-1,RO-cause_of,900341,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions",allergies,hypersensitivity
502540485,7/12/2014 00:28:27,,1321094331,7/12/2014 00:25:40,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,182,234,,,191,250,ALLERGIES,HYPERSENSITIVITY,"food or drug ALLERGIES,",169-174-177-182,211-215-224-234-251-207,non IgE mediated immediate HYPERSENSITIVITY reactions.,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions.",182,234,182,234,191,250,-1,RO-cause_of,900341,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions",allergies,hypersensitivity
502540485,7/12/2014 00:28:29,,1321094342,7/12/2014 00:28:11,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,182,234,,,191,250,ALLERGIES,HYPERSENSITIVITY,"ALLERGIES,",182,234-251,HYPERSENSITIVITY reactions.,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions.",182,234,182,234,191,250,-1,RO-cause_of,900341,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions",allergies,hypersensitivity
502540485,7/12/2014 00:30:51,,1321095629,7/12/2014 00:30:09,instagc,1.0,13763729,USA,"","",75.182.89.225,182,234,,,191,250,ALLERGIES,HYPERSENSITIVITY,"ALLERGIES,",182,234,HYPERSENSITIVITY,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions.",182,234,182,234,191,250,-1,RO-cause_of,900341,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions",allergies,hypersensitivity
502540485,7/12/2014 00:37:18,,1321098900,7/12/2014 00:36:33,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,182,234,,,191,250,ALLERGIES,HYPERSENSITIVITY,"drug ALLERGIES,",177-182,211-215-224-234-251,IgE mediated immediate HYPERSENSITIVITY reactions.,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions.",182,234,182,234,191,250,-1,RO-cause_of,900341,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions",allergies,hypersensitivity
502540485,7/12/2014 00:48:42,,1321103639,7/12/2014 00:47:55,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,182,234,,,191,250,ALLERGIES,HYPERSENSITIVITY,"food or drug ALLERGIES,",169-174-182-177,211-215-224-234-251-207,non IgE mediated immediate HYPERSENSITIVITY reactions.,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions.",182,234,182,234,191,250,-1,RO-cause_of,900341,"This should definitely establish the value of this diagnostic test, particularly in instances where other in vitro or in vivo diagnostic tests are not reliable, such as food or drug allergies, as well as in non-IgE-mediated immediate hypersensitivity reactions",allergies,hypersensitivity
502540486,7/12/2014 00:08:56,,1321083388,7/12/2014 00:08:37,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,79,151,,,87,167,HEADACHE,PHEOCHROMOCYTOMA,"HEADACHE,",79,151,PHEOCHROMOCYTOMA,"Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients.",79,151,79,151,87,167,1,RO-disease_may_have_finding,902651,"Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients",headache,pheochromocytoma
502540486,7/12/2014 00:16:24,,1321087820,7/12/2014 00:16:05,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,79,151,,,87,167,HEADACHE,PHEOCHROMOCYTOMA,"HEADACHE, palpitations, and diaphoresis",79-89-103-107,151,PHEOCHROMOCYTOMA,"Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients.",79,151,79,151,87,167,1,RO-disease_may_have_finding,902651,"Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients",headache,pheochromocytoma
502540486,7/12/2014 00:20:12,,1321089892,7/12/2014 00:19:57,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,79,151,,,87,167,HEADACHE,PHEOCHROMOCYTOMA,"HEADACHE,",79,151,PHEOCHROMOCYTOMA,"Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients.",79,151,79,151,87,167,1,RO-disease_may_have_finding,902651,"Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients",headache,pheochromocytoma
502540486,7/12/2014 00:21:37,,1321090695,7/12/2014 00:21:33,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,79,151,,,87,167,HEADACHE,PHEOCHROMOCYTOMA,"the triad of HEADACHE, palpitations, and diaphoresis",66-70-76-79-89-103-107,135-139-148-151-168-178-182,"the majority of PHEOCHROMOCYTOMA patients, but in","Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients.",79,151,79,151,87,167,1,RO-disease_may_have_finding,902651,"Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients",headache,pheochromocytoma
502540486,7/12/2014 00:35:34,,1321098012,7/12/2014 00:35:13,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,79,151,,,87,167,HEADACHE,PHEOCHROMOCYTOMA,"HEADACHE,",79,151,PHEOCHROMOCYTOMA,"Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients.",79,151,79,151,87,167,1,RO-disease_may_have_finding,902651,"Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients",headache,pheochromocytoma
502540486,7/12/2014 00:37:57,,1321099196,7/12/2014 00:37:11,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,79,151,,,87,167,HEADACHE,PHEOCHROMOCYTOMA,"symptoms symptoms from the triad of HEADACHE, palpitations, and diaphoresis present in majority of pheochromocytoma patients, smaller number of non pheochromocytoma patients.",16-52-61-66-70-76-79-89-103-107-124-132-139-148-151-168-187-195-205-209-226-202,16-52-61-66-70-76-79-89-103-107-135-139-148-151-168-178-182-187-195-202-205-209-226-124,"symptoms symptoms from the triad of headache, palpitations, and diaphoresis present the majority of PHEOCHROMOCYTOMA patients, but in smaller number of non pheochromocytoma patients.","Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients.",79,151,79,151,87,167,1,RO-disease_may_have_finding,902651,"Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients",headache,pheochromocytoma
502540486,7/12/2014 00:39:19,,1321099762,7/12/2014 00:38:58,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,79,151,,,87,167,HEADACHE,PHEOCHROMOCYTOMA,"HEADACHE,",79,151,PHEOCHROMOCYTOMA,"Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients.",79,151,79,151,87,167,1,RO-disease_may_have_finding,902651,"Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients",headache,pheochromocytoma
502540486,7/12/2014 00:41:29,,1321100790,7/12/2014 00:40:59,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,79,151,,,87,167,HEADACHE,PHEOCHROMOCYTOMA,"HEADACHE,",79,151,PHEOCHROMOCYTOMA,"Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients.",79,151,79,151,87,167,1,RO-disease_may_have_finding,902651,"Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients",headache,pheochromocytoma
502540486,7/12/2014 01:07:54,,1321111161,7/12/2014 01:07:42,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,79,151,,,87,167,HEADACHE,PHEOCHROMOCYTOMA,"HEADACHE, palpitations, and diaphoresis",79-89-103-107,151,PHEOCHROMOCYTOMA,"Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients.",79,151,79,151,87,167,1,RO-disease_may_have_finding,902651,"Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients",headache,pheochromocytoma
502540486,7/12/2014 01:21:16,,1321116591,7/12/2014 01:20:52,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,79,151,,,87,167,HEADACHE,PHEOCHROMOCYTOMA,"HEADACHE, were present majority pheochromocytoma patients,",79-119-124-139-151-168,79-89-148-151-107,"headache, palpitations, diaphoresis of PHEOCHROMOCYTOMA","Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients.",79,151,79,151,87,167,1,RO-disease_may_have_finding,902651,"Combinations of symptoms can be of value: 2 or more symptoms from the triad of headache, palpitations, and diaphoresis were present in the majority of pheochromocytoma patients, but in a smaller number of non-pheochromocytoma patients",headache,pheochromocytoma
502540487,7/12/2014 00:10:50,,1321084534,7/12/2014 00:10:20,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,148,124,,,165,130,ATOPIC DERMATITIS,ATOPIC,"ATOPIC DERMATITIS, allergic rhinitis and asthma.",148-155-167-176-185-189,124-131-140-145-148-155-167-176-185-189,"ATOPIC diseases such as atopic dermatitis, allergic rhinitis and asthma.","These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma.",148 155,124,148,124,165,130,-1,RO-cause_of,900156,"These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma",atopic dermatitis,atopic
502540487,7/12/2014 00:19:53,,1321089764,7/12/2014 00:19:39,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,148,124,,,165,130,ATOPIC DERMATITIS,ATOPIC,"ATOPIC DERMATITIS,",148-155,124-131,ATOPIC diseases,"These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma.",148 155,124,148,124,165,130,-1,RO-cause_of,900156,"These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma",atopic dermatitis,atopic
502540487,7/12/2014 00:21:16,,1321090488,7/12/2014 00:20:47,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,148,124,,,165,130,ATOPIC DERMATITIS,ATOPIC,"ATOPIC DERMATITIS,",148-155,124,ATOPIC,"These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma.",148 155,124,148,124,165,130,-1,RO-cause_of,900156,"These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma",atopic dermatitis,atopic
502540487,7/12/2014 00:23:08,,1321091631,7/12/2014 00:22:27,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,148,124,,,165,130,ATOPIC DERMATITIS,ATOPIC,"diseases such as ATOPIC DERMATITIS, allergic rhinitis and",131-140-145-148-155-167-176-185,111-115-121-124-131-140-145,the onset of ATOPIC diseases such as,"These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma.",148 155,124,148,124,165,130,-1,RO-cause_of,900156,"These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma",atopic dermatitis,atopic
502540487,7/12/2014 00:30:34,,1321095400,7/12/2014 00:30:22,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,148,124,,,165,130,ATOPIC DERMATITIS,ATOPIC,"ATOPIC DERMATITIS, allergic rhinitis and asthma.",148-155-167-176-185-189,124-131,ATOPIC diseases,"These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma.",148 155,124,148,124,165,130,-1,RO-cause_of,900156,"These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma",atopic dermatitis,atopic
502540487,7/12/2014 00:32:30,,1321096488,7/12/2014 00:32:12,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,148,124,,,165,130,ATOPIC DERMATITIS,ATOPIC,"ATOPIC DERMATITIS,",148-155,124-131,ATOPIC diseases,"These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma.",148 155,124,148,124,165,130,-1,RO-cause_of,900156,"These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma",atopic dermatitis,atopic
502540487,7/12/2014 00:40:40,,1321100348,7/12/2014 00:40:13,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,148,124,,,165,130,ATOPIC DERMATITIS,ATOPIC,"ATOPIC DERMATITIS,",148-155,124-131,ATOPIC diseases,"These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma.",148 155,124,148,124,165,130,-1,RO-cause_of,900156,"These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma",atopic dermatitis,atopic
502540487,7/12/2014 00:43:55,,1321101840,7/12/2014 00:43:38,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,148,124,,,165,130,ATOPIC DERMATITIS,ATOPIC,"ATOPIC DERMATITIS,",148-155,124-131,ATOPIC diseases,"These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma.",148 155,124,148,124,165,130,-1,RO-cause_of,900156,"These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma",atopic dermatitis,atopic
502540487,7/12/2014 01:00:45,,1321108303,7/12/2014 01:00:30,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,148,124,,,165,130,ATOPIC DERMATITIS,ATOPIC,"ATOPIC DERMATITIS, allergic rhinitis and asthma.",148-155-167-176-185-189,124-131,ATOPIC diseases,"These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma.",148 155,124,148,124,165,130,-1,RO-cause_of,900156,"These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma",atopic dermatitis,atopic
502540487,7/12/2014 01:23:24,,1321117416,7/12/2014 01:21:59,prodege,1.0,2331981,USA,GA,Dallas,108.226.130.98,148,124,,,165,130,ATOPIC DERMATITIS,ATOPIC,"ATOPIC DERMATITIS, allergic rhinitis and asthma.",148-155-167-176-185-189,124-148-155-167-176-185-189,"ATOPIC atopic dermatitis, allergic rhinitis and asthma.","These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma.",148 155,124,148,124,165,130,-1,RO-cause_of,900156,"These Ag may thus be essential for inducing the production of IgE or IgG antibodies, which may in turn lead to the onset of atopic diseases such as atopic dermatitis, allergic rhinitis and asthma",atopic dermatitis,atopic
502540488,7/11/2014 23:57:47,,1321076927,7/11/2014 23:57:12,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,175,129,,,183,142,S. TYPHI,ENTERIC FEVER,"S. TYPHI,",175-178,129-137,ENTERIC FEVER,"The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica.",175 178,129 137,175,129,183,142,1,RO-has_causative_agent,903979,"The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica",S. typhi,enteric fever
502540488,7/11/2014 23:58:16,,1321077201,7/11/2014 23:57:54,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,175,129,,,183,142,S. TYPHI,ENTERIC FEVER,"S. TYPHI,",175-178,129-137,ENTERIC FEVER,"The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica.",175 178,129 137,175,129,183,142,1,RO-has_causative_agent,903979,"The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica",S. typhi,enteric fever
502540488,7/12/2014 00:03:28,,1321080156,7/12/2014 00:03:14,prodege,1.0,23541832,USA,AZ,Tempe,149.169.133.153,175,129,,,183,142,S. TYPHI,ENTERIC FEVER,"S. TYPHI,",175-178,129-137,ENTERIC FEVER,"The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica.",175 178,129 137,175,129,183,142,1,RO-has_causative_agent,903979,"The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica",S. typhi,enteric fever
502540488,7/12/2014 00:17:09,,1321088286,7/12/2014 00:16:41,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,175,129,,,183,142,S. TYPHI,ENTERIC FEVER,"S. TYPHI, S. paratyphi A, paratyphi B, S. paratyphi C, S. choleraesuis, enteritidis, S. krefeld, S. panama,",175-178-185-188-198-204-214-217-220-230-233-236-253-266-269-278-281,112-129-137,bacteria ENTERIC FEVER,"The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica.",175 178,129 137,175,129,183,142,1,RO-has_causative_agent,903979,"The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica",S. typhi,enteric fever
502540488,7/12/2014 00:21:37,,1321090699,7/12/2014 00:20:32,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,175,129,,,183,142,S. TYPHI,ENTERIC FEVER,"S. TYPHI, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica.",175-178-185-188-198-201-204-214-217-220-230-233-236-250-253-266-269-278-281-289-292-305-317-323-335-349-353-362,109-112-121-129-137-143-147-155-161-166,12 bacteria causing ENTERIC FEVER and enteric fever like illness:,"The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica.",175 178,129 137,175,129,183,142,1,RO-has_causative_agent,903979,"The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica",S. typhi,enteric fever
502540488,7/12/2014 00:22:48,,1321091381,7/12/2014 00:22:28,instagc,1.0,13763729,USA,"","",75.182.89.225,175,129,,,183,142,S. TYPHI,ENTERIC FEVER,"S. TYPHI,",175-178,129-137,ENTERIC FEVER,"The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica.",175 178,129 137,175,129,183,142,1,RO-has_causative_agent,903979,"The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica",S. typhi,enteric fever
502540488,7/12/2014 00:27:20,,1321093780,7/12/2014 00:26:36,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,175,129,,,183,142,S. TYPHI,ENTERIC FEVER,"S. TYPHI,",175-178,129-137-143-147-155,ENTERIC FEVER and enteric fever,"The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica.",175 178,129 137,175,129,183,142,1,RO-has_causative_agent,903979,"The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica",S. typhi,enteric fever
502540488,7/12/2014 00:29:17,,1321094722,7/12/2014 00:28:42,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,175,129,,,183,142,S. TYPHI,ENTERIC FEVER,"S. TYPHI,",175-178,129-137,ENTERIC FEVER,"The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica.",175 178,129 137,175,129,183,142,1,RO-has_causative_agent,903979,"The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica",S. typhi,enteric fever
502540488,7/12/2014 00:32:19,,1321096344,7/12/2014 00:31:01,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,175,129,,,183,142,S. TYPHI,ENTERIC FEVER,"antibodies immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever like illness: S. TYPHI, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica.",25-50-65-70-72-78-87-95-104-109-112-121-129-137-143-147-155-161-166-175-178-185-188-198-201-204-214-217-220-230-233-236-250-253-266-269-278-281-289-292-305-317-323-335-349-353-362-81,25-50-65-70-72-78-81-87-95-104-109-112-121-129-137-143-147-155-161-166-175-178-185-188-198-201-204-214-217-220-230-233-236-250-253-266-269-278-281-289-292-305-317-323-335-353-362-349,"antibodies immunoblotting with a panel of crude protein antigens from 12 bacteria causing ENTERIC FEVER and enteric fever like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica.","The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica.",175 178,129 137,175,129,183,142,1,RO-has_causative_agent,903979,"The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica",S. typhi,enteric fever
502540488,7/12/2014 00:37:20,,1321098909,7/12/2014 00:36:30,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,175,129,,,183,142,S. TYPHI,ENTERIC FEVER,"S. TYPHI,",175-178,129-137,ENTERIC FEVER,"The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica.",175 178,129 137,175,129,183,142,1,RO-has_causative_agent,903979,"The specificity of these antibodies was tested by immunoblotting with a panel of crude protein antigens from 12 bacteria causing enteric fever and enteric fever-like illness: S. typhi, S. paratyphi A, S. paratyphi B, S. paratyphi C, S. choleraesuis, S. enteritidis, S. krefeld, S. panama, S. typhimurium, Escherichia coli, Pseudomonas pseudomallei, and Yersinia enterocolitica",S. typhi,enteric fever
502540489,7/11/2014 23:59:59,,1321078092,7/11/2014 23:59:41,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,155,128,,,167,133,TACHYCARDIAS,AVNRT,"reciprocating AV TACHYCARDIAS,",138-152-155,128,AVNRT,"All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced.",155,128,155,128,167,133,-1,RO-has_definitional_manifestation,904558,"All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced",tachycardias,AVNRT
502540489,7/12/2014 00:04:20,,1321080732,7/12/2014 00:03:49,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,155,128,,,167,133,TACHYCARDIAS,AVNRT,"AV TACHYCARDIAS,",152-155,128,AVNRT,"All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced.",155,128,155,128,167,133,-1,RO-has_definitional_manifestation,904558,"All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced",tachycardias,AVNRT
502540489,7/12/2014 00:14:32,,1321086759,7/12/2014 00:14:17,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,155,128,,,167,133,TACHYCARDIAS,AVNRT,"AV TACHYCARDIAS,",152-155,128,AVNRT,"All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced.",155,128,155,128,167,133,-1,RO-has_definitional_manifestation,904558,"All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced",tachycardias,AVNRT
502540489,7/12/2014 00:17:02,,1321088189,7/12/2014 00:15:50,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,155,128,,,167,133,TACHYCARDIAS,AVNRT,"TACHYCARDIAS,",155,128-134-138-152-155,"AVNRT and reciprocating AV tachycardias,","All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced.",155,128,155,128,167,133,-1,RO-has_definitional_manifestation,904558,"All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced",tachycardias,AVNRT
502540489,7/12/2014 00:31:15,,1321095810,7/12/2014 00:30:36,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,155,128,,,167,133,TACHYCARDIAS,AVNRT,"reciprocating AV TACHYCARDIAS,",138-152-155,128,AVNRT,"All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced.",155,128,155,128,167,133,-1,RO-has_definitional_manifestation,904558,"All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced",tachycardias,AVNRT
502540489,7/12/2014 00:34:15,,1321097357,7/12/2014 00:34:03,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,155,128,,,167,133,TACHYCARDIAS,AVNRT,"reciprocating AV TACHYCARDIAS,",138-152-155,128-134-138-152-155,"AVNRT and reciprocating AV tachycardias,","All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced.",155,128,155,128,167,133,-1,RO-has_definitional_manifestation,904558,"All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced",tachycardias,AVNRT
502540489,7/12/2014 00:35:54,,1321098223,7/12/2014 00:35:35,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,155,128,,,167,133,TACHYCARDIAS,AVNRT,"AV TACHYCARDIAS,",152-155,128,AVNRT,"All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced.",155,128,155,128,167,133,-1,RO-has_definitional_manifestation,904558,"All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced",tachycardias,AVNRT
502540489,7/12/2014 01:06:55,,1321110803,7/12/2014 01:06:42,extralunchmoney,1,21506743,USA,AL,Anniston,184.155.108.254,155,128,,,167,133,TACHYCARDIAS,AVNRT,"reciprocating AV TACHYCARDIAS,",138-152-155,128,AVNRT,"All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced.",155,128,155,128,167,133,-1,RO-has_definitional_manifestation,904558,"All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced",tachycardias,AVNRT
502540489,7/12/2014 01:20:34,,1321116387,7/12/2014 01:19:55,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,155,128,,,167,133,TACHYCARDIAS,AVNRT,"reciprocating AV TACHYCARDIAS,",138-152-155,69-72-78-88-128,AV nodal reentrant tachycardia AVNRT,"All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced.",155,128,155,128,167,133,-1,RO-has_definitional_manifestation,904558,"All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced",tachycardias,AVNRT
502540489,7/12/2014 01:28:59,,1321119956,7/12/2014 01:28:37,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,155,128,,,167,133,TACHYCARDIAS,AVNRT,"AV TACHYCARDIAS,",152-155,123-128,both AVNRT,"All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced.",155,128,155,128,167,133,-1,RO-has_definitional_manifestation,904558,"All 6 had dual atrioventricular (AV) nodal pathway physiology, 4 had AV nodal reentrant tachycardia (AVNRT) induced, 1 had both AVNRT and reciprocating AV tachycardias, and 1 had nonsustained AVNRT and an atrial tachycardia induced",tachycardias,AVNRT
502540490,7/12/2014 00:04:19,,1321080715,7/12/2014 00:03:29,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,151,64,,,167,67,THROMBOCYTOPENIA,SLE,"serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or THROMBOCYTOPENIA),",84-95-115-124-136-148-151,64-72-84-95-115-124-136-148-151,"SLE unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia),","Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful.",151,64,151,64,167,67,-1,RO-has_manifestation,906417,"Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful",thrombocytopenia,SLE
502540490,7/12/2014 00:11:43,,1321085015,7/12/2014 00:10:27,clixsense,1,6347705,USA,CA,Carmichael,71.193.56.103,151,64,,,167,67,THROMBOCYTOPENIA,SLE,"SLE serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, THROMBOCYTOPENIA), vasculitis; tachycardia,",64-84-95-115-124-136-151-510-328,64-84-95-115-124-136-151-241-510-328,"SLE serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, thrombocytopenia), SLE vasculitis; tachycardia,","Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful.",151,64,151,64,167,67,-1,RO-has_manifestation,906417,"Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful",thrombocytopenia,SLE
502540490,7/12/2014 00:17:47,,1321088674,7/12/2014 00:17:29,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,151,64,,,167,67,THROMBOCYTOPENIA,SLE,"THROMBOCYTOPENIA),",151,64,SLE,"Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful.",151,64,151,64,167,67,-1,RO-has_manifestation,906417,"Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful",thrombocytopenia,SLE
502540490,7/12/2014 00:21:25,,1321090530,7/12/2014 00:20:58,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,151,64,,,167,67,THROMBOCYTOPENIA,SLE,"hemorrhage, leukopenia, or THROMBOCYTOPENIA), not as a",124-136-148-151-170-174-177,42-51-61-64-72-84,"clinical suspicion of SLE unexplained serositis,","Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful.",151,64,151,64,167,67,-1,RO-has_manifestation,906417,"Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful",thrombocytopenia,SLE
502540490,7/12/2014 00:27:56,,1321094061,7/12/2014 00:27:39,instagc,1.0,13763729,USA,"","",75.182.89.225,151,64,,,167,67,THROMBOCYTOPENIA,SLE,"THROMBOCYTOPENIA),",151,64,SLE,"Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful.",151,64,151,64,167,67,-1,RO-has_manifestation,906417,"Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful",thrombocytopenia,SLE
502540490,7/12/2014 00:37:59,,1321099200,7/12/2014 00:37:39,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,151,64,,,167,67,THROMBOCYTOPENIA,SLE,"THROMBOCYTOPENIA),",151,64,SLE,"Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful.",151,64,151,64,167,67,-1,RO-has_manifestation,906417,"Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful",thrombocytopenia,SLE
502540490,7/12/2014 00:46:11,,1321102675,7/12/2014 00:45:30,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,151,64,,,167,67,THROMBOCYTOPENIA,SLE,"THROMBOCYTOPENIA),",151,64,SLE,"Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful.",151,64,151,64,167,67,-1,RO-has_manifestation,906417,"Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful",thrombocytopenia,SLE
502540490,7/12/2014 01:01:18,,1321108556,7/12/2014 01:00:46,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,151,64,,,167,67,THROMBOCYTOPENIA,SLE,"unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, THROMBOCYTOPENIA),",72-84-95-115-124-136-151,42-51-61-64-68-72-84-95-115-124-136-148-151,"clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia),","Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful.",151,64,151,64,167,67,-1,RO-has_manifestation,906417,"Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful",thrombocytopenia,SLE
502540490,7/12/2014 01:17:13,,1321115071,7/12/2014 01:17:02,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,151,64,,,167,67,THROMBOCYTOPENIA,SLE,"hemorrhage, leukopenia, or THROMBOCYTOPENIA), not as a",124-136-148-151-170-174-177,64-72-84,"SLE unexplained serositis,","Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful.",151,64,151,64,167,67,-1,RO-has_manifestation,906417,"Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful",thrombocytopenia,SLE
502540490,7/12/2014 01:25:41,,1321118397,7/12/2014 01:25:22,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,151,64,,,167,67,THROMBOCYTOPENIA,SLE,"THROMBOCYTOPENIA),",151,64,SLE,"Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful.",151,64,151,64,167,67,-1,RO-has_manifestation,906417,"Antinuclear antibody  Order when there is clinical suspicion of SLE (or unexplained serositis, glomerulonephritis, alveolar hemorrhage, leukopenia, or thrombocytopenia), not as a general screening test for sick patients; negative test makes SLE unlikely ANCA  Order when there is clinical suspicion of WG or MPA or drug-induced vasculitis; test should be performed by both IF and ELISA Drug screen  Order for unexplained CNS symptoms, myocardial ischemia, vascular spasm, panic attacks with systemic features, tachycardia, nasal perforation; urine screen should be done Blood cultures  Useful",thrombocytopenia,SLE
502540491,7/11/2014 23:56:30,,1321076434,7/11/2014 23:56:10,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,49,0,,,64,7,TYPE 1 DIABETES,INSULIN,TYPE 1 DIABETES.,49-54-56,0,INSULIN,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes.,49 54 56,0,49,0,64,7,1,RO-may_treat,908088,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes,type 1 diabetes,Insulin
502540491,7/12/2014 00:02:57,,1321079797,7/12/2014 00:02:47,prodege,1.0,23541832,USA,AZ,Tempe,149.169.133.153,49,0,,,64,7,TYPE 1 DIABETES,INSULIN,TYPE 1 DIABETES.,49-54-56,0-8-16-20,INSULIN peptide B:9 23,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes.,49 54 56,0,49,0,64,7,1,RO-may_treat,908088,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes,type 1 diabetes,Insulin
502540491,7/12/2014 00:07:07,,1321082281,7/12/2014 00:06:03,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,49,0,,,64,7,TYPE 1 DIABETES,INSULIN,TYPE 1 DIABETES.,49-54-56,0-8-16-20-49-54-56,INSULIN peptide B:9 23 type 1 diabetes.,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes.,49 54 56,0,49,0,64,7,1,RO-may_treat,908088,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes,type 1 diabetes,Insulin
502540491,7/12/2014 00:16:13,,1321087699,7/12/2014 00:15:24,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,49,0,,,64,7,TYPE 1 DIABETES,INSULIN,TYPE 1 DIABETES.,49-54-56,0-8-16-20,INSULIN peptide B:9 23,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes.,49 54 56,0,49,0,64,7,1,RO-may_treat,908088,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes,type 1 diabetes,Insulin
502540491,7/12/2014 00:21:32,,1321090615,7/12/2014 00:21:26,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,49,0,,,64,7,TYPE 1 DIABETES,INSULIN,major autoantigen in TYPE 1 DIABETES.,28-34-46-49-54-56,0-8-16-20,INSULIN peptide B:9 23,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes.,49 54 56,0,49,0,64,7,1,RO-may_treat,908088,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes,type 1 diabetes,Insulin
502540491,7/12/2014 00:24:40,,1321092510,7/12/2014 00:24:29,instagc,1.0,13763729,USA,"","",75.182.89.225,49,0,,,64,7,TYPE 1 DIABETES,INSULIN,TYPE 1 DIABETES.,49-54-56,0-8,INSULIN peptide,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes.,49 54 56,0,49,0,64,7,1,RO-may_treat,908088,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes,type 1 diabetes,Insulin
502540491,7/12/2014 00:37:51,,1321099150,7/12/2014 00:37:40,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,49,0,,,64,7,TYPE 1 DIABETES,INSULIN,TYPE 1 DIABETES.,49-54-56,0-8-16-20,INSULIN peptide B:9 23,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes.,49 54 56,0,49,0,64,7,1,RO-may_treat,908088,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes,type 1 diabetes,Insulin
502540491,7/12/2014 00:39:54,,1321100004,7/12/2014 00:39:26,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,49,0,,,64,7,TYPE 1 DIABETES,INSULIN,TYPE 1 DIABETES.,49-54-56,0-8,INSULIN peptide,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes.,49 54 56,0,49,0,64,7,1,RO-may_treat,908088,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes,type 1 diabetes,Insulin
502540491,7/12/2014 01:01:45,,1321108754,7/12/2014 01:01:33,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,49,0,,,64,7,TYPE 1 DIABETES,INSULIN,autoantigen in TYPE 1 DIABETES.,34-46-49-54-56,0-8-16-20,INSULIN peptide B:9 23,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes.,49 54 56,0,49,0,64,7,1,RO-may_treat,908088,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes,type 1 diabetes,Insulin
502540491,7/12/2014 01:15:10,,1321114382,7/12/2014 01:14:58,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,49,0,,,64,7,TYPE 1 DIABETES,INSULIN,major autoantigen in TYPE 1 DIABETES.,28-34-46-49-54-56,0-8-16-20-23-26-28-34,INSULIN peptide B:9 23 is a major autoantigen,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes.,49 54 56,0,49,0,64,7,1,RO-may_treat,908088,Insulin peptide B:9-23 is a major autoantigen in type 1 diabetes,type 1 diabetes,Insulin
502540492,7/11/2014 23:55:46,,1321075961,7/11/2014 23:55:29,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,84,159,,,108,170,VENTRICULAR FIBRILLATION,EPINEPHRINE,VENTRICULAR FIBRILLATION,84-96,159,EPINEPHRINE,"The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest.",84 96,159,84,159,108,170,1,RO-may_treat,907970,"The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest",ventricular fibrillation,epinephrine
502540492,7/11/2014 23:57:11,,1321076731,7/11/2014 23:56:57,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,84,159,,,108,170,VENTRICULAR FIBRILLATION,EPINEPHRINE,VENTRICULAR FIBRILLATION,84-96,159,EPINEPHRINE,"The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest.",84 96,159,84,159,108,170,1,RO-may_treat,907970,"The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest",ventricular fibrillation,epinephrine
502540492,7/12/2014 00:19:39,,1321089612,7/12/2014 00:19:27,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,84,159,,,108,170,VENTRICULAR FIBRILLATION,EPINEPHRINE,VENTRICULAR FIBRILLATION,84-96,159,EPINEPHRINE,"The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest.",84 96,159,84,159,108,170,1,RO-may_treat,907970,"The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest",ventricular fibrillation,epinephrine
502540492,7/12/2014 00:19:41,,1321089652,7/12/2014 00:19:12,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,84,159,,,108,170,VENTRICULAR FIBRILLATION,EPINEPHRINE,"VENTRICULAR FIBRILLATION or pulseless electrical activity,",84-96-109-112-122-133,159-171-175-179-187-197-200-210,EPINEPHRINE for the initial treatment of asystolic arrest;,"The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest.",84 96,159,84,159,108,170,1,RO-may_treat,907970,"The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest",ventricular fibrillation,epinephrine
502540492,7/12/2014 00:23:22,,1321091827,7/12/2014 00:23:15,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,84,159,,,108,170,VENTRICULAR FIBRILLATION,EPINEPHRINE,CA due to VENTRICULAR FIBRILLATION or pulseless electrical,74-77-81-84-96-109-112-122,143-147-156-159-171-175-179,and superior to EPINEPHRINE for the initial,"The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest.",84 96,159,84,159,108,170,1,RO-may_treat,907970,"The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest",ventricular fibrillation,epinephrine
502540492,7/12/2014 00:27:53,,1321094032,7/12/2014 00:27:05,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,84,159,,,108,170,VENTRICULAR FIBRILLATION,EPINEPHRINE,VENTRICULAR FIBRILLATION,84-96,159,EPINEPHRINE,"The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest.",84 96,159,84,159,108,170,1,RO-may_treat,907970,"The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest",ventricular fibrillation,epinephrine
502540492,7/12/2014 00:27:56,,1321094067,7/12/2014 00:27:40,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,84,159,,,108,170,VENTRICULAR FIBRILLATION,EPINEPHRINE,"VENTRICULAR FIBRILLATION pulseless electrical activity,",84-96-112-122-133,159,EPINEPHRINE,"The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest.",84 96,159,84,159,108,170,1,RO-may_treat,907970,"The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest",ventricular fibrillation,epinephrine
502540492,7/12/2014 00:42:17,,1321101143,7/12/2014 00:41:08,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,84,159,,,108,170,VENTRICULAR FIBRILLATION,EPINEPHRINE,"vasopressin is similar to epinephrine for OOH CA due to VENTRICULAR FIBRILLATION or pulseless electrical activity, superior to epinephrine for initial treatment of asystolic arrest; vasopressin and epinephrine is superior to epinephrine alone in treatment of refractory, out of hospital cardiac arrest.",28-40-43-51-54-66-70-74-77-81-84-96-109-112-122-133-147-156-159-171-179-187-197-200-210-263-275-279-291-294-303-306-318-324-331-341-344-356-360-363-372-380,28-40-43-51-54-66-70-74-77-81-84-96-109-112-122-133-143-147-156-159-171-179-187-197-200-210-263-275-279-291-294-303-306-318-324-331-341-344-356-360-362-363-380-372,"vasopressin is similar to epinephrine for OOH CA due to ventricular fibrillation or pulseless electrical activity, and superior to EPINEPHRINE for initial treatment of asystolic arrest; vasopressin and epinephrine is superior to epinephrine alone in treatment of refractory, out of - hospital cardiac arrest.","The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest.",84 96,159,84,159,108,170,1,RO-may_treat,907970,"The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest",ventricular fibrillation,epinephrine
502540492,7/12/2014 00:46:49,,1321102931,7/12/2014 00:46:12,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,84,159,,,108,170,VENTRICULAR FIBRILLATION,EPINEPHRINE,VENTRICULAR FIBRILLATION,84-96,159,EPINEPHRINE,"The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest.",84 96,159,84,159,108,170,1,RO-may_treat,907970,"The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest",ventricular fibrillation,epinephrine
502540492,7/12/2014 01:17:59,,1321115379,7/12/2014 01:17:40,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,84,159,,,108,170,VENTRICULAR FIBRILLATION,EPINEPHRINE,"VENTRICULAR FIBRILLATION or pulseless electrical activity,",84-96-109-112-122-133,159-171-175-179-187-197-200-210,EPINEPHRINE for the initial treatment of asystolic arrest;,"The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest.",84 96,159,84,159,108,170,1,RO-may_treat,907970,"The study demonstrated that vasopressin is similar to epinephrine for OOH-CA due to ventricular fibrillation or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and epinephrine is superior to epinephrine alone in the treatment of refractory, out-of-hospital cardiac arrest",ventricular fibrillation,epinephrine
502540493,7/11/2014 23:58:44,,1321077395,7/11/2014 23:58:23,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,17,76,,,31,93,GYRATE ATROPHY,HYPERORNITHINEMIA,GYRATE ATROPHY,17-24,76,HYPERORNITHINEMIA,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically.,17 24,76,17,76,31,93,1,RO-cause_of,900023,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically,gyrate atrophy,hyperornithinemia
502540493,7/12/2014 00:10:53,,1321084554,7/12/2014 00:10:30,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,17,76,,,31,93,GYRATE ATROPHY,HYPERORNITHINEMIA,GYRATE ATROPHY,17-24,76,HYPERORNITHINEMIA,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically.,17 24,76,17,76,31,93,1,RO-cause_of,900023,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically,gyrate atrophy,hyperornithinemia
502540493,7/12/2014 00:12:02,,1321085184,7/12/2014 00:09:47,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,17,76,,,31,93,GYRATE ATROPHY,HYPERORNITHINEMIA,The diagnosis of GYRATE ATROPHY was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically.,0-4-14-17-24-32-36-46-60-64-76-94-98-100-111-114-124-133-146-151-161,0-4-14-17-24-32-36-46-60-64-76-94-98-100-111-114-124-133-146-151-161,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; HYPERORNITHINEMIA and a deficiency of ornithine ketoacid transaminase were confirmed biochemically.,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically.,17 24,76,17,76,31,93,1,RO-cause_of,900023,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically,gyrate atrophy,hyperornithinemia
502540493,7/12/2014 00:24:23,,1321092375,7/12/2014 00:23:40,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,17,76,,,31,93,GYRATE ATROPHY,HYPERORNITHINEMIA,The diagnosis of GYRATE ATROPHY was confirmed biochemically,0-4-14-17-24-32-36-46,46-60-64-76-94-98-100,biochemically and clinically; HYPERORNITHINEMIA and a deficiency,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically.,17 24,76,17,76,31,93,1,RO-cause_of,900023,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically,gyrate atrophy,hyperornithinemia
502540493,7/12/2014 00:34:43,,1321097577,7/12/2014 00:34:30,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,17,76,,,31,93,GYRATE ATROPHY,HYPERORNITHINEMIA,GYRATE ATROPHY,17-24,76,HYPERORNITHINEMIA,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically.,17 24,76,17,76,31,93,1,RO-cause_of,900023,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically,gyrate atrophy,hyperornithinemia
502540493,7/12/2014 00:45:53,,1321102543,7/12/2014 00:45:11,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,17,76,,,31,93,GYRATE ATROPHY,HYPERORNITHINEMIA,GYRATE ATROPHY,17-24,76,HYPERORNITHINEMIA,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically.,17 24,76,17,76,31,93,1,RO-cause_of,900023,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically,gyrate atrophy,hyperornithinemia
502540493,7/12/2014 01:07:25,,1321110985,7/12/2014 01:07:13,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,17,76,,,31,93,GYRATE ATROPHY,HYPERORNITHINEMIA,diagnosis of GYRATE ATROPHY,4-14-17-24,76,HYPERORNITHINEMIA,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically.,17 24,76,17,76,31,93,1,RO-cause_of,900023,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically,gyrate atrophy,hyperornithinemia
502540493,7/12/2014 01:18:48,,1321115655,7/12/2014 01:18:24,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,17,76,,,31,93,GYRATE ATROPHY,HYPERORNITHINEMIA,The diagnosis of GYRATE ATROPHY was confirmed biochemically and clinically;,0-4-14-17-24-32-36-46-60-64,76-146-151-161,HYPERORNITHINEMIA were confirmed biochemically.,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically.,17 24,76,17,76,31,93,1,RO-cause_of,900023,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically,gyrate atrophy,hyperornithinemia
502540493,7/12/2014 01:24:46,,1321117998,7/12/2014 01:24:21,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,17,76,,,31,93,GYRATE ATROPHY,HYPERORNITHINEMIA,GYRATE ATROPHY,17-24,76,HYPERORNITHINEMIA,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically.,17 24,76,17,76,31,93,1,RO-cause_of,900023,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically,gyrate atrophy,hyperornithinemia
502540493,7/12/2014 01:26:05,,1321118562,7/12/2014 01:25:20,prodege,1,2331981,USA,GA,Dallas,108.226.130.98,17,76,,,31,93,GYRATE ATROPHY,HYPERORNITHINEMIA,GYRATE ATROPHY hyperornithinemia,17-24-76,17-24-76,gyrate atrophy HYPERORNITHINEMIA,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically.,17 24,76,17,76,31,93,1,RO-cause_of,900023,The diagnosis of gyrate atrophy was confirmed biochemically and clinically; hyperornithinemia and a deficiency of ornithine ketoacid transaminase were confirmed biochemically,gyrate atrophy,hyperornithinemia
502540494,7/12/2014 00:07:22,,1321082440,7/12/2014 00:07:00,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,117,31,,,121,53,DRUG,ADVERSE DRUG REACTIONS,DRUG,117,31-39-44,ADVERSE DRUG REACTIONS,"The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition.",117,31 39 44,117,31,121,53,-1,RO-has_causative_agent,903694,"The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition",drug,adverse drug reactions
502540494,7/12/2014 00:16:47,,1321088049,7/12/2014 00:16:30,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,117,31,,,121,53,DRUG,ADVERSE DRUG REACTIONS,DRUG,117,31-39-44,ADVERSE DRUG REACTIONS,"The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition.",117,31 39 44,117,31,121,53,-1,RO-has_causative_agent,903694,"The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition",drug,adverse drug reactions
502540494,7/12/2014 00:20:31,,1321090068,7/12/2014 00:19:42,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,117,31,,,121,53,DRUG,ADVERSE DRUG REACTIONS,"interaction of one DRUG with another,",98-110-113-117-122-127,16-28-31-39-44,predisposed to ADVERSE DRUG REACTIONS,"The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition.",117,31 39 44,117,31,121,53,-1,RO-has_causative_agent,903694,"The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition",drug,adverse drug reactions
502540494,7/12/2014 00:20:41,,1321090180,7/12/2014 00:20:25,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,117,31,,,121,53,DRUG,ADVERSE DRUG REACTIONS,DRUG,117,31-39-44,ADVERSE DRUG REACTIONS,"The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition.",117,31 39 44,117,31,121,53,-1,RO-has_causative_agent,903694,"The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition",drug,adverse drug reactions
502540494,7/12/2014 00:24:35,,1321092453,7/12/2014 00:24:30,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,117,31,,,121,53,DRUG,ADVERSE DRUG REACTIONS,"interaction of one DRUG with another, and",98-110-113-117-122-127-136,12-16-28-31-39-44-54-62-65,are predisposed to ADVERSE DRUG REACTIONS because of age,"The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition.",117,31 39 44,117,31,121,53,-1,RO-has_causative_agent,903694,"The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition",drug,adverse drug reactions
502540494,7/12/2014 00:31:08,,1321095764,7/12/2014 00:30:55,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,117,31,,,121,53,DRUG,ADVERSE DRUG REACTIONS,DRUG,117,31-39-44,ADVERSE DRUG REACTIONS,"The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition.",117,31 39 44,117,31,121,53,-1,RO-has_causative_agent,903694,"The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition",drug,adverse drug reactions
502540494,7/12/2014 00:31:12,,1321095802,7/12/2014 00:30:51,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,117,31,,,121,53,DRUG,ADVERSE DRUG REACTIONS,DRUG,117,31-39-44,ADVERSE DRUG REACTIONS,"The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition.",117,31 39 44,117,31,121,53,-1,RO-has_causative_agent,903694,"The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition",drug,adverse drug reactions
502540494,7/12/2014 00:31:41,,1321096068,7/12/2014 00:31:16,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,117,31,,,121,53,DRUG,ADVERSE DRUG REACTIONS,DRUG,117,31-39-44,ADVERSE DRUG REACTIONS,"The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition.",117,31 39 44,117,31,121,53,-1,RO-has_causative_agent,903694,"The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition",drug,adverse drug reactions
502540494,7/12/2014 00:39:39,,1321099917,7/12/2014 00:39:07,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,117,31,,,121,53,DRUG,ADVERSE DRUG REACTIONS,DRUG,117,31-39-44,ADVERSE DRUG REACTIONS,"The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition.",117,31 39 44,117,31,121,53,-1,RO-has_causative_agent,903694,"The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition",drug,adverse drug reactions
502540494,7/12/2014 01:03:03,,1321109206,7/12/2014 01:02:48,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,117,31,,,121,53,DRUG,ADVERSE DRUG REACTIONS,"interaction of one DRUG with another,",98-110-113-117-122-127,16-28-31-39-44-54-62-65-69-77-89,"predisposed to ADVERSE DRUG REACTIONS because of age related physiologic changes,","The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition.",117,31 39 44,117,31,121,53,-1,RO-has_causative_agent,903694,"The elderly are predisposed to adverse drug reactions because of age-related physiologic changes, interaction of one drug with another, and interaction between a drug and a coexisting medical condition",drug,adverse drug reactions
502540495,7/11/2014 23:53:12,,1321074734,7/11/2014 23:53:00,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,112,91,,,124,100,TUBERCULOSIS,ISONIAZID,"TUBERCULOSIS,",112,91,ISONIAZID,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments.",112,91,112,91,124,100,1,RO-may_prevent,907365,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments",tuberculosis,isoniazid
502540495,7/12/2014 00:10:19,,1321084270,7/12/2014 00:09:41,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,112,91,,,124,100,TUBERCULOSIS,ISONIAZID,"taking isoniazid to prevent TUBERCULOSIS,",91-101-104-112-84,84-91-101-104-112,"taking ISONIAZID to prevent tuberculosis,","After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments.",112,91,112,91,124,100,1,RO-may_prevent,907365,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments",tuberculosis,isoniazid
502540495,7/12/2014 00:12:29,,1321085509,7/12/2014 00:11:44,clixsense,1.0,6347705,USA,CA,Carmichael,71.193.56.103,112,91,,,124,100,TUBERCULOSIS,ISONIAZID,"isoniazid TUBERCULOSIS, isoniazid",91-112-129,21-91-112-129,"hepatitis ISONIAZID tuberculosis, isoniazid","After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments.",112,91,112,91,124,100,1,RO-may_prevent,907365,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments",tuberculosis,isoniazid
502540495,7/12/2014 00:16:44,,1321088028,7/12/2014 00:16:28,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,112,91,,,124,100,TUBERCULOSIS,ISONIAZID,"TUBERCULOSIS,",112,91,ISONIAZID,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments.",112,91,112,91,124,100,1,RO-may_prevent,907365,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments",tuberculosis,isoniazid
502540495,7/12/2014 00:34:01,,1321097267,7/12/2014 00:33:35,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,112,91,,,124,100,TUBERCULOSIS,ISONIAZID,"TUBERCULOSIS,",112,91,ISONIAZID,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments.",112,91,112,91,124,100,1,RO-may_prevent,907365,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments",tuberculosis,isoniazid
502540495,7/12/2014 00:34:02,,1321097270,7/12/2014 00:33:49,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,112,91,,,124,100,TUBERCULOSIS,ISONIAZID,"TUBERCULOSIS,",112,91,ISONIAZID,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments.",112,91,112,91,124,100,1,RO-may_prevent,907365,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments",tuberculosis,isoniazid
502540495,7/12/2014 00:42:55,,1321101408,7/12/2014 00:42:07,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,112,91,,,124,100,TUBERCULOSIS,ISONIAZID,"TUBERCULOSIS,",112,91,ISONIAZID,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments.",112,91,112,91,124,100,1,RO-may_prevent,907365,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments",tuberculosis,isoniazid
502540495,7/12/2014 01:07:42,,1321111072,7/12/2014 01:07:26,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,112,91,,,124,100,TUBERCULOSIS,ISONIAZID,"TUBERCULOSIS,",112,91,ISONIAZID,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments.",112,91,112,91,124,100,1,RO-may_prevent,907365,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments",tuberculosis,isoniazid
502540495,7/12/2014 01:17:39,,1321115226,7/12/2014 01:17:13,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,112,91,,,124,100,TUBERCULOSIS,ISONIAZID,"isoniazid to prevent TUBERCULOSIS, an isoniazid surveillance",101-104-112-126-129-139-91,91-101-104-112,"ISONIAZID to prevent tuberculosis,","After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments.",112,91,112,91,124,100,1,RO-may_prevent,907365,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments",tuberculosis,isoniazid
502540495,7/12/2014 01:27:16,,1321119163,7/12/2014 01:26:18,prodege,1.0,21318648,GBR,G7,Kingston Upon Thames,81.157.193.175,112,91,,,124,100,TUBERCULOSIS,ISONIAZID,"hepatitis isoniazid TUBERCULOSIS, isoniazid health",21-91-112-129-213,21-91-112-129-213,"hepatitis ISONIAZID tuberculosis, isoniazid health","After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments.",112,91,112,91,124,100,1,RO-may_prevent,907365,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent tuberculosis, an isoniazid surveillance study was conducted among 13,838 persons in 21 participating health departments",tuberculosis,isoniazid
502540496,7/12/2014 00:00:35,,1321078395,7/12/2014 00:00:20,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,129,160,,,144,167,ALLERGIC ASTHMA,ALLERGY,ALLERGIC ASTHMA,129-138,149-160,inhalative ALLERGY,"In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy.",129 138,160,129,160,144,167,-1,RO-cause_of,900437,"In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy",allergic asthma,allergy
502540496,7/12/2014 00:09:21,,1321083653,7/12/2014 00:08:57,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,129,160,,,144,167,ALLERGIC ASTHMA,ALLERGY,ALLERGIC ASTHMA,129-138,149-160,inhalative ALLERGY,"In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy.",129 138,160,129,160,144,167,-1,RO-cause_of,900437,"In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy",allergic asthma,allergy
502540496,7/12/2014 00:09:39,,1321083863,7/12/2014 00:08:04,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,129,160,,,144,167,ALLERGIC ASTHMA,ALLERGY,chronic or recurrent infection is associated with ALLERGIC ASTHMA and inhalative allergy nonallergic asthma and noninhalative allergy.,79-87-90-100-110-113-124-129-138-145-149-160-182-194-201-205-219,129-138-145-149-160-182-194-201-205-219,allergic asthma and inhalative ALLERGY nonallergic asthma and noninhalative allergy.,"In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy.",129 138,160,129,160,144,167,-1,RO-cause_of,900437,"In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy",allergic asthma,allergy
502540496,7/12/2014 00:17:47,,1321088683,7/12/2014 00:17:15,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,129,160,,,144,167,ALLERGIC ASTHMA,ALLERGY,ALLERGIC ASTHMA,129-138,149-160,inhalative ALLERGY,"In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy.",129 138,160,129,160,144,167,-1,RO-cause_of,900437,"In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy",allergic asthma,allergy
502540496,7/12/2014 00:24:09,,1321092244,7/12/2014 00:23:55,instagc,1.0,13763729,USA,"","",75.182.89.225,129,160,,,144,167,ALLERGIC ASTHMA,ALLERGY,ALLERGIC ASTHMA,129-138,160,ALLERGY,"In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy.",129 138,160,129,160,144,167,-1,RO-cause_of,900437,"In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy",allergic asthma,allergy
502540496,7/12/2014 00:25:21,,1321092827,7/12/2014 00:25:16,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,129,160,,,144,167,ALLERGIC ASTHMA,ALLERGY,is associated with ALLERGIC ASTHMA and inhalative allergy,110-113-124-129-138-145-149-160,138-145-149-160-168-171-179,asthma and inhalative ALLERGY as opposed to,"In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy.",129 138,160,129,160,144,167,-1,RO-cause_of,900437,"In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy",allergic asthma,allergy
502540496,7/12/2014 00:28:59,,1321094580,7/12/2014 00:28:47,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,129,160,,,144,167,ALLERGIC ASTHMA,ALLERGY,ALLERGIC ASTHMA inhalative allergy,129-138-149-160,138-145-149-160,asthma and inhalative ALLERGY,"In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy.",129 138,160,129,160,144,167,-1,RO-cause_of,900437,"In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy",allergic asthma,allergy
502540496,7/12/2014 00:30:11,,1321095215,7/12/2014 00:29:29,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,129,160,,,144,167,ALLERGIC ASTHMA,ALLERGY,"asthma and allergy, chronic or recurrent infection is associated with ALLERGIC ASTHMA and inhalative allergy nonallergic asthma noninhalative allergy.",55-62-66-79-87-90-100-110-113-124-129-138-145-149-160-182-194-205-219,55-62-66-79-87-90-138-145-149-160-182-194-205-219,"asthma and allergy, chronic or recurrent asthma and inhalative ALLERGY nonallergic asthma noninhalative allergy.","In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy.",129 138,160,129,160,144,167,-1,RO-cause_of,900437,"In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy",allergic asthma,allergy
502540496,7/12/2014 00:44:02,,1321101880,7/12/2014 00:43:40,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,129,160,,,144,167,ALLERGIC ASTHMA,ALLERGY,ALLERGIC ASTHMA,129-138,149-160,inhalative ALLERGY,"In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy.",129 138,160,129,160,144,167,-1,RO-cause_of,900437,"In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy",allergic asthma,allergy
502540496,7/12/2014 01:07:12,,1321110886,7/12/2014 01:06:56,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,129,160,,,144,167,ALLERGIC ASTHMA,ALLERGY,ALLERGIC ASTHMA,129-138,149-160,inhalative ALLERGY,"In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy.",129 138,160,129,160,144,167,-1,RO-cause_of,900437,"In our population CPI does not associate directly with asthma and allergy, but chronic or recurrent infection is associated with allergic asthma and inhalative allergy as opposed to nonallergic asthma and noninhalative allergy",allergic asthma,allergy
502540497,7/12/2014 00:01:53,,1321079244,7/12/2014 00:01:39,prodege,1.0,23541832,USA,AZ,Tempe,149.169.133.153,20,71,,,40,77,PARKINSON'S SYNDROME,L-DOPA,PARKINSON'S SYNDROME,20-32,70-73-78-83-94-108,(L DOPA with peripheral decarboxylase inhibitor),In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa.,20 32,73,20,71,40,77,1,RO-may_treat,908179,In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa,Parkinson's syndrome,L-dopa
502540497,7/12/2014 00:05:50,,1321081549,7/12/2014 00:05:12,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,20,71,,,40,77,PARKINSON'S SYNDROME,L-DOPA,PARKINSON'S SYNDROME,20-32,70-73,(L DOPA,In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa.,20 32,73,20,71,40,77,1,RO-may_treat,908179,In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa,Parkinson's syndrome,L-dopa
502540497,7/12/2014 00:08:50,,1321083319,7/12/2014 00:08:34,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,20,71,,,40,77,PARKINSON'S SYNDROME,L-DOPA,PARKINSON'S SYNDROME,20-32,70-73-78-83-94-108,(L DOPA with peripheral decarboxylase inhibitor),In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa.,20 32,73,20,71,40,77,1,RO-may_treat,908179,In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa,Parkinson's syndrome,L-dopa
502540497,7/12/2014 00:19:55,,1321089780,7/12/2014 00:19:39,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,20,71,,,40,77,PARKINSON'S SYNDROME,L-DOPA,PARKINSON'S SYNDROME,20-32,70-73-78-83-94-108,(L DOPA with peripheral decarboxylase inhibitor),In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa.,20 32,73,20,71,40,77,1,RO-may_treat,908179,In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa,Parkinson's syndrome,L-dopa
502540497,7/12/2014 00:23:39,,1321091949,7/12/2014 00:23:33,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,20,71,,,40,77,PARKINSON'S SYNDROME,L-DOPA,38 patients with PARKINSON'S SYNDROME Madopar preparation was,3-6-15-20-32-41-49-61,61-65-70-73-78-83-94,was used (L DOPA with peripheral decarboxylase,In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa.,20 32,73,20,71,40,77,1,RO-may_treat,908179,In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa,Parkinson's syndrome,L-dopa
502540497,7/12/2014 00:25:56,,1321093118,7/12/2014 00:25:29,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,20,71,,,40,77,PARKINSON'S SYNDROME,L-DOPA,PARKINSON'S SYNDROME,20-32,70-73-78-83-94-108,(L DOPA with peripheral decarboxylase inhibitor),In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa.,20 32,73,20,71,40,77,1,RO-may_treat,908179,In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa,Parkinson's syndrome,L-dopa
502540497,7/12/2014 01:05:22,,1321110201,7/12/2014 01:05:12,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,20,71,,,40,77,PARKINSON'S SYNDROME,L-DOPA,PARKINSON'S SYNDROME Madopar preparation,20-32-41-49,70-73-78-83-94-108-72,(L - DOPA with peripheral decarboxylase inhibitor),In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa.,20 32,73,20,71,40,77,1,RO-may_treat,908179,In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa,Parkinson's syndrome,L-dopa
502540497,7/12/2014 01:27:15,,1321119164,7/12/2014 01:27:00,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,20,71,,,40,77,PARKINSON'S SYNDROME,L-DOPA,PARKINSON'S SYNDROME Madopar preparation,20-32-41-49,70-73-78-83-94-108,(L DOPA with peripheral decarboxylase inhibitor),In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa.,20 32,73,20,71,40,77,1,RO-may_treat,908179,In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa,Parkinson's syndrome,L-dopa
502540497,7/12/2014 01:34:05,,1321122303,7/12/2014 01:33:03,prodege,1.0,21318648,GBR,G7,Kingston Upon Thames,81.157.193.175,20,71,,,40,77,PARKINSON'S SYNDROME,L-DOPA,patients PARKINSON'S SYNDROME Madopar (L dopa peripheral decarboxylase inhibitor) drug L dopa.,6-20-32-41-70-73-83-94-108-181-183-143,6-20-32-41-70-73-83-94-108-181-183-143,patients Parkinson's syndrome Madopar (L DOPA peripheral decarboxylase inhibitor) drug L dopa.,In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa.,20 32,73,20,71,40,77,1,RO-may_treat,908179,In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa,Parkinson's syndrome,L-dopa
502540497,7/12/2014 01:36:57,,1321123401,7/12/2014 01:34:40,elite,1.0,28276268,USA,CA,San Diego,76.88.95.100,20,71,,,40,77,PARKINSON'S SYNDROME,L-DOPA,PARKINSON'S SYNDROME,20-32,70-73,(L DOPA,In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa.,20 32,73,20,71,40,77,1,RO-may_treat,908179,In 38 patients with Parkinson's syndrome Madopar preparation was used (L-dopa with peripheral decarboxylase inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L-dopa,Parkinson's syndrome,L-dopa
502540498,7/11/2014 23:53:31,,1321074905,7/11/2014 23:53:08,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,247,334,,,258,357,TACHYCARDIA,VENTRICULAR TACHYCARDIA,"atrioventricular nodal reentry TACHYCARDIA,",216-233-239-247,334-346,VENTRICULAR TACHYCARDIA.,"During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia.",247,334 346,247,334,258,357,-1,RO-has_definitional_manifestation,904645,"During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia",tachycardia,ventricular tachycardia
502540498,7/12/2014 00:07:30,,1321082538,7/12/2014 00:07:12,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,247,334,,,258,357,TACHYCARDIA,VENTRICULAR TACHYCARDIA,"TACHYCARDIA,",247,334-346,VENTRICULAR TACHYCARDIA.,"During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia.",247,334 346,247,334,258,357,-1,RO-has_definitional_manifestation,904645,"During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia",tachycardia,ventricular tachycardia
502540498,7/12/2014 00:17:14,,1321088352,7/12/2014 00:17:02,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,247,334,,,258,357,TACHYCARDIA,VENTRICULAR TACHYCARDIA,"TACHYCARDIA,",247,334-346,VENTRICULAR TACHYCARDIA.,"During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia.",247,334 346,247,334,258,357,-1,RO-has_definitional_manifestation,904645,"During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia",tachycardia,ventricular tachycardia
502540498,7/12/2014 00:18:13,,1321088936,7/12/2014 00:18:02,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,247,334,,,258,357,TACHYCARDIA,VENTRICULAR TACHYCARDIA,"TACHYCARDIA,",247,334-346,VENTRICULAR TACHYCARDIA.,"During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia.",247,334 346,247,334,258,357,-1,RO-has_definitional_manifestation,904645,"During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia",tachycardia,ventricular tachycardia
502540498,7/12/2014 00:19:39,,1321089625,7/12/2014 00:19:30,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,247,334,,,258,357,TACHYCARDIA,VENTRICULAR TACHYCARDIA,"atrioventricular nodal reentry TACHYCARDIA, atrial tachycardia",216-233-239-247-260-267,309-316-330-334-346,"atrial fibrillation, and VENTRICULAR TACHYCARDIA.","During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia.",247,334 346,247,334,258,357,-1,RO-has_definitional_manifestation,904645,"During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia",tachycardia,ventricular tachycardia
502540498,7/12/2014 00:30:07,,1321095150,7/12/2014 00:29:29,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,247,334,,,258,357,TACHYCARDIA,VENTRICULAR TACHYCARDIA,"atrioventricular nodal reentry TACHYCARDIA,",216-233-239-247,334-346,VENTRICULAR TACHYCARDIA.,"During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia.",247,334 346,247,334,258,357,-1,RO-has_definitional_manifestation,904645,"During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia",tachycardia,ventricular tachycardia
502540498,7/12/2014 00:36:31,,1321098507,7/12/2014 00:36:12,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,247,334,,,258,357,TACHYCARDIA,VENTRICULAR TACHYCARDIA,"atrioventricular nodal reentry TACHYCARDIA,",216-233-239-247,334-346,VENTRICULAR TACHYCARDIA.,"During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia.",247,334 346,247,334,258,357,-1,RO-has_definitional_manifestation,904645,"During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia",tachycardia,ventricular tachycardia
502540498,7/12/2014 00:36:32,,1321098515,7/12/2014 00:35:49,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,247,334,,,258,357,TACHYCARDIA,VENTRICULAR TACHYCARDIA,"atrioventricular nodal reentry TACHYCARDIA,",216-233-239-247,334-346,VENTRICULAR TACHYCARDIA.,"During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia.",247,334 346,247,334,258,357,-1,RO-has_definitional_manifestation,904645,"During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia",tachycardia,ventricular tachycardia
502540498,7/12/2014 00:49:42,,1321103952,7/12/2014 00:49:23,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,247,334,,,258,357,TACHYCARDIA,VENTRICULAR TACHYCARDIA,"atrioventricular nodal reentry TACHYCARDIA,",216-233-239-247,334-346,VENTRICULAR TACHYCARDIA.,"During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia.",247,334 346,247,334,258,357,-1,RO-has_definitional_manifestation,904645,"During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia",tachycardia,ventricular tachycardia
502540498,7/12/2014 01:10:49,,1321112334,7/12/2014 01:10:29,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,247,334,,,258,357,TACHYCARDIA,VENTRICULAR TACHYCARDIA,"atrioventricular nodal reentry TACHYCARDIA,",216-233-239-247,334-346,VENTRICULAR TACHYCARDIA.,"During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia.",247,334 346,247,334,258,357,-1,RO-has_definitional_manifestation,904645,"During the course of our experience with Fontan conversion our surgical strategy has evolved to include various ablative techniques to treat macro re-entrant atrial tachycardia, focal (automatic) atrial tachycardia, atrioventricular nodal reentry tachycardia, atrial tachycardia due to accessory connections, atrial fibrillation, and ventricular tachycardia",tachycardia,ventricular tachycardia
502540499,7/11/2014 23:52:59,,1321074573,7/11/2014 23:52:26,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,109,145,,,126,161,ALLERGIC DISORDER,HYPERSENSITIVITY,familial ALLERGIC DISORDER,100-109-118,130-140-145,immediate type HYPERSENSITIVITY,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens.",109 118,145,109,145,126,161,-1,RO-cause_of,900347,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens",allergic disorder,hypersensitivity
502540499,7/12/2014 00:10:29,,1321084364,7/12/2014 00:10:00,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,109,145,,,126,161,ALLERGIC DISORDER,HYPERSENSITIVITY,ALLERGIC DISORDER,109-118,145,HYPERSENSITIVITY,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens.",109 118,145,109,145,126,161,-1,RO-cause_of,900347,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens",allergic disorder,hypersensitivity
502540499,7/12/2014 00:13:05,,1321085883,7/12/2014 00:12:45,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,109,145,,,126,161,ALLERGIC DISORDER,HYPERSENSITIVITY,ALLERGIC DISORDER,109-118,130-140-145,immediate type HYPERSENSITIVITY,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens.",109 118,145,109,145,126,161,-1,RO-cause_of,900347,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens",allergic disorder,hypersensitivity
502540499,7/12/2014 00:13:33,,1321086126,7/12/2014 00:13:17,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,109,145,,,126,161,ALLERGIC DISORDER,HYPERSENSITIVITY,ALLERGIC DISORDER,109-118,145,HYPERSENSITIVITY,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens.",109 118,145,109,145,126,161,-1,RO-cause_of,900347,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens",allergic disorder,hypersensitivity
502540499,7/12/2014 00:22:12,,1321091082,7/12/2014 00:21:55,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,109,145,,,126,161,ALLERGIC DISORDER,HYPERSENSITIVITY,"atopy, the familial ALLERGIC DISORDER of immediate type hypersensitivity to environmental allergens.",89-96-100-109-118-127-130-140-145-162-165-179,130-140-145-162-165-179,immediate type HYPERSENSITIVITY to environmental allergens.,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens.",109 118,145,109,145,126,161,-1,RO-cause_of,900347,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens",allergic disorder,hypersensitivity
502540499,7/12/2014 00:25:14,,1321092757,7/12/2014 00:25:08,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,109,145,,,126,161,ALLERGIC DISORDER,HYPERSENSITIVITY,"atopy, the familial ALLERGIC DISORDER of immediate type",89-96-100-109-118-127-130-140,127-130-140-145-162-165-179,of immediate type HYPERSENSITIVITY to environmental allergens.,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens.",109 118,145,109,145,126,161,-1,RO-cause_of,900347,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens",allergic disorder,hypersensitivity
502540499,7/12/2014 00:32:18,,1321096345,7/12/2014 00:31:40,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,109,145,,,126,161,ALLERGIC DISORDER,HYPERSENSITIVITY,familial ALLERGIC DISORDER,100-109-118,130-140-145-162-165-179,immediate type HYPERSENSITIVITY to environmental allergens.,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens.",109 118,145,109,145,126,161,-1,RO-cause_of,900347,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens",allergic disorder,hypersensitivity
502540499,7/12/2014 00:33:48,,1321097141,7/12/2014 00:33:34,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,109,145,,,126,161,ALLERGIC DISORDER,HYPERSENSITIVITY,familial ALLERGIC DISORDER,100-109-118,130-140-145-162-165-179,immediate type HYPERSENSITIVITY to environmental allergens.,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens.",109 118,145,109,145,126,161,-1,RO-cause_of,900347,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens",allergic disorder,hypersensitivity
502540499,7/12/2014 00:41:53,,1321100961,7/12/2014 00:41:30,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,109,145,,,126,161,ALLERGIC DISORDER,HYPERSENSITIVITY,familial ALLERGIC DISORDER,100-109-118,130-140-145,immediate type HYPERSENSITIVITY,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens.",109 118,145,109,145,126,161,-1,RO-cause_of,900347,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens",allergic disorder,hypersensitivity
502540499,7/12/2014 00:47:54,,1321103310,7/12/2014 00:46:50,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,109,145,,,126,161,ALLERGIC DISORDER,HYPERSENSITIVITY,familial ALLERGIC DISORDER,109-118-100,130-140-145-162-165-179,immediate type HYPERSENSITIVITY to environmental allergens.,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens.",109 118,145,109,145,126,161,-1,RO-cause_of,900347,"The human pathological condition most commonly associated with hyperproduction of IgE is atopy, the familial allergic disorder of immediate-type hypersensitivity to environmental allergens",allergic disorder,hypersensitivity
502540500,7/12/2014 00:02:46,,1321079699,7/12/2014 00:02:31,prodege,1.0,23541832,USA,AZ,Tempe,149.169.133.153,40,69,,,65,81,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,non specific BRONCHIAL HYPERREACTIVITY,27-31-40-50,69,"METHACHOLINE,","We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year.",40 50,69,40,69,65,81,1,RO-may_diagnose,906849,"We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year",bronchial hyperreactivity,methacholine
502540500,7/12/2014 00:09:43,,1321083888,7/12/2014 00:09:22,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,40,69,,,65,81,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,BRONCHIAL HYPERREACTIVITY,40-50,69,"METHACHOLINE,","We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year.",40 50,69,40,69,65,81,1,RO-may_diagnose,906849,"We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year",bronchial hyperreactivity,methacholine
502540500,7/12/2014 00:17:00,,1321088184,7/12/2014 00:16:45,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,40,69,,,65,81,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,BRONCHIAL HYPERREACTIVITY,40-50,69,"METHACHOLINE,","We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year.",40 50,69,40,69,65,81,1,RO-may_diagnose,906849,"We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year",bronchial hyperreactivity,methacholine
502540500,7/12/2014 00:18:11,,1321088899,7/12/2014 00:17:30,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,40,69,,,65,81,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,"of non specific BRONCHIAL HYPERREACTIVITY to methacholine, UNDW mite asthma treated with local immunotherapy subcutaneous immunotherapy",24-27-31-40-50-66-69-83-130-135-142-150-155-161-204-217,40-50-66-69-83-88-92-161-204-217-155,"bronchial hyperreactivity to METHACHOLINE, UNDW and exercise local immunotherapy subcutaneous immunotherapy","We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year.",40 50,69,40,69,65,81,1,RO-may_diagnose,906849,"We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year",bronchial hyperreactivity,methacholine
502540500,7/12/2014 00:20:45,,1321090216,7/12/2014 00:20:12,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,40,69,,,65,81,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,BRONCHIAL HYPERREACTIVITY,40-50,69,"METHACHOLINE,","We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year.",40 50,69,40,69,65,81,1,RO-may_diagnose,906849,"We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year",bronchial hyperreactivity,methacholine
502540500,7/12/2014 00:24:28,,1321092402,7/12/2014 00:24:10,instagc,1.0,13763729,USA,"","",75.182.89.225,40,69,,,65,81,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,BRONCHIAL HYPERREACTIVITY,40-50,69,"METHACHOLINE,","We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year.",40 50,69,40,69,65,81,1,RO-may_diagnose,906849,"We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year",bronchial hyperreactivity,methacholine
502540500,7/12/2014 00:25:53,,1321093088,7/12/2014 00:25:47,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,40,69,,,65,81,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,"of non specific BRONCHIAL HYPERREACTIVITY to methacholine, UNDW",24-27-31-40-50-66-69-83,40-50-66-69-83-88-92,"bronchial hyperreactivity to METHACHOLINE, UNDW and exercise","We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year.",40 50,69,40,69,65,81,1,RO-may_diagnose,906849,"We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year",bronchial hyperreactivity,methacholine
502540500,7/12/2014 00:30:04,,1321095137,7/12/2014 00:28:39,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,40,69,,,65,81,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,non specific BRONCHIAL HYPERREACTIVITY,27-31-40-50,69,"METHACHOLINE,","We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year.",40 50,69,40,69,65,81,1,RO-may_diagnose,906849,"We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year",bronchial hyperreactivity,methacholine
502540500,7/12/2014 00:35:11,,1321097806,7/12/2014 00:34:44,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,40,69,,,65,81,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,BRONCHIAL HYPERREACTIVITY,40-50,69,"METHACHOLINE,","We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year.",40 50,69,40,69,65,81,1,RO-may_diagnose,906849,"We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year",bronchial hyperreactivity,methacholine
502540500,7/12/2014 01:02:17,,1321108910,7/12/2014 01:01:58,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,40,69,,,65,81,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,"BRONCHIAL HYPERREACTIVITY to methacholine,",40-50-66-69,40-50-66-69,"bronchial hyperreactivity to METHACHOLINE,","We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year.",40 50,69,40,69,65,81,1,RO-may_diagnose,906849,"We compared the changes of non-specific bronchial hyperreactivity to methacholine, UNDW and exercise in 2 groups of patients with mite asthma treated with local immunotherapy (LIT group: 12 patients) and subcutaneous immunotherapy (SIT group: 8 patients) for 1 year",bronchial hyperreactivity,methacholine
502540501,7/12/2014 00:00:44,,1321078501,7/12/2014 00:00:20,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,21,74,,,48,79,ANTIPHOSPHOLIPID ANTIBODIES,LUPUS,ANTIPHOSPHOLIPID ANTIBODIES:,21-38,74-80,LUPUS anticoagulant,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance.",21 38,74,21,74,48,79,-1,RO-has_manifestation,906461,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance",Antiphospholipid antibodies,lupus
502540501,7/12/2014 00:01:16,,1321078848,7/12/2014 00:00:54,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,21,74,,,48,79,ANTIPHOSPHOLIPID ANTIBODIES,LUPUS,ANTIPHOSPHOLIPID ANTIBODIES:,21-38,74-80,LUPUS anticoagulant,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance.",21 38,74,21,74,48,79,-1,RO-has_manifestation,906461,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance",Antiphospholipid antibodies,lupus
502540501,7/12/2014 00:11:14,,1321084713,7/12/2014 00:10:54,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,21,74,,,48,79,ANTIPHOSPHOLIPID ANTIBODIES,LUPUS,ANTIPHOSPHOLIPID ANTIBODIES:,21-38,74-80,LUPUS anticoagulant,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance.",21 38,74,21,74,48,79,-1,RO-has_manifestation,906461,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance",Antiphospholipid antibodies,lupus
502540501,7/12/2014 00:20:39,,1321090160,7/12/2014 00:20:25,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,21,74,,,48,79,ANTIPHOSPHOLIPID ANTIBODIES,LUPUS,ANTIPHOSPHOLIPID ANTIBODIES:,21-38,74,LUPUS,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance.",21 38,74,21,74,48,79,-1,RO-has_manifestation,906461,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance",Antiphospholipid antibodies,lupus
502540501,7/12/2014 00:25:27,,1321092864,7/12/2014 00:25:22,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,21,74,,,48,79,ANTIPHOSPHOLIPID ANTIBODIES,LUPUS,"PE, Santoro SA: ANTIPHOSPHOLIPID ANTIBODIES: anticardiolipin and the",5-9-17-21-38-50-66-70,50-66-70-74-80-94-97,anticardiolipin and the LUPUS anticoagulant in systemic,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance.",21 38,74,21,74,48,79,-1,RO-has_manifestation,906461,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance",Antiphospholipid antibodies,lupus
502540501,7/12/2014 00:33:35,,1321097031,7/12/2014 00:32:55,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,21,74,,,48,79,ANTIPHOSPHOLIPID ANTIBODIES,LUPUS,ANTIPHOSPHOLIPID ANTIBODIES:,21-38,74-80,LUPUS anticoagulant,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance.",21 38,74,21,74,48,79,-1,RO-has_manifestation,906461,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance",Antiphospholipid antibodies,lupus
502540501,7/12/2014 00:34:04,,1321097294,7/12/2014 00:33:39,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,21,74,,,48,79,ANTIPHOSPHOLIPID ANTIBODIES,LUPUS,ANTIPHOSPHOLIPID ANTIBODIES:,21-38,74-80,LUPUS anticoagulant,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance.",21 38,74,21,74,48,79,-1,RO-has_manifestation,906461,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance",Antiphospholipid antibodies,lupus
502540501,7/12/2014 00:44:54,,1321102161,7/12/2014 00:44:31,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,21,74,,,48,79,ANTIPHOSPHOLIPID ANTIBODIES,LUPUS,ANTIPHOSPHOLIPID ANTIBODIES:,21-38,74-80,LUPUS anticoagulant,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance.",21 38,74,21,74,48,79,-1,RO-has_manifestation,906461,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance",Antiphospholipid antibodies,lupus
502540501,7/12/2014 01:12:52,,1321113357,7/12/2014 01:12:25,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,21,74,,,48,79,ANTIPHOSPHOLIPID ANTIBODIES,LUPUS,ANTIPHOSPHOLIPID ANTIBODIES: anticardiolipin and the lupus anticoagulant,21-38-50-66-70-74-80,74-158-169-173-182,LUPUS prevalence and clinical significance.,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance.",21 38,74,21,74,48,79,-1,RO-has_manifestation,906461,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance",Antiphospholipid antibodies,lupus
502540501,7/12/2014 01:27:34,,1321119316,7/12/2014 01:27:18,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,21,74,,,48,79,ANTIPHOSPHOLIPID ANTIBODIES,LUPUS,"PE, Santoro SA: ANTIPHOSPHOLIPID ANTIBODIES: anticardiolipin",5-9-17-21-38-50,50-66-70-74-80,anticardiolipin and the LUPUS anticoagulant,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance.",21 38,74,21,74,48,79,-1,RO-has_manifestation,906461,"Love PE, Santoro SA: Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance",Antiphospholipid antibodies,lupus
502540502,7/12/2014 00:00:00,,1321078093,7/11/2014 23:59:37,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,149,56,,,153,70,SKIN,LICHEN NITIDUS,"normal palmar SKIN,",135-142-149,49-56-63,palmar LICHEN NITIDUS,"We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus.",149,56 63,149,56,153,70,1,RO-has_finding_site,905453,"We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus",skin,lichen nitidus
502540502,7/12/2014 00:18:01,,1321088788,7/12/2014 00:17:48,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,149,56,,,153,70,SKIN,LICHEN NITIDUS,"SKIN,",149,56-63,LICHEN NITIDUS,"We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus.",149,56 63,149,56,153,70,1,RO-has_finding_site,905453,"We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus",skin,lichen nitidus
502540502,7/12/2014 00:18:29,,1321089044,7/12/2014 00:18:13,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,149,56,,,153,70,SKIN,LICHEN NITIDUS,"normal palmar SKIN,",135-142-149,49-56-63,palmar LICHEN NITIDUS,"We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus.",149,56 63,149,56,153,70,1,RO-has_finding_site,905453,"We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus",skin,lichen nitidus
502540502,7/12/2014 00:19:37,,1321089602,7/12/2014 00:18:51,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,149,56,,,153,70,SKIN,LICHEN NITIDUS,"palmar SKIN,",142-149,49-56-63,palmar LICHEN NITIDUS,"We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus.",149,56 63,149,56,153,70,1,RO-has_finding_site,905453,"We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus",skin,lichen nitidus
502540502,7/12/2014 00:26:15,,1321093283,7/12/2014 00:25:57,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,149,56,,,153,70,SKIN,LICHEN NITIDUS,"normal palmar SKIN,",135-142-149,49-56-63,palmar LICHEN NITIDUS,"We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus.",149,56 63,149,56,153,70,1,RO-has_finding_site,905453,"We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus",skin,lichen nitidus
502540502,7/12/2014 00:38:59,,1321099612,7/12/2014 00:36:57,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,149,56,,,153,70,SKIN,LICHEN NITIDUS,"normal palmar SKIN,",135-142-149,49-56-63,palmar LICHEN NITIDUS,"We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus.",149,56 63,149,56,153,70,1,RO-has_finding_site,905453,"We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus",skin,lichen nitidus
502540502,7/12/2014 00:42:50,,1321101383,7/12/2014 00:42:28,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,149,56,,,153,70,SKIN,LICHEN NITIDUS,"palmar SKIN,",142-149,49-56-63,palmar LICHEN NITIDUS,"We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus.",149,56 63,149,56,153,70,1,RO-has_finding_site,905453,"We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus",skin,lichen nitidus
502540502,7/12/2014 01:04:59,,1321110021,7/12/2014 01:04:37,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,149,56,,,153,70,SKIN,LICHEN NITIDUS,"normal palmar SKIN,",135-142-149,49-56-63,palmar LICHEN NITIDUS,"We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus.",149,56 63,149,56,153,70,1,RO-has_finding_site,905453,"We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus",skin,lichen nitidus
502540502,7/12/2014 01:17:09,,1321115058,7/12/2014 01:15:47,prodege,1.0,21318648,GBR,G7,Kingston Upon Thames,81.157.193.175,149,56,,,153,70,SKIN,LICHEN NITIDUS,"histopathologic palmar lichen nitidus lichen nitidus palmar SKIN, hypertrophic lichen planus.",22-49-56-63-117-142-149-189-202-209-124,22-49-56-63-117-124-142-149-189-202-209,"histopathologic palmar LICHEN NITIDUS lichen nitidus palmar skin, hypertrophic lichen planus.","We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus.",149,56 63,149,56,153,70,1,RO-has_finding_site,905453,"We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus",skin,lichen nitidus
502540502,7/12/2014 01:19:34,,1321115911,7/12/2014 01:19:13,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,149,56,,,153,70,SKIN,LICHEN NITIDUS,"superimposition of lichen nitidus on normal palmar SKIN, a",98-114-117-124-132-135-149-168-142,22-38-46-49-56-63,histopathologic feature in palmar LICHEN NITIDUS,"We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus.",149,56 63,149,56,153,70,1,RO-has_finding_site,905453,"We conclude that this histopathologic feature in palmar lichen nitidus could be the result of the superimposition of lichen nitidus on normal palmar skin, resulting in a picture resembling hypertrophic lichen planus",skin,lichen nitidus
502540503,7/12/2014 00:11:38,,1321084977,7/12/2014 00:11:16,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,52,89,,,65,103,PRION PROTEIN,PRION DISEASES,cellular PRION PROTEIN,43-52-58,89-95,PRION DISEASES,"Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice.",52 58,89 95,52,89,65,103,-1,RO-has_causative_agent,903988,"Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice",prion protein,prion diseases
502540503,7/12/2014 00:11:56,,1321085138,7/12/2014 00:11:27,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,52,89,,,65,103,PRION PROTEIN,PRION DISEASES,cellular PRION PROTEIN,43-52-58,89-95,PRION DISEASES,"Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice.",52 58,89 95,52,89,65,103,-1,RO-has_causative_agent,903988,"Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice",prion protein,prion diseases
502540503,7/12/2014 00:14:45,,1321086921,7/12/2014 00:14:33,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,52,89,,,65,103,PRION PROTEIN,PRION DISEASES,PRION PROTEIN,52-58,89-95,PRION DISEASES,"Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice.",52 58,89 95,52,89,65,103,-1,RO-has_causative_agent,903988,"Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice",prion protein,prion diseases
502540503,7/12/2014 00:19:10,,1321089387,7/12/2014 00:18:27,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,52,89,,,65,103,PRION PROTEIN,PRION DISEASES,function of cellular PRION PROTEIN,31-40-43-52-58,89-95-104-109-112-123-124-130,"PRION DISEASES such as Creutzfeldt - Jakob disease,","Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice.",52 58,89 95,52,89,65,103,-1,RO-has_causative_agent,903988,"Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice",prion protein,prion diseases
502540503,7/12/2014 00:24:30,,1321092412,7/12/2014 00:24:24,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,52,89,,,65,103,PRION PROTEIN,PRION DISEASES,function of cellular PRION PROTEIN has been acquired,31-40-43-52-58-66-70-75,70-75-84-89-95-104-109-112,been acquired from PRION DISEASES such as Creutzfeldt,"Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice.",52 58,89 95,52,89,65,103,-1,RO-has_causative_agent,903988,"Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice",prion protein,prion diseases
502540503,7/12/2014 00:26:22,,1321093322,7/12/2014 00:26:04,instagc,1.0,13763729,USA,"","",75.182.89.225,52,89,,,65,103,PRION PROTEIN,PRION DISEASES,cellular PRION PROTEIN,43-52-58,89-95,PRION DISEASES,"Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice.",52 58,89 95,52,89,65,103,-1,RO-has_causative_agent,903988,"Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice",prion protein,prion diseases
502540503,7/12/2014 00:27:45,,1321093984,7/12/2014 00:27:05,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,52,89,,,65,103,PRION PROTEIN,PRION DISEASES,physiological function of cellular PRION PROTEIN has been acquired prion diseases Creutzfeldt Jakob transgenic mice.,17-31-40-43-52-58-66-70-75-89-95-112-124-169-180,17-31-40-43-52-58-70-75-84-89-95-104-109-112-124-130-169-180,"physiological function of cellular prion protein been acquired from PRION DISEASES such as Creutzfeldt Jakob disease, transgenic mice.","Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice.",52 58,89 95,52,89,65,103,-1,RO-has_causative_agent,903988,"Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice",prion protein,prion diseases
502540503,7/12/2014 00:32:10,,1321096271,7/12/2014 00:31:42,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,52,89,,,65,103,PRION PROTEIN,PRION DISEASES,cellular PRION PROTEIN,43-52-58,89-95,PRION DISEASES,"Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice.",52 58,89 95,52,89,65,103,-1,RO-has_causative_agent,903988,"Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice",prion protein,prion diseases
502540503,7/12/2014 00:40:33,,1321100273,7/12/2014 00:40:15,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,52,89,,,65,103,PRION PROTEIN,PRION DISEASES,cellular PRION PROTEIN,43-52-58,89-95,PRION DISEASES,"Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice.",52 58,89 95,52,89,65,103,-1,RO-has_causative_agent,903988,"Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice",prion protein,prion diseases
502540503,7/12/2014 00:42:09,,1321101061,7/12/2014 00:41:49,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,52,89,,,65,103,PRION PROTEIN,PRION DISEASES,cellular PRION PROTEIN,43-52-58,89-95,PRION DISEASES,"Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice.",52 58,89 95,52,89,65,103,-1,RO-has_causative_agent,903988,"Knowledge of the physiological function of cellular prion protein has been acquired from prion diseases such as Creutzfeldt-Jakob disease, as well as PRNP knock out and transgenic mice",prion protein,prion diseases
502540504,7/11/2014 23:54:56,,1321075527,7/11/2014 23:54:37,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,118,55,,,136,68,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,118-128,55,DEXAMETHASONE,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients.,118 128,55,118,55,136,68,1,RO-may_diagnose,906906,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients,Cushing's syndrome,dexamethasone
502540504,7/12/2014 00:00:23,,1321078248,7/12/2014 00:00:08,prodege,1.0,23541832,USA,AZ,Tempe,149.169.133.153,118,55,,,136,68,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,118-128,55-73-84-69,DEXAMETHASONE and metyrapone tests,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients.,118 128,55,118,55,136,68,1,RO-may_diagnose,906906,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients,Cushing's syndrome,dexamethasone
502540504,7/12/2014 00:23:35,,1321091921,7/12/2014 00:23:18,instagc,1.0,13763729,USA,"","",75.182.89.225,118,55,,,136,68,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,118-128,55,DEXAMETHASONE,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients.,118 128,55,118,55,136,68,1,RO-may_diagnose,906906,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients,Cushing's syndrome,dexamethasone
502540504,7/12/2014 00:27:04,,1321093653,7/12/2014 00:26:42,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,118,55,,,136,68,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,118-128,55-69-73-84,DEXAMETHASONE and metyrapone tests,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients.,118 128,55,118,55,136,68,1,RO-may_diagnose,906906,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients,Cushing's syndrome,dexamethasone
502540504,7/12/2014 00:30:20,,1321095288,7/12/2014 00:30:04,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,118,55,,,136,68,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,118-128,55-69-73-84,DEXAMETHASONE and metyrapone tests,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients.,118 128,55,118,55,136,68,1,RO-may_diagnose,906906,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients,Cushing's syndrome,dexamethasone
502540504,7/12/2014 00:33:08,,1321096815,7/12/2014 00:32:37,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,118,55,,,136,68,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,118-128,55,DEXAMETHASONE,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients.,118 128,55,118,55,136,68,1,RO-may_diagnose,906906,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients,Cushing's syndrome,dexamethasone
502540504,7/12/2014 00:33:53,,1321097188,7/12/2014 00:33:31,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,118,55,,,136,68,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,118-128,39-48-51-55-69-73-84,accuracy of the DEXAMETHASONE and metyrapone tests,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients.,118 128,55,118,55,136,68,1,RO-may_diagnose,906906,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients,Cushing's syndrome,dexamethasone
502540504,7/12/2014 00:40:14,,1321100168,7/12/2014 00:39:00,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,118,55,,,136,68,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,118-128,55,DEXAMETHASONE,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients.,118 128,55,118,55,136,68,1,RO-may_diagnose,906906,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients,Cushing's syndrome,dexamethasone
502540504,7/12/2014 00:42:26,,1321101230,7/12/2014 00:42:10,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,118,55,,,136,68,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,118-128,55,DEXAMETHASONE,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients.,118 128,55,118,55,136,68,1,RO-may_diagnose,906906,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients,Cushing's syndrome,dexamethasone
502540504,7/12/2014 01:06:09,,1321110496,7/12/2014 01:05:57,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,118,55,,,136,68,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,118-128,55-69-73-84,DEXAMETHASONE and metyrapone tests,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients.,118 128,55,118,55,136,68,1,RO-may_diagnose,906906,This study prospectively evaluated the accuracy of the dexamethasone and metyrapone tests in determining the cause of Cushing's syndrome in a series of 25 unselected patients,Cushing's syndrome,dexamethasone
502540505,7/11/2014 23:57:54,,1321077007,7/11/2014 23:57:42,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,69,101,,,74,117,JOINT,SEPTIC ARTHRITIS,JOINT,69,101-108,SEPTIC ARTHRITIS.,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis.,69,101 108,69,101,74,117,1,RO-disease_has_primary_anatomic_site,902029,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis,joint,septic arthritis
502540505,7/12/2014 00:06:51,,1321082134,7/12/2014 00:06:35,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,69,101,,,74,117,JOINT,SEPTIC ARTHRITIS,JOINT,69,101-108,SEPTIC ARTHRITIS.,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis.,69,101 108,69,101,74,117,1,RO-disease_has_primary_anatomic_site,902029,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis,joint,septic arthritis
502540505,7/12/2014 00:08:01,,1321082806,7/12/2014 00:07:07,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,69,101,,,74,117,JOINT,SEPTIC ARTHRITIS,affected JOINT suspected septic arthritis.,60-69-91-101-108,60-69-91-101-108,affected joint suspected SEPTIC ARTHRITIS.,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis.,69,101 108,69,101,74,117,1,RO-disease_has_primary_anatomic_site,902029,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis,joint,septic arthritis
502540505,7/12/2014 00:14:16,,1321086592,7/12/2014 00:14:06,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,69,101,,,74,117,JOINT,SEPTIC ARTHRITIS,JOINT,69,101-108,SEPTIC ARTHRITIS.,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis.,69,101 108,69,101,74,117,1,RO-disease_has_primary_anatomic_site,902029,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis,joint,septic arthritis
502540505,7/12/2014 00:22:07,,1321091012,7/12/2014 00:21:46,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,69,101,,,74,117,JOINT,SEPTIC ARTHRITIS,JOINT,69,101-108-91,suspected SEPTIC ARTHRITIS.,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis.,69,101 108,69,101,74,117,1,RO-disease_has_primary_anatomic_site,902029,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis,joint,septic arthritis
502540505,7/12/2014 00:24:10,,1321092246,7/12/2014 00:23:07,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,69,101,,,74,117,JOINT,SEPTIC ARTHRITIS,affected JOINT,60-69,101-108,SEPTIC ARTHRITIS.,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis.,69,101 108,69,101,74,117,1,RO-disease_has_primary_anatomic_site,902029,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis,joint,septic arthritis
502540505,7/12/2014 00:34:28,,1321097443,7/12/2014 00:34:17,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,69,101,,,74,117,JOINT,SEPTIC ARTHRITIS,JOINT,69,101-108,SEPTIC ARTHRITIS.,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis.,69,101 108,69,101,74,117,1,RO-disease_has_primary_anatomic_site,902029,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis,joint,septic arthritis
502540505,7/12/2014 00:44:27,,1321101999,7/12/2014 00:44:14,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,69,101,,,74,117,JOINT,SEPTIC ARTHRITIS,JOINT,69,101-108,SEPTIC ARTHRITIS.,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis.,69,101 108,69,101,74,117,1,RO-disease_has_primary_anatomic_site,902029,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis,joint,septic arthritis
502540505,7/12/2014 00:44:50,,1321102140,7/12/2014 00:44:31,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,69,101,,,74,117,JOINT,SEPTIC ARTHRITIS,affected JOINT,69-60,101-108,SEPTIC ARTHRITIS.,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis.,69,101 108,69,101,74,117,1,RO-disease_has_primary_anatomic_site,902029,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis,joint,septic arthritis
502540505,7/12/2014 01:00:04,,1321108046,7/12/2014 00:59:04,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,69,101,,,74,117,JOINT,SEPTIC ARTHRITIS,the affected JOINT,56-60-69,88-91-101-108-82,cases of suspected SEPTIC ARTHRITIS.,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis.,69,101 108,69,101,74,117,1,RO-disease_has_primary_anatomic_site,902029,BC]  Specific recommendation: ? Obtain joint fluid from the affected joint in all cases of suspected septic arthritis,joint,septic arthritis
502540506,7/12/2014 00:00:19,,1321078211,7/12/2014 00:00:00,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,161,176,,,167,189,BREAST,BREAST CANCER,"(advanced BREAST cancer,",151-161-168,176-183-190,"BREAST CANCER mortality,","STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality.",161,176 183,161,176,167,189,1,RO-disease_has_primary_anatomic_site,902100,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality",breast,breast cancer
502540506,7/12/2014 00:13:16,,1321085943,7/12/2014 00:12:17,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,161,176,,,167,189,BREAST,BREAST CANCER,"(advanced BREAST cancer,",151-161-168,176-183,BREAST CANCER,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality.",161,176 183,161,176,167,189,1,RO-disease_has_primary_anatomic_site,902100,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality",breast,breast cancer
502540506,7/12/2014 00:14:25,,1321086696,7/12/2014 00:13:58,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,161,176,,,167,189,BREAST,BREAST CANCER,"(advanced BREAST cancer,",151-161-168,176-183,BREAST CANCER,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality.",161,176 183,161,176,167,189,1,RO-disease_has_primary_anatomic_site,902100,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality",breast,breast cancer
502540506,7/12/2014 00:17:28,,1321088513,7/12/2014 00:16:22,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,161,176,,,167,189,BREAST,BREAST CANCER,"randomized controlled trials (RCTs) clinical outcome (advanced BREAST cancer, breast cancer",52-63-74-134-143-151-161-168-176-183-81,52-63-81-151-161-168-176-183-190-201-204-74,"randomized controlled trials (RCTs) (advanced breast cancer, BREAST CANCER mortality, or all","STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality.",161,176 183,161,176,167,189,1,RO-disease_has_primary_anatomic_site,902100,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality",breast,breast cancer
502540506,7/12/2014 00:26:41,,1321093475,7/12/2014 00:26:17,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,161,176,,,167,189,BREAST,BREAST CANCER,"(advanced BREAST cancer,",151-161-168,176-183-190,"BREAST CANCER mortality,","STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality.",161,176 183,161,176,167,189,1,RO-disease_has_primary_anatomic_site,902100,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality",breast,breast cancer
502540506,7/12/2014 00:34:03,,1321097290,7/12/2014 00:33:32,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,161,176,,,167,189,BREAST,BREAST CANCER,"(advanced BREAST cancer,",151-161-168,176-183-190,"BREAST CANCER mortality,","STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality.",161,176 183,161,176,167,189,1,RO-disease_has_primary_anatomic_site,902100,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality",breast,breast cancer
502540506,7/12/2014 01:11:27,,1321112629,7/12/2014 01:10:06,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,161,176,,,167,189,BREAST,BREAST CANCER,"clinical outcome (advanced BREAST cancer, breast cancer",134-143-151-161-168-176-183,176-183-190-201-204-208-214,"BREAST CANCER mortality, or all cause mortality.","STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality.",161,176 183,161,176,167,189,1,RO-disease_has_primary_anatomic_site,902100,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality",breast,breast cancer
502540506,7/12/2014 01:24:37,,1321117940,7/12/2014 01:23:49,prodege,1,16656406,CAN,AB,Calgary,162.157.237.93,161,176,,,167,189,BREAST,BREAST CANCER,"(advanced BREAST cancer, breast cancer",151-161-168-176-183,151-161-168-176-183,"(advanced breast cancer, BREAST CANCER","STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality.",161,176 183,161,176,167,189,1,RO-disease_has_primary_anatomic_site,902100,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality",breast,breast cancer
502540506,7/12/2014 01:26:22,,1321118726,7/12/2014 01:26:06,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,161,176,,,167,189,BREAST,BREAST CANCER,"BREAST cancer, breast cancer",161-168-176-183,151-161-168-176-183,"(advanced breast cancer, BREAST CANCER","STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality.",161,176 183,161,176,167,189,1,RO-disease_has_primary_anatomic_site,902100,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality",breast,breast cancer
502540506,7/12/2014 01:33:02,,1321121820,7/12/2014 01:31:50,prodege,1.0,21318648,GBR,G7,Kingston Upon Thames,81.157.193.175,161,176,,,167,189,BREAST,BREAST CANCER,"breast cancer clinical BREAST cancer, breast cancer mortality, mortality.",91-98-134-161-168-176-183-190-214,91-98-134-161-168-176-183-214-190,"breast cancer clinical breast cancer, BREAST CANCER mortality, mortality.","STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality.",161,176 183,161,176,167,189,1,RO-disease_has_primary_anatomic_site,902100,"STUDY SELECTION  Studies were selected if they were randomized controlled trials (RCTs) of breast cancer screening and had a relevant clinical outcome (advanced breast cancer, breast cancer mortality, or all-cause mortality",breast,breast cancer
502540507,7/11/2014 23:55:28,,1321075784,7/11/2014 23:55:11,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,44,15,,,66,23,VARICELLA ZOSTER VIRUS,SHINGLES,VARICELLA ZOSTER VIRUS,44-54-61,0-7-14,Herpes zoster (SHINGLES),Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated.,44 54 61,,44,15,66,23,1,RO-has_causative_agent,903737,Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated,varicella zoster virus,shingles
502540507,7/11/2014 23:59:20,,1321077754,7/11/2014 23:59:02,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,44,15,,,66,23,VARICELLA ZOSTER VIRUS,SHINGLES,VARICELLA ZOSTER VIRUS,44-54-61,0-7-14,Herpes zoster (SHINGLES),Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated.,44 54 61,,44,15,66,23,1,RO-has_causative_agent,903737,Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated,varicella zoster virus,shingles
502540507,7/12/2014 00:02:13,,1321079431,7/12/2014 00:01:54,prodege,1.0,23541832,USA,AZ,Tempe,149.169.133.153,44,15,,,66,23,VARICELLA ZOSTER VIRUS,SHINGLES,VARICELLA ZOSTER VIRUS,44-54-61,0-7-14,Herpes zoster (SHINGLES),Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated.,44 54 61,,44,15,66,23,1,RO-has_causative_agent,903737,Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated,varicella zoster virus,shingles
502540507,7/12/2014 00:10:10,,1321084159,7/12/2014 00:09:45,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,44,15,,,66,23,VARICELLA ZOSTER VIRUS,SHINGLES,VARICELLA ZOSTER VIRUS,44-54-61,0-7-14,Herpes zoster (SHINGLES),Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated.,44 54 61,,44,15,66,23,1,RO-has_causative_agent,903737,Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated,varicella zoster virus,shingles
502540507,7/12/2014 00:22:26,,1321091210,7/12/2014 00:22:04,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,44,15,,,66,23,VARICELLA ZOSTER VIRUS,SHINGLES,Herpes zoster (shingles) caused when the VARICELLA ZOSTER VIRUS that has remained varicella infection (chicken pox),0-7-14-28-35-40-44-54-61-67-72-76-109-119-129-138,0-7-14-25-28-35-44-54-61-109-119-129-138,Herpes zoster (SHINGLES) is caused when varicella zoster virus varicella infection (chicken pox),Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated.,44 54 61,,44,15,66,23,1,RO-has_causative_agent,903737,Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated,varicella zoster virus,shingles
502540507,7/12/2014 00:22:52,,1321091428,7/12/2014 00:22:08,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,44,15,,,66,23,VARICELLA ZOSTER VIRUS,SHINGLES,VARICELLA ZOSTER VIRUS,44-54-61,14,(SHINGLES),Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated.,44 54 61,,44,15,66,23,1,RO-has_causative_agent,903737,Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated,varicella zoster virus,shingles
502540507,7/12/2014 00:30:50,,1321095619,7/12/2014 00:30:28,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,44,15,,,66,23,VARICELLA ZOSTER VIRUS,SHINGLES,VARICELLA ZOSTER VIRUS,44-54-61,0-7-14,Herpes zoster (SHINGLES),Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated.,44 54 61,,44,15,66,23,1,RO-has_causative_agent,903737,Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated,varicella zoster virus,shingles
502540507,7/12/2014 00:33:30,,1321096982,7/12/2014 00:33:06,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,44,15,,,66,23,VARICELLA ZOSTER VIRUS,SHINGLES,VARICELLA ZOSTER VIRUS,44-54-61,0-7-14,Herpes zoster (SHINGLES),Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated.,44 54 61,,44,15,66,23,1,RO-has_causative_agent,903737,Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated,varicella zoster virus,shingles
502540507,7/12/2014 00:43:06,,1321101480,7/12/2014 00:42:51,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,44,15,,,66,23,VARICELLA ZOSTER VIRUS,SHINGLES,VARICELLA ZOSTER VIRUS,44-54-61,0-7-14,Herpes zoster (SHINGLES),Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated.,44 54 61,,44,15,66,23,1,RO-has_causative_agent,903737,Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated,varicella zoster virus,shingles
502540507,7/12/2014 00:50:01,,1321104035,7/12/2014 00:49:42,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,44,15,,,66,23,VARICELLA ZOSTER VIRUS,SHINGLES,VARICELLA ZOSTER VIRUS,44-54-61,0-7-14,Herpes zoster (SHINGLES),Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated.,44 54 61,,44,15,66,23,1,RO-has_causative_agent,903737,Herpes zoster (shingles) is caused when the varicella zoster virus that has remained latent since an earlier varicella infection (chicken-pox) is reactivated,varicella zoster virus,shingles
502540508,7/11/2014 23:53:07,,1321074687,7/11/2014 23:52:41,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,235,303,,,247,316,BRAIN TISSUE,PRION DISEASE,human BRAIN TISSUE,229-235-241,281-291-294-303-309,"suspected or atypical PRION DISEASE,","No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures.",235 241,303 309,235,303,247,316,1,RO-has_finding_site,905060,"No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures",brain tissue,prion disease
502540508,7/12/2014 00:01:38,,1321079078,7/12/2014 00:01:22,prodege,1.0,23541832,USA,AZ,Tempe,149.169.133.153,235,303,,,247,316,BRAIN TISSUE,PRION DISEASE,human BRAIN TISSUE,229-235-241,303-309,"PRION DISEASE,","No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures.",235 241,303 309,235,303,247,316,1,RO-has_finding_site,905060,"No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures",brain tissue,prion disease
502540508,7/12/2014 00:07:56,,1321082776,7/12/2014 00:07:23,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,235,303,,,247,316,BRAIN TISSUE,PRION DISEASE,BRAIN TISSUE,235-241,294-303-309,"atypical PRION DISEASE,","No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures.",235 241,303 309,235,303,247,316,1,RO-has_finding_site,905060,"No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures",brain tissue,prion disease
502540508,7/12/2014 00:24:02,,1321092181,7/12/2014 00:23:11,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,235,303,,,247,316,BRAIN TISSUE,PRION DISEASE,beta (A4) amyloid plaques spongiform encephalopathy (SE) previously with human BRAIN TISSUE from three younger,3-8-13-21-147-158-213-224-229-235-241-248-253-259-173,3-8-13-21-158-173-281-291-294-303-309-318-321-324-147,"beta (A4) amyloid plaques spongiform encephalopathy (SE) suspected or atypical PRION DISEASE, or in 10","No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures.",235 241,303 309,235,303,247,316,1,RO-has_finding_site,905060,"No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures",brain tissue,prion disease
502540508,7/12/2014 00:27:28,,1321093820,7/12/2014 00:27:11,instagc,1.0,13763729,USA,"","",75.182.89.225,235,303,,,247,316,BRAIN TISSUE,PRION DISEASE,BRAIN TISSUE,235-241,303-309,"PRION DISEASE,","No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures.",235 241,303 309,235,303,247,316,1,RO-has_finding_site,905060,"No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures",brain tissue,prion disease
502540508,7/12/2014 00:34:19,,1321097383,7/12/2014 00:34:05,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,235,303,,,247,316,BRAIN TISSUE,PRION DISEASE,BRAIN TISSUE,235-241,303-309,"PRION DISEASE,","No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures.",235 241,303 309,235,303,247,316,1,RO-has_finding_site,905060,"No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures",brain tissue,prion disease
502540508,7/12/2014 00:45:04,,1321102236,7/12/2014 00:44:46,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,235,303,,,247,316,BRAIN TISSUE,PRION DISEASE,human BRAIN TISSUE,229-235-241,294-303-309,"atypical PRION DISEASE,","No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures.",235 241,303 309,235,303,247,316,1,RO-has_finding_site,905060,"No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures",brain tissue,prion disease
502540508,7/12/2014 01:02:46,,1321109083,7/12/2014 01:02:18,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,235,303,,,247,316,BRAIN TISSUE,PRION DISEASE,human BRAIN TISSUE,235-241-229,281-291-303-309-294,"suspected or atypical PRION DISEASE,","No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures.",235 241,303 309,235,303,247,316,1,RO-has_finding_site,905060,"No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures",brain tissue,prion disease
502540508,7/12/2014 01:28:17,,1321119669,7/12/2014 01:28:03,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,235,303,,,247,316,BRAIN TISSUE,PRION DISEASE,human BRAIN TISSUE,229-235-241,281-291-294-303-309,"suspected or atypical PRION DISEASE,","No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures.",235 241,303 309,235,303,247,316,1,RO-has_finding_site,905060,"No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures",brain tissue,prion disease
502540508,7/12/2014 01:31:49,,1321121253,7/12/2014 01:30:29,prodege,1.0,21318648,GBR,G7,Kingston Upon Thames,81.157.193.175,235,303,,,247,316,BRAIN TISSUE,PRION DISEASE,"(A4) amyloid plaques marmosets injected marmosets spongiform encephalopathy (SE) injected BRAIN TISSUE patients atypical prion disease, marmosets neurosurgical",8-13-21-54-88-114-147-158-173-190-235-241-267-294-303-309-335-371,8-13-21-54-147-158-190-235-267-294-303-309-335-371-241,"(A4) amyloid plaques marmosets spongiform encephalopathy injected brain tissue patients atypical PRION DISEASE, marmosets neurosurgical","No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures.",235 241,303 309,235,303,247,316,1,RO-has_finding_site,905060,"No beta (A4)-amyloid plaques or CAA were found in six marmosets who were older than the injected animals, in four marmosets that had not developed spongiform encephalopathy (SE) having been injected several years previously with human brain tissue from three younger patients with suspected or atypical prion disease, or in 10 younger marmosets who had undergone various neurosurgical procedures",brain tissue,prion disease
502540509,7/12/2014 00:12:45,,1321085680,7/12/2014 00:12:27,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,6,29,,,27,33,BUTYRYLCHOLINESTERASE,BCHE,BUTYRYLCHOLINESTERASE,6,0-6-28,Human butyrylcholinesterase (BCHE),Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers.,6,,6,29,27,33,-1,RO-has_manifestation,906140,Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers,butyrylcholinesterase,BChE
502540509,7/12/2014 00:28:16,,1321094221,7/12/2014 00:27:56,instagc,1.0,13763729,USA,"","",75.182.89.225,6,29,,,27,33,BUTYRYLCHOLINESTERASE,BCHE,BUTYRYLCHOLINESTERASE,6,28,(BCHE),Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers.,6,,6,29,27,33,-1,RO-has_manifestation,906140,Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers,butyrylcholinesterase,BChE
502540509,7/12/2014 00:31:39,,1321096044,7/12/2014 00:31:12,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,6,29,,,27,33,BUTYRYLCHOLINESTERASE,BCHE,Human BUTYRYLCHOLINESTERASE (BChE),0-6-28,0-6-28,Human butyrylcholinesterase (BCHE),Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers.,6,,6,29,27,33,-1,RO-has_manifestation,906140,Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers,butyrylcholinesterase,BChE
502540509,7/12/2014 00:33:34,,1321097023,7/12/2014 00:33:09,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,6,29,,,27,33,BUTYRYLCHOLINESTERASE,BCHE,BUTYRYLCHOLINESTERASE,6,28,(BCHE),Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers.,6,,6,29,27,33,-1,RO-has_manifestation,906140,Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers,butyrylcholinesterase,BChE
502540509,7/12/2014 00:38:27,,1321099365,7/12/2014 00:38:04,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,6,29,,,27,33,BUTYRYLCHOLINESTERASE,BCHE,Human BUTYRYLCHOLINESTERASE,0-6,0-6-28,Human butyrylcholinesterase (BCHE),Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers.,6,,6,29,27,33,-1,RO-has_manifestation,906140,Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers,butyrylcholinesterase,BChE
502540509,7/12/2014 00:45:29,,1321102403,7/12/2014 00:44:51,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,6,29,,,27,33,BUTYRYLCHOLINESTERASE,BCHE,Human BUTYRYLCHOLINESTERASE (BChE),6-28-0,6-28-0,Human butyrylcholinesterase (BCHE),Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers.,6,,6,29,27,33,-1,RO-has_manifestation,906140,Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers,butyrylcholinesterase,BChE
502540509,7/12/2014 01:01:56,,1321108807,7/12/2014 01:01:46,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,6,29,,,27,33,BUTYRYLCHOLINESTERASE,BCHE,Human BUTYRYLCHOLINESTERASE (BChE),0-6-28,0-6-28,Human butyrylcholinesterase (BCHE),Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers.,6,,6,29,27,33,-1,RO-has_manifestation,906140,Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers,butyrylcholinesterase,BChE
502540509,7/12/2014 01:13:32,,1321113669,7/12/2014 01:13:19,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,6,29,,,27,33,BUTYRYLCHOLINESTERASE,BCHE,Human BUTYRYLCHOLINESTERASE in serum,0-6-35-38,0-6-28,Human butyrylcholinesterase (BCHE),Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers.,6,,6,29,27,33,-1,RO-has_manifestation,906140,Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers,butyrylcholinesterase,BChE
502540509,7/12/2014 01:19:53,,1321116055,7/12/2014 01:19:19,prodege,1.0,21318648,GBR,G7,Kingston Upon Thames,81.157.193.175,6,29,,,27,33,BUTYRYLCHOLINESTERASE,BCHE,Human BUTYRYLCHOLINESTERASE (BChE) serum tetramers.,0-6-38-73-28,0-6-38-73-28,Human butyrylcholinesterase (BCHE) serum tetramers.,Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers.,6,,6,29,27,33,-1,RO-has_manifestation,906140,Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers,butyrylcholinesterase,BChE
502540509,7/12/2014 01:25:19,,1321118205,7/12/2014 01:24:38,prodege,1.0,2331981,USA,GA,Dallas,108.226.130.98,6,29,,,27,33,BUTYRYLCHOLINESTERASE,BCHE,BUTYRYLCHOLINESTERASE (BChE),6-28,6-28,butyrylcholinesterase (BCHE),Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers.,6,,6,29,27,33,-1,RO-has_manifestation,906140,Human butyrylcholinesterase (BChE) in serum is composed predominantly of tetramers,butyrylcholinesterase,BChE
502540510,7/11/2014 23:54:15,,1321075209,7/11/2014 23:54:00,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,50,25,,,62,34,HYPERTENSION,DOXAZOSIN,mild HYPERTENSION.,45-50,25,DOXAZOSIN,He took a 1 mg tablet of doxazosin daily for mild hypertension.,50,25,50,25,62,34,1,RO-may_treat,908046,He took a 1 mg tablet of doxazosin daily for mild hypertension,hypertension,doxazosin
502540510,7/11/2014 23:56:08,,1321076188,7/11/2014 23:55:43,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,50,25,,,62,34,HYPERTENSION,DOXAZOSIN,HYPERTENSION.,50,25,DOXAZOSIN,He took a 1 mg tablet of doxazosin daily for mild hypertension.,50,25,50,25,62,34,1,RO-may_treat,908046,He took a 1 mg tablet of doxazosin daily for mild hypertension,hypertension,doxazosin
502540510,7/11/2014 23:59:25,,1321077805,7/11/2014 23:59:02,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,50,25,,,62,34,HYPERTENSION,DOXAZOSIN,mild HYPERTENSION.,50-45,25,DOXAZOSIN,He took a 1 mg tablet of doxazosin daily for mild hypertension.,50,25,50,25,62,34,1,RO-may_treat,908046,He took a 1 mg tablet of doxazosin daily for mild hypertension,hypertension,doxazosin
502540510,7/12/2014 00:13:17,,1321085957,7/12/2014 00:12:50,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,50,25,,,62,34,HYPERTENSION,DOXAZOSIN,HYPERTENSION.,50,25,DOXAZOSIN,He took a 1 mg tablet of doxazosin daily for mild hypertension.,50,25,50,25,62,34,1,RO-may_treat,908046,He took a 1 mg tablet of doxazosin daily for mild hypertension,hypertension,doxazosin
502540510,7/12/2014 00:18:41,,1321089135,7/12/2014 00:18:15,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,50,25,,,62,34,HYPERTENSION,DOXAZOSIN,HYPERTENSION.,50,25,DOXAZOSIN,He took a 1 mg tablet of doxazosin daily for mild hypertension.,50,25,50,25,62,34,1,RO-may_treat,908046,He took a 1 mg tablet of doxazosin daily for mild hypertension,hypertension,doxazosin
502540510,7/12/2014 00:20:50,,1321090274,7/12/2014 00:20:41,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,50,25,,,62,34,HYPERTENSION,DOXAZOSIN,HYPERTENSION.,50,25,DOXAZOSIN,He took a 1 mg tablet of doxazosin daily for mild hypertension.,50,25,50,25,62,34,1,RO-may_treat,908046,He took a 1 mg tablet of doxazosin daily for mild hypertension,hypertension,doxazosin
502540510,7/12/2014 00:23:29,,1321091864,7/12/2014 00:23:16,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,50,25,,,62,34,HYPERTENSION,DOXAZOSIN,1 mg tablet of doxazosin daily for mild HYPERTENSION.,10-12-15-25-35-41-45-50-22,10-12-15-22-25-35-41-45-50,1 mg tablet of DOXAZOSIN daily for mild hypertension.,He took a 1 mg tablet of doxazosin daily for mild hypertension.,50,25,50,25,62,34,1,RO-may_treat,908046,He took a 1 mg tablet of doxazosin daily for mild hypertension,hypertension,doxazosin
502540510,7/12/2014 00:40:11,,1321100127,7/12/2014 00:39:41,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,50,25,,,62,34,HYPERTENSION,DOXAZOSIN,HYPERTENSION.,50,25,DOXAZOSIN,He took a 1 mg tablet of doxazosin daily for mild hypertension.,50,25,50,25,62,34,1,RO-may_treat,908046,He took a 1 mg tablet of doxazosin daily for mild hypertension,hypertension,doxazosin
502540510,7/12/2014 00:42:49,,1321101367,7/12/2014 00:42:22,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,50,25,,,62,34,HYPERTENSION,DOXAZOSIN,HYPERTENSION.,50,25,DOXAZOSIN,He took a 1 mg tablet of doxazosin daily for mild hypertension.,50,25,50,25,62,34,1,RO-may_treat,908046,He took a 1 mg tablet of doxazosin daily for mild hypertension,hypertension,doxazosin
502540510,7/12/2014 01:04:03,,1321109628,7/12/2014 01:03:48,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,50,25,,,62,34,HYPERTENSION,DOXAZOSIN,mild HYPERTENSION.,45-50,12-15-22-25-10,1 mg tablet of DOXAZOSIN,He took a 1 mg tablet of doxazosin daily for mild hypertension.,50,25,50,25,62,34,1,RO-may_treat,908046,He took a 1 mg tablet of doxazosin daily for mild hypertension,hypertension,doxazosin
502540511,7/12/2014 00:13:57,,1321086398,7/12/2014 00:13:44,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,71,66,,,84,67,BREAST CANCER,2,"BREAST CANCER,",71-78,66,2,"Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest.",71 78,66,71,66,84,67,-1,RO-has_manifestation,906299,"Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest",breast cancer,2
502540511,7/12/2014 00:24:48,,1321092589,7/12/2014 00:24:33,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,71,66,,,84,67,BREAST CANCER,2,"BREAST CANCER,",71-78,66-68-71-78,"2 of breast cancer,","Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest.",71 78,66,71,66,84,67,-1,RO-has_manifestation,906299,"Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest",breast cancer,2
502540511,7/12/2014 00:28:45,,1321094499,7/12/2014 00:28:30,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,71,66,,,84,67,BREAST CANCER,2,"BREAST CANCER,",71-78,66,2,"Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest.",71 78,66,71,66,84,67,-1,RO-has_manifestation,906299,"Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest",breast cancer,2
502540511,7/12/2014 00:43:47,,1321101758,7/12/2014 00:43:08,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,71,66,,,84,67,BREAST CANCER,2,"BREAST CANCER,",71-78,66,2,"Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest.",71 78,66,71,66,84,67,-1,RO-has_manifestation,906299,"Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest",breast cancer,2
502540511,7/12/2014 01:03:33,,1321109407,7/12/2014 01:03:04,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,71,66,,,84,67,BREAST CANCER,2,"7 have died: 2 of BREAST CANCER, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest.",53-55-60-66-68-71-78-86-88-91-100-117-127-131-133-136-144,53-55-60-66-68-71-78-86-88-91-100-117-127-131-133-136-144,"7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest.","Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest.",71 78,66,71,66,84,67,-1,RO-has_manifestation,906299,"Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest",breast cancer,2
502540511,7/12/2014 01:18:24,,1321115519,7/12/2014 01:18:00,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,71,66,,,84,67,BREAST CANCER,2,"died: 2 of BREAST CANCER,",60-66-68-71-78,53-55-60-66-68-71-78,"7 have died: 2 of breast cancer,","Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest.",71 78,66,71,66,84,67,-1,RO-has_manifestation,906299,"Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest",breast cancer,2
502540511,7/12/2014 01:18:39,,1321115595,7/12/2014 01:17:10,prodege,1.0,21318648,GBR,G7,Kingston Upon Thames,81.157.193.175,71,66,,,84,67,BREAST CANCER,2,"patients disease, 2 BREAST CANCER, immunodeficiency syndrome, cardiac",10-44-66-71-78-100-117-136,10-44-66-71-78-100-117-136,"patients disease, 2 breast cancer, immunodeficiency syndrome, cardiac","Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest.",71 78,66,71,66,84,67,-1,RO-has_manifestation,906299,"Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest",breast cancer,2
502540511,7/12/2014 01:26:05,,1321118565,7/12/2014 01:25:43,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,71,66,,,84,67,BREAST CANCER,2,"BREAST CANCER,",71-78,66-71-78,"2 breast cancer,","Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest.",71 78,66,71,66,84,67,-1,RO-has_manifestation,906299,"Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest",breast cancer,2
502540511,7/12/2014 01:37:15,,1321123491,7/12/2014 01:36:32,instagc,1.0,25387994,CAN,BC,Cache Creek,208.114.155.4,71,66,,,84,67,BREAST CANCER,2,"BREAST CANCER,",71-78,66,2,"Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest.",71 78,66,71,66,84,67,-1,RO-has_manifestation,906299,"Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest",breast cancer,2
502540511,7/12/2014 01:38:03,,1321123778,7/12/2014 01:36:40,rewardsspot,1,24482174,GBR,H9,London,46.23.68.180,71,66,,,84,67,BREAST CANCER,2,"died: 2 of BREAST CANCER, 4 of acquired immunodeficiency syndrome,",60-66-68-71-78-86-88-91-100-117,53-55-60-66-68-71-78-91-100-117,"7 have died: 2 of breast cancer, acquired immunodeficiency syndrome,","Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest.",71 78,66,71,66,84,67,-1,RO-has_manifestation,906299,"Of the 18 patients who presented with local disease, 7 have died: 2 of breast cancer, 4 of acquired immunodeficiency syndrome, and 1 of cardiac arrest",breast cancer,2
502540512,7/11/2014 23:53:25,,1321074842,7/11/2014 23:53:14,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,110,179,,,130,188,VITAMIN A DEFICIENCY,VITAMIN A,VITAMIN A DEFICIENCY,110-118-120,179-187,VITAMIN A,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver.,110 118 120,179 187,110,179,130,188,1,RO-may_prevent,907453,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver,vitamin A deficiency,vitamin A
502540512,7/11/2014 23:59:35,,1321077872,7/11/2014 23:59:22,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,110,179,,,130,188,VITAMIN A DEFICIENCY,VITAMIN A,VITAMIN A DEFICIENCY,110-118-120,179-187,VITAMIN A,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver.,110 118 120,179 187,110,179,130,188,1,RO-may_prevent,907453,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver,vitamin A deficiency,vitamin A
502540512,7/12/2014 00:21:44,,1321090771,7/12/2014 00:21:18,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,110,179,,,130,188,VITAMIN A DEFICIENCY,VITAMIN A,VITAMIN A DEFICIENCY,110-118-120,179-187,VITAMIN A,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver.,110 118 120,179 187,110,179,130,188,1,RO-may_prevent,907453,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver,vitamin A deficiency,vitamin A
502540512,7/12/2014 00:23:59,,1321092158,7/12/2014 00:23:47,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,110,179,,,130,188,VITAMIN A DEFICIENCY,VITAMIN A,VITAMIN A DEFICIENCY,110-118-120,153-163-176-179-187-189-194-198,defective mobilization of VITAMIN A from the liver.,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver.,110 118 120,179 187,110,179,130,188,1,RO-may_prevent,907453,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver,vitamin A deficiency,vitamin A
502540512,7/12/2014 00:32:40,,1321096538,7/12/2014 00:32:26,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,110,179,,,130,188,VITAMIN A DEFICIENCY,VITAMIN A,VITAMIN A DEFICIENCY,110-118-120,179-187,VITAMIN A,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver.,110 118 120,179 187,110,179,130,188,1,RO-may_prevent,907453,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver,vitamin A deficiency,vitamin A
502540512,7/12/2014 00:35:24,,1321097935,7/12/2014 00:34:52,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,110,179,,,130,188,VITAMIN A DEFICIENCY,VITAMIN A,VITAMIN A DEFICIENCY,110-118-120,179-187,VITAMIN A,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver.,110 118 120,179 187,110,179,130,188,1,RO-may_prevent,907453,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver,vitamin A deficiency,vitamin A
502540512,7/12/2014 00:36:12,,1321098371,7/12/2014 00:35:49,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,110,179,,,130,188,VITAMIN A DEFICIENCY,VITAMIN A,VITAMIN A DEFICIENCY,110-118-120,153-163-176-179-187-189-194-198,defective mobilization of VITAMIN A from the liver.,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver.,110 118 120,179 187,110,179,130,188,1,RO-may_prevent,907453,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver,vitamin A deficiency,vitamin A
502540512,7/12/2014 01:01:32,,1321108699,7/12/2014 01:01:19,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,110,179,,,130,188,VITAMIN A DEFICIENCY,VITAMIN A,VITAMIN A DEFICIENCY,110-118-120,153-163-176-179-187-189-194-198,defective mobilization of VITAMIN A from the liver.,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver.,110 118 120,179 187,110,179,130,188,1,RO-may_prevent,907453,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver,vitamin A deficiency,vitamin A
502540512,7/12/2014 01:12:11,,1321113015,7/12/2014 01:11:46,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,110,179,,,130,188,VITAMIN A DEFICIENCY,VITAMIN A,primary biliary cirrhosis a consequence of VITAMIN A DEFICIENCY,59-67-75-93-95-107-110-118-120,29-33-39-49-153-163-176-179-187-189-194-198-47,low serum vitamin A levels defective mobilization of VITAMIN A from the liver.,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver.,110 118 120,179 187,110,179,130,188,1,RO-may_prevent,907453,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver,vitamin A deficiency,vitamin A
502540512,7/12/2014 01:26:58,,1321119020,7/12/2014 01:26:41,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,110,179,,,130,188,VITAMIN A DEFICIENCY,VITAMIN A,VITAMIN A DEFICIENCY,110-118-120,153-163-176-179-187,defective mobilization of VITAMIN A,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver.,110 118 120,179 187,110,179,130,188,1,RO-may_prevent,907453,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of vitamin A deficiency but instead reflect a defective mobilization of vitamin A from the liver,vitamin A deficiency,vitamin A
502540513,7/11/2014 23:54:37,,1321075349,7/11/2014 23:54:20,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,113,17,,,127,29,ABDOMINAL MASS,WILMS' TUMOR,ABDOMINAL MASS,113-123,17-24,"WILMS' TUMOR,","In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs.",113 123,17 24,113,17,127,29,1,RO-disease_may_have_finding,902763,"In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs",abdominal mass,Wilms' tumor
502540513,7/11/2014 23:55:47,,1321075976,7/11/2014 23:55:24,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,113,17,,,127,29,ABDOMINAL MASS,WILMS' TUMOR,ABDOMINAL MASS,113-123,17-24,"WILMS' TUMOR,","In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs.",113 123,17 24,113,17,127,29,1,RO-disease_may_have_finding,902763,"In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs",abdominal mass,Wilms' tumor
502540513,7/11/2014 23:57:36,,1321076867,7/11/2014 23:56:55,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,113,17,,,127,29,ABDOMINAL MASS,WILMS' TUMOR,ABDOMINAL MASS,113-123,17-24,"WILMS' TUMOR,","In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs.",113 123,17 24,113,17,127,29,1,RO-disease_may_have_finding,902763,"In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs",abdominal mass,Wilms' tumor
502540513,7/12/2014 00:00:07,,1321078148,7/11/2014 23:59:12,prodege,1.0,23541832,USA,AZ,Tempe,149.169.133.153,113,17,,,127,29,ABDOMINAL MASS,WILMS' TUMOR,smaller ABDOMINAL MASS,105-113-123,17-24,"WILMS' TUMOR,","In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs.",113 123,17 24,113,17,127,29,1,RO-disease_may_have_finding,902763,"In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs",abdominal mass,Wilms' tumor
502540513,7/12/2014 00:12:15,,1321085340,7/12/2014 00:11:57,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,113,17,,,127,29,ABDOMINAL MASS,WILMS' TUMOR,ABDOMINAL MASS,113-123,17-24,"WILMS' TUMOR,","In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs.",113 123,17 24,113,17,127,29,1,RO-disease_may_have_finding,902763,"In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs",abdominal mass,Wilms' tumor
502540513,7/12/2014 00:15:35,,1321087364,7/12/2014 00:15:22,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,113,17,,,127,29,ABDOMINAL MASS,WILMS' TUMOR,ABDOMINAL MASS,113-123,17-24,"WILMS' TUMOR,","In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs.",113 123,17 24,113,17,127,29,1,RO-disease_may_have_finding,902763,"In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs",abdominal mass,Wilms' tumor
502540513,7/12/2014 00:19:15,,1321089432,7/12/2014 00:18:42,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,113,17,,,127,29,ABDOMINAL MASS,WILMS' TUMOR,ABDOMINAL MASS,113-123,17-24,"WILMS' TUMOR,","In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs.",113 123,17 24,113,17,127,29,1,RO-disease_may_have_finding,902763,"In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs",abdominal mass,Wilms' tumor
502540513,7/12/2014 00:32:54,,1321096708,7/12/2014 00:32:40,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,113,17,,,127,29,ABDOMINAL MASS,WILMS' TUMOR,ABDOMINAL MASS,113-123,17-24,"WILMS' TUMOR,","In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs.",113 123,17 24,113,17,127,29,1,RO-disease_may_have_finding,902763,"In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs",abdominal mass,Wilms' tumor
502540513,7/12/2014 01:15:22,,1321114451,7/12/2014 01:15:10,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,113,17,,,127,29,ABDOMINAL MASS,WILMS' TUMOR,with a smaller ABDOMINAL MASS which is frequently,98-103-105-113-123-128-134-137,17-24-31-37-42,"WILMS' TUMOR, renal cell carcinoma","In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs.",113 123,17 24,113,17,127,29,1,RO-disease_may_have_finding,902763,"In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs",abdominal mass,Wilms' tumor
502540513,7/12/2014 01:28:36,,1321119831,7/12/2014 01:28:19,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,113,17,,,127,29,ABDOMINAL MASS,WILMS' TUMOR,ABDOMINAL MASS,113-123,17-24-31-37-42,"WILMS' TUMOR, renal cell carcinoma","In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs.",113 123,17 24,113,17,127,29,1,RO-disease_may_have_finding,902763,"In comparison to Wilms' tumor, renal cell carcinoma in childhood and adolescence usually presents with a smaller abdominal mass which is frequently not palpable or visible on plain abdominal radiographs",abdominal mass,Wilms' tumor
502540514,7/11/2014 23:56:54,,1321076625,7/11/2014 23:56:31,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,83,166,,,100,179,VASOVAGAL SYNCOPE,ISOPROTERENOL,VASOVAGAL SYNCOPE;,83-93,166-180,ISOPROTERENOL test.,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test.,83 93,166,83,166,100,179,1,RO-may_diagnose,906826,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test,vasovagal syncope,isoproterenol
502540514,7/11/2014 23:58:21,,1321077252,7/11/2014 23:58:06,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,83,166,,,100,179,VASOVAGAL SYNCOPE,ISOPROTERENOL,VASOVAGAL SYNCOPE;,83-93,166-180,ISOPROTERENOL test.,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test.,83 93,166,83,166,100,179,1,RO-may_diagnose,906826,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test,vasovagal syncope,isoproterenol
502540514,7/12/2014 00:11:26,,1321084837,7/12/2014 00:10:53,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,83,166,,,100,179,VASOVAGAL SYNCOPE,ISOPROTERENOL,VASOVAGAL SYNCOPE;,83-93,166-180,ISOPROTERENOL test.,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test.,83 93,166,83,166,100,179,1,RO-may_diagnose,906826,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test,vasovagal syncope,isoproterenol
502540514,7/12/2014 00:13:50,,1321086332,7/12/2014 00:13:35,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,83,166,,,100,179,VASOVAGAL SYNCOPE,ISOPROTERENOL,VASOVAGAL SYNCOPE;,83-93,166,ISOPROTERENOL,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test.,83 93,166,83,166,100,179,1,RO-may_diagnose,906826,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test,vasovagal syncope,isoproterenol
502540514,7/12/2014 00:17:51,,1321088724,7/12/2014 00:17:36,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,83,166,,,100,179,VASOVAGAL SYNCOPE,ISOPROTERENOL,VASOVAGAL SYNCOPE;,83-93,166-180,ISOPROTERENOL test.,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test.,83 93,166,83,166,100,179,1,RO-may_diagnose,906826,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test,vasovagal syncope,isoproterenol
502540514,7/12/2014 00:19:39,,1321089621,7/12/2014 00:19:16,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,83,166,,,100,179,VASOVAGAL SYNCOPE,ISOPROTERENOL,VASOVAGAL SYNCOPE;,83-93,166,ISOPROTERENOL,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test.,83 93,166,83,166,100,179,1,RO-may_diagnose,906826,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test,vasovagal syncope,isoproterenol
502540514,7/12/2014 00:25:35,,1321092937,7/12/2014 00:25:21,instagc,1.0,13763729,USA,"","",75.182.89.225,83,166,,,100,179,VASOVAGAL SYNCOPE,ISOPROTERENOL,VASOVAGAL SYNCOPE;,83-93,166,ISOPROTERENOL,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test.,83 93,166,83,166,100,179,1,RO-may_diagnose,906826,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test,vasovagal syncope,isoproterenol
502540514,7/12/2014 00:26:04,,1321093192,7/12/2014 00:24:03,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,83,166,,,100,179,VASOVAGAL SYNCOPE,ISOPROTERENOL,nitroglycerin test for diagnosis of VASOVAGAL SYNCOPE; it is equally isoproterenol test.,9-66-70-80-83-93-102-105-108-166-180-23,9-23-83-148-157-162-166-180-93,nitroglycerin test vasovagal syncope; feasible than the ISOPROTERENOL test.,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test.,83 93,166,83,166,100,179,1,RO-may_diagnose,906826,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test,vasovagal syncope,isoproterenol
502540514,7/12/2014 00:41:47,,1321100901,7/12/2014 00:41:26,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,83,166,,,100,179,VASOVAGAL SYNCOPE,ISOPROTERENOL,VASOVAGAL SYNCOPE;,83-93,166-180,ISOPROTERENOL test.,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test.,83 93,166,83,166,100,179,1,RO-may_diagnose,906826,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test,vasovagal syncope,isoproterenol
502540514,7/12/2014 00:44:30,,1321102028,7/12/2014 00:44:03,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,83,166,,,100,179,VASOVAGAL SYNCOPE,ISOPROTERENOL,VASOVAGAL SYNCOPE;,83-93,166-180,ISOPROTERENOL test.,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test.,83 93,166,83,166,100,179,1,RO-may_diagnose,906826,Thus the nitroglycerin test seems to be a useful alternative tool for diagnosis of vasovagal syncope; it is equally specific but more sensitive and feasible than the isoproterenol test,vasovagal syncope,isoproterenol
502540515,7/11/2014 23:53:36,,1321074955,7/11/2014 23:53:26,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,18,51,,,40,58,SICK BUILDING SYNDROME,ALLERGY,SICK BUILDING SYNDROME,18-23-32,51,ALLERGY.,Bioaerosols cause sick building syndrome (SBS) and allergy.,18 23 32,51,18,51,40,58,-1,RO-cause_of,900356,Bioaerosols cause sick building syndrome (SBS) and allergy,sick building syndrome,allergy
502540515,7/11/2014 23:54:44,,1321075427,7/11/2014 23:54:32,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,18,51,,,40,58,SICK BUILDING SYNDROME,ALLERGY,SICK BUILDING SYNDROME (SBS),18-23-32-41,51,ALLERGY.,Bioaerosols cause sick building syndrome (SBS) and allergy.,18 23 32,51,18,51,40,58,-1,RO-cause_of,900356,Bioaerosols cause sick building syndrome (SBS) and allergy,sick building syndrome,allergy
502540515,7/11/2014 23:55:42,,1321075902,7/11/2014 23:55:23,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,18,51,,,40,58,SICK BUILDING SYNDROME,ALLERGY,SICK BUILDING SYNDROME,18-23-32,51,ALLERGY.,Bioaerosols cause sick building syndrome (SBS) and allergy.,18 23 32,51,18,51,40,58,-1,RO-cause_of,900356,Bioaerosols cause sick building syndrome (SBS) and allergy,sick building syndrome,allergy
502540515,7/12/2014 00:14:36,,1321086822,7/12/2014 00:14:26,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,18,51,,,40,58,SICK BUILDING SYNDROME,ALLERGY,SICK BUILDING SYNDROME (SBS),18-23-32-41,51,ALLERGY.,Bioaerosols cause sick building syndrome (SBS) and allergy.,18 23 32,51,18,51,40,58,-1,RO-cause_of,900356,Bioaerosols cause sick building syndrome (SBS) and allergy,sick building syndrome,allergy
502540515,7/12/2014 00:25:39,,1321092966,7/12/2014 00:25:20,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,18,51,,,40,58,SICK BUILDING SYNDROME,ALLERGY,Bioaerosols cause SICK BUILDING SYNDROME (SBS) and allergy.,0-12-18-23-32-47-51-41,0-12-18-32-41-47-51-23,Bioaerosols cause sick building syndrome (SBS) and ALLERGY.,Bioaerosols cause sick building syndrome (SBS) and allergy.,18 23 32,51,18,51,40,58,-1,RO-cause_of,900356,Bioaerosols cause sick building syndrome (SBS) and allergy,sick building syndrome,allergy
502540515,7/12/2014 00:26:03,,1321093162,7/12/2014 00:25:52,instagc,1.0,13763729,USA,"","",75.182.89.225,18,51,,,40,58,SICK BUILDING SYNDROME,ALLERGY,SICK BUILDING SYNDROME,18-23-32,51,ALLERGY.,Bioaerosols cause sick building syndrome (SBS) and allergy.,18 23 32,51,18,51,40,58,-1,RO-cause_of,900356,Bioaerosols cause sick building syndrome (SBS) and allergy,sick building syndrome,allergy
502540515,7/12/2014 01:03:47,,1321109446,7/12/2014 01:03:34,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,18,51,,,40,58,SICK BUILDING SYNDROME,ALLERGY,SICK BUILDING SYNDROME (SBS) and allergy.,18-23-32-41-47-51,23-32-41-47-51-18,sick building syndrome (SBS) and ALLERGY.,Bioaerosols cause sick building syndrome (SBS) and allergy.,18 23 32,51,18,51,40,58,-1,RO-cause_of,900356,Bioaerosols cause sick building syndrome (SBS) and allergy,sick building syndrome,allergy
502540515,7/12/2014 01:13:44,,1321113728,7/12/2014 01:13:32,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,18,51,,,40,58,SICK BUILDING SYNDROME,ALLERGY,Bioaerosols cause SICK BUILDING SYNDROME,0-12-18-23-32,0-12-18-32-41-47-51-23,Bioaerosols cause sick building syndrome (SBS) and ALLERGY.,Bioaerosols cause sick building syndrome (SBS) and allergy.,18 23 32,51,18,51,40,58,-1,RO-cause_of,900356,Bioaerosols cause sick building syndrome (SBS) and allergy,sick building syndrome,allergy
502540515,7/12/2014 01:26:40,,1321118846,7/12/2014 01:26:23,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,18,51,,,40,58,SICK BUILDING SYNDROME,ALLERGY,Bioaerosols cause SICK BUILDING SYNDROME (SBS) and allergy.,0-12-18-23-32-41-51-47,32-41-47-51-0,Bioaerosols syndrome (SBS) and ALLERGY.,Bioaerosols cause sick building syndrome (SBS) and allergy.,18 23 32,51,18,51,40,58,-1,RO-cause_of,900356,Bioaerosols cause sick building syndrome (SBS) and allergy,sick building syndrome,allergy
502540515,7/12/2014 01:28:04,,1321119579,7/12/2014 01:27:18,prodege,1.0,21318648,GBR,G7,Kingston Upon Thames,81.157.193.175,18,51,,,40,58,SICK BUILDING SYNDROME,ALLERGY,Bioaerosols SICK BUILDING SYNDROME (SBS) allergy.,0-18-23-32-41-51,18-23-32-41-51-0,Bioaerosols sick building syndrome (SBS) ALLERGY.,Bioaerosols cause sick building syndrome (SBS) and allergy.,18 23 32,51,18,51,40,58,-1,RO-cause_of,900356,Bioaerosols cause sick building syndrome (SBS) and allergy,sick building syndrome,allergy
502540516,7/12/2014 00:02:54,,1321079781,7/12/2014 00:02:18,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,159,214,,,171,225,INFLAMMATION,LOTEPREDNOL,total ocular INFLAMMATION,146-152-159,198-209-214,tobramycin 0.3% LOTEPREDNOL,"Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis.",159,214,159,214,171,225,1,RO-may_treat,908259,"Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis",inflammation,loteprednol
502540516,7/12/2014 00:26:12,,1321093261,7/12/2014 00:26:03,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,159,214,,,171,225,INFLAMMATION,LOTEPREDNOL,and total ocular INFLAMMATION scores when compared,142-146-152-159-172-179-184,193-198-209-214-226-231-234,with tobramycin 0.3% LOTEPREDNOL 0.5% in patients,"Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis.",159,214,159,214,171,225,1,RO-may_treat,908259,"Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis",inflammation,loteprednol
502540516,7/12/2014 00:34:55,,1321097657,7/12/2014 00:34:44,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,159,214,,,171,225,INFLAMMATION,LOTEPREDNOL,ocular INFLAMMATION,152-159,198-209-214-226,tobramycin 0.3% LOTEPREDNOL 0.5%,"Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis.",159,214,159,214,171,225,1,RO-may_treat,908259,"Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis",inflammation,loteprednol
502540516,7/12/2014 00:38:59,,1321099620,7/12/2014 00:38:28,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,159,214,,,171,225,INFLAMMATION,LOTEPREDNOL,ocular INFLAMMATION scores,152-159-172,198-209-214-226,tobramycin 0.3% LOTEPREDNOL 0.5%,"Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis.",159,214,159,214,171,225,1,RO-may_treat,908259,"Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis",inflammation,loteprednol
502540516,7/12/2014 01:19:12,,1321115772,7/12/2014 01:18:49,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,159,214,,,171,225,INFLAMMATION,LOTEPREDNOL,significantly decreased clinical signs and total ocular INFLAMMATION,35-49-59-142-146-152-159-68,214-226-231-234-243-248-257-260-267-276,LOTEPREDNOL 0.5% in patients with moderate to severe blepharo keratoconjunctivitis.,"Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis.",159,214,159,214,171,225,1,RO-may_treat,908259,"Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis",inflammation,loteprednol
502540516,7/12/2014 01:24:20,,1321117831,7/12/2014 01:23:45,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,159,214,,,171,225,INFLAMMATION,LOTEPREDNOL,total ocular INFLAMMATION,146-152-159,198-214,tobramycin LOTEPREDNOL,"Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis.",159,214,159,214,171,225,1,RO-may_treat,908259,"Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis",inflammation,loteprednol
502540516,7/12/2014 01:24:37,,1321117946,7/12/2014 01:23:26,prodege,1.0,2331981,USA,GA,Dallas,108.226.130.98,159,214,,,171,225,INFLAMMATION,LOTEPREDNOL,"ocular inflammation blepharitis, discharge, conjunctivitis) and total ocular INFLAMMATION moderate to severe blepharo keratoconjunctivitis.",77-84-102-126-142-146-152-159-248-257-260-267-276-115,77-84-102-115-126-152-159-214,"ocular inflammation blepharitis, discharge, conjunctivitis) ocular inflammation LOTEPREDNOL","Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis.",159,214,159,214,171,225,1,RO-may_treat,908259,"Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis",inflammation,loteprednol
502540516,7/12/2014 01:26:17,,1321118682,7/12/2014 01:25:04,prodege,1.0,21318648,GBR,G7,Kingston Upon Thames,81.157.193.175,159,214,,,171,225,INFLAMMATION,LOTEPREDNOL,"Tobramycin clinical ocular inflammation blepharitis, discharge, conjunctivitis) and total ocular INFLAMMATION compared tobramycin loteprednol patients blepharo keratoconjunctivitis.",0-77-84-102-115-126-142-146-152-159-184-198-214-234-267-276-59,0-16-59-77-84-102-115-126-152-159-198-214-234-267-276,"Tobramycin dexamethasone clinical ocular inflammation blepharitis, discharge, conjunctivitis) ocular inflammation tobramycin LOTEPREDNOL patients blepharo keratoconjunctivitis.","Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis.",159,214,159,214,171,225,1,RO-may_treat,908259,"Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis",inflammation,loteprednol
502540516,7/12/2014 01:35:47,,1321122946,7/12/2014 01:34:59,instagc,1.0,25387994,CAN,BC,Cache Creek,208.114.155.4,159,214,,,171,225,INFLAMMATION,LOTEPREDNOL,total ocular INFLAMMATION,146-152-159,198-209-214-226,tobramycin 0.3% LOTEPREDNOL 0.5%,"Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis.",159,214,159,214,171,225,1,RO-may_treat,908259,"Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis",inflammation,loteprednol
502540516,7/12/2014 01:37:34,,1321123596,7/12/2014 01:37:01,elite,1,28276268,USA,CA,San Diego,76.88.95.100,159,214,,,171,225,INFLAMMATION,LOTEPREDNOL,INFLAMMATION,159,214,LOTEPREDNOL,"Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis.",159,214,159,214,171,225,1,RO-may_treat,908259,"Tobramycin 0.3%/dexamethasone 0.1% significantly decreased clinical signs of ocular inflammation (ie, blepharitis, discharge, conjunctivitis) and total ocular inflammation scores when compared with tobramycin 0.3%/loteprednol 0.5% in patients with moderate to severe blepharo-keratoconjunctivitis",inflammation,loteprednol
502540517,7/12/2014 00:01:06,,1321078698,7/12/2014 00:00:37,prodege,1.0,23541832,USA,AZ,Tempe,149.169.133.153,72,25,,,80,58,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,severe acute respiratory syndrome coronavirus (SARS COV),25-32-38-59-71-77-50,25-32-38-50-59,SEVERE ACUTE RESPIRATORY SYNDROME coronavirus,The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein.,77,25 32 38 50,72,25,80,58,-1,RO-has_causative_agent,903631,The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein,SARS-CoV,severe acute respiratory syndrome
502540517,7/12/2014 00:18:45,,1321089177,7/12/2014 00:18:33,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,72,25,,,80,58,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,(SARS COV),71-77,25-32-38-50,SEVERE ACUTE RESPIRATORY SYNDROME,The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein.,77,25 32 38 50,72,25,80,58,-1,RO-has_causative_agent,903631,The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein,SARS-CoV,severe acute respiratory syndrome
502540517,7/12/2014 00:18:50,,1321089190,7/12/2014 00:17:49,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,72,25,,,80,58,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,severe acute respiratory syndrome coronavirus (SARS COV),25-32-50-59-71-77-38,25-32-38-50-59-77-71,SEVERE ACUTE RESPIRATORY SYNDROME coronavirus (SARS CoV),The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein.,77,25 32 38 50,72,25,80,58,-1,RO-has_causative_agent,903631,The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein,SARS-CoV,severe acute respiratory syndrome
502540517,7/12/2014 00:24:48,,1321092588,7/12/2014 00:24:43,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,72,25,,,80,58,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,syndrome coronavirus (SARS COV) is an important,50-59-71-77-82-85-88,10-14-22-25-32-38-50-59-77,(S) protein of SEVERE ACUTE RESPIRATORY SYNDROME coronavirus CoV),The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein.,77,25 32 38 50,72,25,80,58,-1,RO-has_causative_agent,903631,The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein,SARS-CoV,severe acute respiratory syndrome
502540517,7/12/2014 00:29:04,,1321094597,7/12/2014 00:28:20,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,72,25,,,80,58,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,(SARS COV),71-77,25-32-38-50-59-71-77,SEVERE ACUTE RESPIRATORY SYNDROME coronavirus (SARS CoV),The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein.,77,25 32 38 50,72,25,80,58,-1,RO-has_causative_agent,903631,The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein,SARS-CoV,severe acute respiratory syndrome
502540517,7/12/2014 00:33:18,,1321096905,7/12/2014 00:33:07,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,72,25,,,80,58,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,syndrome coronavirus (SARS COV),50-59-71-77,25-32-38-50-59-77-71,SEVERE ACUTE RESPIRATORY SYNDROME coronavirus (SARS CoV),The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein.,77,25 32 38 50,72,25,80,58,-1,RO-has_causative_agent,903631,The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein,SARS-CoV,severe acute respiratory syndrome
502540517,7/12/2014 00:36:56,,1321098705,7/12/2014 00:34:05,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,72,25,,,80,58,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,severe acute respiratory syndrome coronavirus (SARS COV),25-32-38-50-59-71-77,25-32-38-50-71,SEVERE ACUTE RESPIRATORY SYNDROME (SARS,The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein.,77,25 32 38 50,72,25,80,58,-1,RO-has_causative_agent,903631,The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein,SARS-CoV,severe acute respiratory syndrome
502540517,7/12/2014 00:39:06,,1321099660,7/12/2014 00:38:39,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,72,25,,,80,58,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,(SARS COV),71-77,25-32-38-50-59,SEVERE ACUTE RESPIRATORY SYNDROME coronavirus,The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein.,77,25 32 38 50,72,25,80,58,-1,RO-has_causative_agent,903631,The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein,SARS-CoV,severe acute respiratory syndrome
502540517,7/12/2014 01:00:28,,1321108208,7/12/2014 01:00:06,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,72,25,,,80,58,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,syndrome coronavirus (SARS COV),50-59-71-77,10-14-22-25-32-38-50-59-71-77-76,(S) protein of SEVERE ACUTE RESPIRATORY SYNDROME coronavirus (SARS - CoV),The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein.,77,25 32 38 50,72,25,80,58,-1,RO-has_causative_agent,903631,The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein,SARS-CoV,severe acute respiratory syndrome
502540517,7/12/2014 01:21:39,,1321116707,7/12/2014 01:21:17,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,72,25,,,80,58,SARS-COV,SEVERE ACUTE RESPIRATORY SYNDROME,severe acute respiratory syndrome coronavirus (SARS COV),25-32-38-50-59-71-77,25-32-38-50-59-71-77,SEVERE ACUTE RESPIRATORY SYNDROME coronavirus (SARS CoV),The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein.,77,25 32 38 50,72,25,80,58,-1,RO-has_causative_agent,903631,The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is an important viral structural protein,SARS-CoV,severe acute respiratory syndrome
502540518,7/11/2014 23:52:25,,1321074257,7/11/2014 23:52:03,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,293,323,,,299,338,ATAXIA,ALPERS SYNDROME,spino cerebellar ATAXIA,276-282-293,323-330,ALPERS SYNDROME.,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome.",293,323 330,293,323,299,338,1,RO-has_manifestation,906151,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome",ataxia,Alpers syndrome
502540518,7/12/2014 00:08:15,,1321082954,7/12/2014 00:07:56,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,293,323,,,299,338,ATAXIA,ALPERS SYNDROME,spino cerebellar ATAXIA,276-282-293,323-330,ALPERS SYNDROME.,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome.",293,323 330,293,323,299,338,1,RO-has_manifestation,906151,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome",ataxia,Alpers syndrome
502540518,7/12/2014 00:14:05,,1321086484,7/12/2014 00:13:52,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,293,323,,,299,338,ATAXIA,ALPERS SYNDROME,spino cerebellar ATAXIA,276-282-293,323-330,ALPERS SYNDROME.,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome.",293,323 330,293,323,299,338,1,RO-has_manifestation,906151,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome",ataxia,Alpers syndrome
502540518,7/12/2014 00:16:21,,1321087778,7/12/2014 00:13:54,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,293,323,,,299,338,ATAXIA,ALPERS SYNDROME,"ANT1, TWINKLE and POLG genes affect mtDNA stability involved in autosomal dominant PEO, POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino cerebellar ATAXIA and epilepsy (SCAE) or Alpers syndrome.",0-6-14-18-23-29-36-42-60-69-72-82-91-115-120-124-136-140-149-158-173-183-193-203-208-216-223-235-246-250-267-276-282-293-300-304-313-320-323-330,0-6-14-18-23-29-36-42-72-82-91-115-203-208-216-223-235-250-276-282-304-313-320-323-330-293,"ANT1, TWINKLE and POLG genes affect mtDNA stability autosomal dominant PEO, POLG PEO, sensory ataxic neuropathy, dysarthria ophthalmoparesis spino cerebellar ataxia epilepsy (SCAE) or ALPERS SYNDROME.","ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome.",293,323 330,293,323,299,338,1,RO-has_manifestation,906151,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome",ataxia,Alpers syndrome
502540518,7/12/2014 00:18:14,,1321088953,7/12/2014 00:17:10,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,293,323,,,299,338,ATAXIA,ALPERS SYNDROME,spino cerebellar ATAXIA,276-282-293,323-330,ALPERS SYNDROME.,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome.",293,323 330,293,323,299,338,1,RO-has_manifestation,906151,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome",ataxia,Alpers syndrome
502540518,7/12/2014 00:21:55,,1321090918,7/12/2014 00:21:51,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,293,323,,,299,338,ATAXIA,ALPERS SYNDROME,"(SANDO), spino cerebellar ATAXIA and epilepsy",267-276-282-293-300-304,304-313-320-323-330,epilepsy (SCAE) or ALPERS SYNDROME.,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome.",293,323 330,293,323,299,338,1,RO-has_manifestation,906151,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome",ataxia,Alpers syndrome
502540518,7/12/2014 00:23:17,,1321091759,7/12/2014 00:22:49,instagc,1.0,13763729,USA,"","",75.182.89.225,293,323,,,299,338,ATAXIA,ALPERS SYNDROME,ATAXIA,293,323-330,ALPERS SYNDROME.,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome.",293,323 330,293,323,299,338,1,RO-has_manifestation,906151,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome",ataxia,Alpers syndrome
502540518,7/12/2014 00:44:03,,1321101877,7/12/2014 00:43:48,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,293,323,,,299,338,ATAXIA,ALPERS SYNDROME,spino cerebellar ATAXIA,276-282-293,323-330,ALPERS SYNDROME.,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome.",293,323 330,293,323,299,338,1,RO-has_manifestation,906151,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome",ataxia,Alpers syndrome
502540518,7/12/2014 01:06:41,,1321110717,7/12/2014 01:06:09,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,293,323,,,299,338,ATAXIA,ALPERS SYNDROME,"ophthalmoparesis (SANDO), spino cerebellar ATAXIA and epilepsy (SCAE)",250-267-276-282-293-300-304-313,323-330,ALPERS SYNDROME.,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome.",293,323 330,293,323,299,338,1,RO-has_manifestation,906151,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome",ataxia,Alpers syndrome
502540518,7/12/2014 01:19:53,,1321116047,7/12/2014 01:19:35,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,293,323,,,299,338,ATAXIA,ALPERS SYNDROME,spino cerebellar ATAXIA,276-293-282,276-282-304-313-320-323-330-293,spino cerebellar ataxia epilepsy (SCAE) or ALPERS SYNDROME.,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome.",293,323 330,293,323,299,338,1,RO-has_manifestation,906151,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), spino-cerebellar ataxia and epilepsy (SCAE) or Alpers syndrome",ataxia,Alpers syndrome
502540519,7/11/2014 23:58:05,,1321077114,7/11/2014 23:57:48,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,35,78,,,45,92,ARRHYTHMIA,ANTIARRHYTHMIC,ARRHYTHMIA,35,78-93,ANTIARRHYTHMIC therapy,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14.,35,78,35,78,45,92,1,RO-may_prevent,907383,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14,arrhythmia,antiarrhythmic
502540519,7/12/2014 00:15:10,,1321087217,7/12/2014 00:14:55,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,35,78,,,45,92,ARRHYTHMIA,ANTIARRHYTHMIC,ARRHYTHMIA,35,78-93,ANTIARRHYTHMIC therapy,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14.,35,78,35,78,45,92,1,RO-may_prevent,907383,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14,arrhythmia,antiarrhythmic
502540519,7/12/2014 00:20:12,,1321089890,7/12/2014 00:19:40,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,35,78,,,45,92,ARRHYTHMIA,ANTIARRHYTHMIC,ARRHYTHMIA,35,78,ANTIARRHYTHMIC,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14.,35,78,35,78,45,92,1,RO-may_prevent,907383,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14,arrhythmia,antiarrhythmic
502540519,7/12/2014 00:22:13,,1321091109,7/12/2014 00:21:58,instagc,1.0,13763729,USA,"","",75.182.89.225,35,78,,,45,92,ARRHYTHMIA,ANTIARRHYTHMIC,ARRHYTHMIA,35,78,ANTIARRHYTHMIC,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14.,35,78,35,78,45,92,1,RO-may_prevent,907383,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14,arrhythmia,antiarrhythmic
502540519,7/12/2014 00:31:24,,1321095879,7/12/2014 00:31:09,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,35,78,,,45,92,ARRHYTHMIA,ANTIARRHYTHMIC,ARRHYTHMIA recurrence,35-46,78-93,ANTIARRHYTHMIC therapy,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14.,35,78,35,78,45,92,1,RO-may_prevent,907383,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14,arrhythmia,antiarrhythmic
502540519,7/12/2014 00:35:49,,1321098143,7/12/2014 00:35:25,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,35,78,,,45,92,ARRHYTHMIA,ANTIARRHYTHMIC,ARRHYTHMIA,35,78-93,ANTIARRHYTHMIC therapy,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14.,35,78,35,78,45,92,1,RO-may_prevent,907383,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14,arrhythmia,antiarrhythmic
502540519,7/12/2014 00:38:33,,1321099416,7/12/2014 00:38:18,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,35,78,,,45,92,ARRHYTHMIA,ANTIARRHYTHMIC,ARRHYTHMIA,35,78-93,ANTIARRHYTHMIC therapy,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14.,35,78,35,78,45,92,1,RO-may_prevent,907383,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14,arrhythmia,antiarrhythmic
502540519,7/12/2014 01:05:56,,1321110411,7/12/2014 01:05:46,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,35,78,,,45,92,ARRHYTHMIA,ANTIARRHYTHMIC,ARRHYTHMIA recurrence,35-46,78-93,ANTIARRHYTHMIC therapy,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14.,35,78,35,78,45,92,1,RO-may_prevent,907383,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14,arrhythmia,antiarrhythmic
502540519,7/12/2014 01:16:30,,1321114872,7/12/2014 01:16:10,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,35,78,,,45,92,ARRHYTHMIA,ANTIARRHYTHMIC,ARRHYTHMIA have required no antiarrhythmic therapy,35-61-66-75-78-93,78-93-101-107,ANTIARRHYTHMIC therapy after a,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14.,35,78,35,78,45,92,1,RO-may_prevent,907383,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14,arrhythmia,antiarrhythmic
502540519,7/12/2014 01:25:20,,1321118214,7/12/2014 01:25:01,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,35,78,,,45,92,ARRHYTHMIA,ANTIARRHYTHMIC,ARRHYTHMIA,35,78-93,ANTIARRHYTHMIC therapy,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14.,35,78,35,78,45,92,1,RO-may_prevent,907383,All patients have remained free of arrhythmia recurrence and have required no antiarrhythmic therapy after a follow-up of 5 to 28 months (mean 14,arrhythmia,antiarrhythmic
502540520,7/11/2014 23:59:01,,1321077604,7/11/2014 23:58:35,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,52,116,,,64,135,HYPERTENSION,HYPERTENSIVE CRISIS,sustained HYPERTENSION,42-52,116-129,HYPERTENSIVE CRISIS,"A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented.",52,116 129,52,116,64,135,-1,RO-disease_has_finding,901608,"A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented",hypertension,hypertensive crisis
502540520,7/12/2014 00:01:12,,1321078824,7/12/2014 00:00:58,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,52,116,,,64,135,HYPERTENSION,HYPERTENSIVE CRISIS,severe sustained HYPERTENSION,35-42-52,116-129,HYPERTENSIVE CRISIS,"A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented.",52,116 129,52,116,64,135,-1,RO-disease_has_finding,901608,"A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented",hypertension,hypertensive crisis
502540520,7/12/2014 00:01:22,,1321078909,7/12/2014 00:01:07,prodege,1.0,23541832,USA,AZ,Tempe,149.169.133.153,52,116,,,64,135,HYPERTENSION,HYPERTENSIVE CRISIS,severe sustained HYPERTENSION,35-52-42,116-129,HYPERTENSIVE CRISIS,"A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented.",52,116 129,52,116,64,135,-1,RO-disease_has_finding,901608,"A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented",hypertension,hypertensive crisis
502540520,7/12/2014 00:07:55,,1321082771,7/12/2014 00:07:31,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,52,116,,,64,135,HYPERTENSION,HYPERTENSIVE CRISIS,HYPERTENSION,52,107-116-129,frequent HYPERTENSIVE CRISIS,"A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented.",52,116 129,52,116,64,135,-1,RO-disease_has_finding,901608,"A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented",hypertension,hypertensive crisis
502540520,7/12/2014 00:19:00,,1321089306,7/12/2014 00:18:46,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,52,116,,,64,135,HYPERTENSION,HYPERTENSIVE CRISIS,severe sustained HYPERTENSION to,35-42-52-75,83-100-107-116-129,"antihypertensive drugs, frequent HYPERTENSIVE CRISIS","A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented.",52,116 129,52,116,64,135,-1,RO-disease_has_finding,901608,"A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented",hypertension,hypertensive crisis
502540520,7/12/2014 00:19:25,,1321089490,7/12/2014 00:19:13,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,52,116,,,64,135,HYPERTENSION,HYPERTENSIVE CRISIS,HYPERTENSION,52,116-129,HYPERTENSIVE CRISIS,"A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented.",52,116 129,52,116,64,135,-1,RO-disease_has_finding,901608,"A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented",hypertension,hypertensive crisis
502540520,7/12/2014 00:29:39,,1321094919,7/12/2014 00:29:22,instagc,1.0,13763729,USA,"","",75.182.89.225,52,116,,,64,135,HYPERTENSION,HYPERTENSIVE CRISIS,HYPERTENSION,52,116-129,HYPERTENSIVE CRISIS,"A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented.",52,116 129,52,116,64,135,-1,RO-disease_has_finding,901608,"A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented",hypertension,hypertensive crisis
502540520,7/12/2014 00:29:42,,1321094929,7/12/2014 00:29:17,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,52,116,,,64,135,HYPERTENSION,HYPERTENSIVE CRISIS,HYPERTENSION,52,116-129,HYPERTENSIVE CRISIS,"A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented.",52,116 129,52,116,64,135,-1,RO-disease_has_finding,901608,"A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented",hypertension,hypertensive crisis
502540520,7/12/2014 00:40:58,,1321100454,7/12/2014 00:40:33,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,52,116,,,64,135,HYPERTENSION,HYPERTENSIVE CRISIS,severe sustained HYPERTENSION,35-42-52,116-129,HYPERTENSIVE CRISIS,"A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented.",52,116 129,52,116,64,135,-1,RO-disease_has_finding,901608,"A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented",hypertension,hypertensive crisis
502540520,7/12/2014 00:42:21,,1321101173,7/12/2014 00:41:50,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,52,116,,,64,135,HYPERTENSION,HYPERTENSIVE CRISIS,severe sustained HYPERTENSION,35-42-52,116-129-136-140,HYPERTENSIVE CRISIS and symptoms,"A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented.",52,116 129,52,116,64,135,-1,RO-disease_has_finding,901608,"A case of a 43-year-old woman with severe sustained hypertension resistant to many antihypertensive drugs, frequent hypertensive crisis and symptoms suggestive of pheochromocytoma (symptomatic triad) is presented",hypertension,hypertensive crisis
502540521,7/11/2014 23:56:03,,1321076138,7/11/2014 23:55:49,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,45,100,,,69,112,BLOOD PRESSURE ELEVATION,HYPERTENSION,BLOOD PRESSURE ELEVATION,45-51-60,100,"HYPERTENSION,","There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation.",45 51 60,100,45,100,69,112,-1,RO-has_definitional_manifestation,904736,"There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation",blood pressure elevation,hypertension
502540521,7/12/2014 00:06:02,,1321081636,7/12/2014 00:05:06,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,45,100,,,69,112,BLOOD PRESSURE ELEVATION,HYPERTENSION,"BLOOD PRESSURE ELEVATION hypertension, sodium sensitive hypertension,",45-51-60-100-135-142-152,45-51-100-135-142-152-60,"blood pressure elevation HYPERTENSION, sodium sensitive hypertension,","There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation.",45 51 60,100,45,100,69,112,-1,RO-has_definitional_manifestation,904736,"There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation",blood pressure elevation,hypertension
502540521,7/12/2014 00:10:53,,1321084563,7/12/2014 00:10:33,clixsense,1.0,19803139,NLD,11,Leiden,82.139.76.131,45,100,,,69,112,BLOOD PRESSURE ELEVATION,HYPERTENSION,BLOOD PRESSURE ELEVATION,45-51-60,100,"HYPERTENSION,","There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation.",45 51 60,100,45,100,69,112,-1,RO-has_definitional_manifestation,904736,"There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation",blood pressure elevation,hypertension
502540521,7/12/2014 00:16:40,,1321087962,7/12/2014 00:16:25,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,45,100,,,69,112,BLOOD PRESSURE ELEVATION,HYPERTENSION,BLOOD PRESSURE ELEVATION,45-51-60,97-100-135-142-152,"of HYPERTENSION, sodium sensitive hypertension,","There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation.",45 51 60,100,45,100,69,112,-1,RO-has_definitional_manifestation,904736,"There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation",blood pressure elevation,hypertension
502540521,7/12/2014 00:22:03,,1321090975,7/12/2014 00:21:57,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,45,100,,,69,112,BLOOD PRESSURE ELEVATION,HYPERTENSION,ET 1 in BLOOD PRESSURE ELEVATION in some experimental,37-40-42-45-51-60-70-73-78,78-91-97-100-114-127-135,"experimental forms of HYPERTENSION, particularly severe, sodium","There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation.",45 51 60,100,45,100,69,112,-1,RO-has_definitional_manifestation,904736,"There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation",blood pressure elevation,hypertension
502540521,7/12/2014 00:25:51,,1321093076,7/12/2014 00:25:37,instagc,1.0,13763729,USA,"","",75.182.89.225,45,100,,,69,112,BLOOD PRESSURE ELEVATION,HYPERTENSION,BLOOD PRESSURE ELEVATION,45-51-60,100,"HYPERTENSION,","There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation.",45 51 60,100,45,100,69,112,-1,RO-has_definitional_manifestation,904736,"There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation",blood pressure elevation,hypertension
502540521,7/12/2014 00:31:25,,1321095887,7/12/2014 00:30:56,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,45,100,,,69,112,BLOOD PRESSURE ELEVATION,HYPERTENSION,BLOOD PRESSURE ELEVATION,45-51-60,100,"HYPERTENSION,","There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation.",45 51 60,100,45,100,69,112,-1,RO-has_definitional_manifestation,904736,"There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation",blood pressure elevation,hypertension
502540521,7/12/2014 00:35:18,,1321097859,7/12/2014 00:35:08,instagc,1.0,15445601,USA,FL,Jacksonville,24.129.68.254,45,100,,,69,112,BLOOD PRESSURE ELEVATION,HYPERTENSION,ET 1 in BLOOD PRESSURE ELEVATION,37-40-42-45-51-60,78-91-97-100,"experimental forms of HYPERTENSION,","There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation.",45 51 60,100,45,100,69,112,-1,RO-has_definitional_manifestation,904736,"There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation",blood pressure elevation,hypertension
502540521,7/12/2014 00:38:08,,1321099253,7/12/2014 00:37:52,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,45,100,,,69,112,BLOOD PRESSURE ELEVATION,HYPERTENSION,ET 1 in BLOOD PRESSURE ELEVATION,37-40-42-45-51-60,78-91-97-100,"experimental forms of HYPERTENSION,","There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation.",45 51 60,100,45,100,69,112,-1,RO-has_definitional_manifestation,904736,"There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation",blood pressure elevation,hypertension
502540521,7/12/2014 00:38:39,,1321099452,7/12/2014 00:37:58,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,45,100,,,69,112,BLOOD PRESSURE ELEVATION,HYPERTENSION,"ET 1 in BLOOD PRESSURE ELEVATION in some experimental hypertension, sodium sensitive hypertension, blood pressure elevation.",37-40-42-45-51-60-70-73-78-100-135-142-152-233-239-248,37-40-42-45-51-78-91-97-100-114-127-135-142-152-233-239-248-60,"ET 1 in blood pressure elevation experimental forms of HYPERTENSION, particularly severe, sodium sensitive hypertension, blood pressure elevation.","There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation.",45 51 60,100,45,100,69,112,-1,RO-has_definitional_manifestation,904736,"There is some evidence for a role of ET-1 in blood pressure elevation in some experimental forms of hypertension, particularly severe, sodium-sensitive hypertension, in which it may play a role in accentuating rather than initiating blood pressure elevation",blood pressure elevation,hypertension
502540522,7/11/2014 23:57:42,,1321076908,7/11/2014 23:57:31,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,78,45,,,87,54,POISONING,ANTIDOTES,OP POISONING.,75-78,45,ANTIDOTES,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning.,78,45,78,45,87,54,1,RO-may_treat,907976,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning,poisoning,antidotes
502540522,7/12/2014 00:00:36,,1321078396,7/12/2014 00:00:24,prodege,1.0,23541832,USA,AZ,Tempe,149.169.133.153,78,45,,,87,54,POISONING,ANTIDOTES,OP POISONING.,75-78,45-55-58-62-72-75-78,ANTIDOTES in the treatment of OP poisoning.,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning.,78,45,78,45,87,54,1,RO-may_treat,907976,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning,poisoning,antidotes
502540522,7/12/2014 00:00:57,,1321078601,7/12/2014 00:00:46,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,78,45,,,87,54,POISONING,ANTIDOTES,OP POISONING.,75-78,45,ANTIDOTES,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning.,78,45,78,45,87,54,1,RO-may_treat,907976,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning,poisoning,antidotes
502540522,7/12/2014 00:18:03,,1321088819,7/12/2014 00:17:39,neodev,1.0,21515166,NLD,11,Nootdorp,83.86.58.179,78,45,,,87,54,POISONING,ANTIDOTES,treatment of OP POISONING.,62-72-75-78,33-38-45-55-58-62-72-75-78,most useful ANTIDOTES in the treatment of OP poisoning.,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning.,78,45,78,45,87,54,1,RO-may_treat,907976,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning,poisoning,antidotes
502540522,7/12/2014 00:18:44,,1321089172,7/12/2014 00:18:31,neodev,1.0,15848372,AUS,02,Jannali,27.96.208.89,78,45,,,87,54,POISONING,ANTIDOTES,OP POISONING.,75-78,45,ANTIDOTES,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning.,78,45,78,45,87,54,1,RO-may_treat,907976,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning,poisoning,antidotes
502540522,7/12/2014 00:23:32,,1321091889,7/12/2014 00:23:23,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,78,45,,,87,54,POISONING,ANTIDOTES,treatment of OP POISONING.,62-72-75-78,29-33-38-45-55-58-62,the most useful ANTIDOTES in the treatment,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning.,78,45,78,45,87,54,1,RO-may_treat,907976,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning,poisoning,antidotes
502540522,7/12/2014 00:27:04,,1321093654,7/12/2014 00:26:44,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,78,45,,,87,54,POISONING,ANTIDOTES,Atropine pralidoxime antidotes treatment of OP POISONING.,0-13-62-72-75-78-45,0-13-29-33-38-45-55-58-62-75-78,Atropine pralidoxime the most useful ANTIDOTES in the treatment OP poisoning.,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning.,78,45,78,45,87,54,1,RO-may_treat,907976,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning,poisoning,antidotes
502540522,7/12/2014 00:30:18,,1321095280,7/12/2014 00:29:43,elite,1.0,27385296,GBR,U8,Edinburgh,77.102.46.226,78,45,,,87,54,POISONING,ANTIDOTES,POISONING.,78,45,ANTIDOTES,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning.,78,45,78,45,87,54,1,RO-may_treat,907976,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning,poisoning,antidotes
502540522,7/12/2014 00:42:07,,1321101053,7/12/2014 00:41:54,eup_slw,1.0,19200983,USA,WA,Renton,63.224.47.154,78,45,,,87,54,POISONING,ANTIDOTES,OP POISONING.,75-78,45,ANTIDOTES,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning.,78,45,78,45,87,54,1,RO-may_treat,907976,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning,poisoning,antidotes
502540522,7/12/2014 01:10:27,,1321112184,7/12/2014 01:10:15,extralunchmoney,1.0,21506743,USA,AL,Anniston,184.155.108.254,78,45,,,87,54,POISONING,ANTIDOTES,OP POISONING.,75-78,45,ANTIDOTES,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning.,78,45,78,45,87,54,1,RO-may_treat,907976,Atropine and pralidoxime are the most useful antidotes in the treatment of OP poisoning,poisoning,antidotes
502540523,7/11/2014 23:53:58,,1321075106,7/11/2014 23:53:48,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,69,0,,,83,9,OSTEOARTHRITIS,PIROXICAM,OSTEOARTHRITIS,69,0,PIROXICAM,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116.,69,0,69,0,83,9,1,RO-may_treat,908057,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116,osteoarthritis,piroxicam
502540523,7/12/2014 00:16:27,,1321087872,7/12/2014 00:16:14,clixsense,1.0,26889820,GBR,C3,Shelford,92.18.120.203,69,0,,,83,9,OSTEOARTHRITIS,PIROXICAM,OSTEOARTHRITIS (OA),69-84,0,PIROXICAM,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116.,69,0,69,0,83,9,1,RO-may_treat,908057,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116,osteoarthritis,piroxicam
502540523,7/12/2014 00:16:57,,1321088147,7/12/2014 00:16:49,instagc,1.0,25990856,USA,NV,Las Vegas,68.108.98.78,69,0,,,83,9,OSTEOARTHRITIS,PIROXICAM,OSTEOARTHRITIS,69,0,PIROXICAM,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116.,69,0,69,0,83,9,1,RO-may_treat,908057,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116,osteoarthritis,piroxicam
502540523,7/12/2014 00:24:41,,1321092525,7/12/2014 00:24:36,neodev,1.0,25224036,CAN,ON,Sudbury,67.204.218.187,69,0,,,83,9,OSTEOARTHRITIS,PIROXICAM,= 95) or OSTEOARTHRITIS 116.,60-62-66-69-94,0-10-13-17,PIROXICAM in 211 patients,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116.,69,0,69,0,83,9,1,RO-may_treat,908057,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116,osteoarthritis,piroxicam
502540523,7/12/2014 00:27:38,,1321093931,7/12/2014 00:27:29,instagc,1.0,13763729,USA,"","",75.182.89.225,69,0,,,83,9,OSTEOARTHRITIS,PIROXICAM,OSTEOARTHRITIS,69,0,PIROXICAM,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116.,69,0,69,0,83,9,1,RO-may_treat,908057,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116,osteoarthritis,piroxicam
502540523,7/12/2014 00:30:10,,1321095205,7/12/2014 00:29:53,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.185.45,69,0,,,83,9,OSTEOARTHRITIS,PIROXICAM,OSTEOARTHRITIS,69,0,PIROXICAM,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116.,69,0,69,0,83,9,1,RO-may_treat,908057,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116,osteoarthritis,piroxicam
502540523,7/12/2014 00:32:39,,1321096549,7/12/2014 00:32:19,quickrewards,1.0,20452113,USA,NY,Port Henry,108.176.206.207,69,0,,,83,9,OSTEOARTHRITIS,PIROXICAM,OSTEOARTHRITIS (OA),69-84,0,PIROXICAM,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116.,69,0,69,0,83,9,1,RO-may_treat,908057,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116,osteoarthritis,piroxicam
502540523,7/12/2014 00:37:10,,1321098810,7/12/2014 00:36:35,instagc,1.0,19686223,CAN,BC,Surrey,184.65.16.6,69,0,,,83,9,OSTEOARTHRITIS,PIROXICAM,piroxicam in 211 patients with rheumatoid arthritis (RA) OSTEOARTHRITIS,0-10-13-17-26-31-42-52-69,0-10-13-17-26-31-42-52-66-69,PIROXICAM in 211 patients with rheumatoid arthritis (RA) or osteoarthritis,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116.,69,0,69,0,83,9,1,RO-may_treat,908057,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116,osteoarthritis,piroxicam
502540523,7/12/2014 00:45:08,,1321102271,7/12/2014 00:44:55,bitcoinget,1.0,24792414,USA,"","",166.181.81.197,69,0,,,83,9,OSTEOARTHRITIS,PIROXICAM,OSTEOARTHRITIS,69,0,PIROXICAM,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116.,69,0,69,0,83,9,1,RO-may_treat,908057,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116,osteoarthritis,piroxicam
502540523,7/12/2014 01:11:45,,1321112772,7/12/2014 01:11:29,prodege,1.0,7664351,USA,NY,Cicero,74.111.0.21,69,0,,,83,9,OSTEOARTHRITIS,PIROXICAM,rheumatoid arthritis OSTEOARTHRITIS,31-42-69,0-26-31-42,PIROXICAM with rheumatoid arthritis,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116.,69,0,69,0,83,9,1,RO-may_treat,908057,piroxicam in 211 patients with rheumatoid arthritis (RA) (n = 95) or osteoarthritis (OA) (n = 116,osteoarthritis,piroxicam
